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Figure 1. My dad’s motorhome 
 
 
Figure 2.  In addition to the numerous peace symbols on my dad’s new car, he has chosen the license 
plate “Shanata”, the last name that Brandi and I selected: it means “peaceful”.    
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 My mom also helped me to value learning broadly.  During my 6th grade 
year, my mom, dad, and I lived in and traveled across the US (all contiguous 48 
states) in a motorhome and I was homeschooled.  My mom made a tremendous 
effort to help place my schoolwork in the context of the historical sites and natural 
wonders that we were visiting.  As a result, starting with middle school I had a 
whole new perspective, and learning has been a core value of mine since then. 
I guess it could go without saying that I will never be able to repay my 
parents for everything that they‘ve done for me over the past few decades – but I 
will say it anyway.  They provided me with a happy childhood, a loving 
environment, and the financial and emotional support to get me to college.  More 
importantly, my parents taught me, and still maintain, that I can do anything.  
That‘s exactly what parents should teach their children, and I believe it is true. 
The support and encouragement of my wife‘s family, including Dennis 
Logan, Mary Logan, and Ashli Logan, has meant a lot to me, too.  Spending time 
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with them is always a welcome escape from work, and a truly relaxing 
experience.  They have provided a caring and supportive home away from home. 
 
 The second to last person I would like to acknowledge is Mark Kendall.  
As my best friend for over a decade, in many ways no one understands me 
better than Mark does.  He has been an incredible source of emotional support 
and has dedicated countless hours to listening to me; he always makes time to 
do so. 
 Laughter may not be the best medicine, but it is close.  I‘ve spent more 
time laughing—many times literally rolling on the floor while doing so—with Mark 
than anyone else.  I suspect that that will still be true in a decade; he has a truly 
spectacular sense of humor.  Equally important, though, is that I can always 
count on him.  Mark is intense about what matters most, and deeply passionate 
about the things he values.  With these qualities Mark was an incredible friend 
through high school, college, and the first two years of graduate school.   
Then, in 2007, Mark enrolled at Caltech!  Since then he has provided me 
with distractions when that‘s what I‘ve needed, and with ample encouragement.  
He also has provided a valuable different perspective on my science.  He (and 
Brandi) are the ones who read my research proposals for my proposal exam in 
my final year of graduate school.  And, it is with Mark that I can most readily 
discuss what is and is not working in lab; my science even benefitted from his 
expertise in physics.  Last but not least, Mark has also been my computer tech 
support, including free backup storage on his server for all of the single-channel 
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data that I‘ve collected during the past 5 years (> 100 GB; though this represents 
only ~ 10% of his server‘s capacity).  
 
While the driving scientific (and financial) support for my thesis work 
comes from Dennis, I‘m a human being, and for the past decade I have received 
emotional support from the most incredible person I‘ve met—my wife, Brandi 
Shanata.  Brandi has a rare combination of intelligence, kindness, and wisdom—
especially for someone so young and beautiful.  I arrived at Cornell College in 
late August of 2001 with high expectations for the quality of education that would 
be available to me but with no expectations with respect to dating, let alone 
romance. 
 By mid October of 2001, I was spending every meal and evening with 
Brandi.  I was falling in love.  The phrase that Brandi and I started using early to 
describe our relationship was that it just felt ‗natural‘; we are a ‗perfect match‘, as 
best as we can tell.  I don‘t know how I got so lucky.  And, there are several other 
characteristics that make her an exceptional partner.  She has exceptionally clear 
thoughts and her well-formed and well-supported beliefs helped to challenge 
some of my stereotypes, especially early on in our relationship.  Brandi also 
knows how to help direct my energy to more efficient pursuits.  When I‘m feeling 
that our country—or humanity as a whole—may be a bit off-track, all I have to do 
is think of my wife.  Knowing that there are people like Brandi in this world gives 
me all the evidence I need to restore my confidence in humanity.    
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 Brandi‘s support of me over a number of years has been a key element of 
my success.  I will list just a few instances of times when Brandi‘s support has 
made all the difference in the world during graduate school.  In my first year 
Brandi sustained me through the grueling combination of TAing, selecting and 
starting in a research lab, and taking classes.  And again, in my second year, as I 
focused on acquiring and analyzing data for candidacy.  And again, through a 
few years of projects with varying levels of success and the corresponding ups 
and downs.  And again during the exceptionally busy and emotionally draining 
time as GSC Chair (May 2009-September 2010), Brandi played a particularly 
important role.  During this time, her support allowed me to continue to make 
research progress while maintaining the duties of my elected position and 
explore this passion of mine.  Perhaps it was during this time that Brandi‘s 
willingness to support my nontraditional sleep schedule was the most trying for 
her, yet she persevered to allow me to achieve my goals.  And again in October 
2010–February 2011, when I was a Visiting Lecturer at Cornell College, Brandi 
packed up a big chunk of our lives in Pasadena, moved us to Mount Vernon, 
Iowa, then brought us back home to Pasadena while I focused on teaching, 
applying for faculty positions, and going on interviews.  And now, again, as I‘m 
writing my thesis. 
 I‘ve told several GSC BoD members as they retire that I wish that we had 
been better able to recognize their efforts.  That statement is true—but infinitely 
more so—for Brandi.  I just don‘t know how to express my appreciation.  In many 
ways, I think that our success as a couple derives from our team approach.  But, 
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for the last few years, Brandi has borne the lion‘s share of our ‗team‘ work.  I look 
forward to trying to repay her all throughout our lives together.  Perhaps most of 
all, I look forward to raising a family together.   
 
Other Support: Loyola University, Music, Funding, and My 
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 In my final few months as a graduate student at Caltech, I had the 
opportunity to begin transitioning to my new role as a faculty member at Loyola 
University, New Orleans.  This process was facilitated by the Caltech Chemistry 
Ph.D. requirements of writing 3 research proposals before defending the thesis.  
As I finalized my research proposals for implementation at Loyola University, I 
had the strong support of the Loyola Chemistry Department as I completed 
budgets, selected a lab space, thought more about teaching, and selected a 
textbook to use for teaching Organic Chemistry (in conjunction with CJ 
Stephenson).   
 These details, and numerous others are just the beginning of what the 
next phase of my career holds for me—and I‘m very grateful to have the support 
of the Loyola family as I move forwards.  In my dozens of hours of conversations 
with the chemistry faculty, I have found them to be genuine and supportive.  And, 
already, Lyle Henderson, Office Manager has been a great source of information. 
 
During my time in graduate school, I have spent thousands of hours 
listening to music.  Key themes that I‘ve appreciated have included: passion, 
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peace, and social justice.  My life-long favorite musical genre is classical music 
and, before graduate school when I had time to play the piano, I most enjoyed 
playing pieces by Mozart, but I have come to appreciate other music in the past 
several years, too.  I am thankful to the hundreds of musicians who have shared 
their enjoyable, interesting, and challenging work with us. 
 The work described in the following pages was supported by the NIH (NS 
34407; NS 11756) and the California Tobacco-Related Disease Research 
Program of the University of California, grant number 16RT-0160.  I was also 
partially supported by an NRSA training grant. 
 Last but not least, the vast majority of non-lab bench work was, 
technically, performed by the computer pictured below.  I just told it what to do.  It 
listened very faithfully (usually).  I truly could not have completed my thesis 
without it as well as the single-channel rig and a variety of other equipment 
described in Chapter 2. 
 
 
Figure 3.  My computer (MacBook) for most of graduate school.  Photo credit: MacBook’s 
built in camera (with the help of a mirror) 
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Chapter 1 
 
 
 
Introduction: 
Brains, Chemistry, and Electrophysiology 
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1.1 Overview and Motivation 
Brains are important; really important.  Don’t even try to imagine your life 
without your brain, it will make your head hurt.  Yet, a comprehensive description 
of human brains is not yet at hand.  Why not?  For one, the human brain is 
immensely complex.  It contains hundreds of billions of nerve cells (neurons) 
each of which make thousands of connections (synapses) with each other.  The 
resulting network with > 1014 synapses makes it the single most complex entity 
we know of on Earth(1, 2).  Understanding the human brain may well present the 
greatest challenge science faces today. 
 Neuroscience aims to elucidate brain structure and function.  One ultimate 
goal is to explain how our experiences arise from what happens in our brains.  
Given the unique complexity of the human brain, neuroscience also has the 
potential of helping us to understand what it means to be human.  On the other 
hand, there is the possibility that humans will never be able to understand and 
completely describe what’s physically going on in our brains.  Moreover, these 
physical brain processes give rise to our everyday experiences may be even 
more complicated(3).   There are a wide range of perspectives on the 
relationship between our physical body, including brain, and our experiences.  
Learning about the physical aspects of brains will undoubtedly help us to 
understand the human experience.  
 In reality, the grants that supported the work described in this thesis don’t 
aim to understand the human brain with the goal of offering better explanations of 
the human experience.  They are, in fact, much more targeted than that.  
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Fortunately, in addition to better explanations of the human experience, 
understanding how brains function may enable advances in a wide variety of 
fields including medicine, learning and memory, and control of our bodies to 
name just a few.  Key aspects of brain function include how information is 
encoded and transmitted in brains.  This thesis will focus on the latter.   
One core type of information transfer in the brain is a signaling process 
that occurs at synapses.  Here, an electrical signal is converted to a chemical 
signal when small molecules called neurotransmitters are released.  These small 
molecules diffuse across the synaptic cleft and bind to integral membrane 
proteins called ion channels which are thereby activated.  These 
neurotransmitters act as ligands for the ion channels, and the activation process 
of ion channels is termed gating, so these types of channels are termed ligand-
gated ion channels (LGICs).  LGICs mediate rapid synaptic transmission in the 
central nervous system (CNS) and peripheral nervous system (PNS)(4).  In the 
case of the nicotinic acetylcholine receptors (nAChRs) that are the focus of this 
thesis, activation results in a conformational change that opens a central pore.  
Ions flowing through this open pore produce currents that are an electrical signal.  
Thus, at the synapse, an electrical signal is converted to a chemical signal, then 
back to an electrical signal at ion channels (Figure 1.1).     
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Figure 1.1. An artist‘s rendition of neurons, axons, synapses, and electrical and chemical 
signaling in brain cells.  The image is taken from ―Chemical Synapse‖, Wikipedia: The Free 
Encyclopedia, 
http://en.wikipedia.org/w/index.php?title=Chemical_synapse&oldid=423746201.  
 
The control of neuroreceptors such as ion channels that regulate our 
thoughts and actions is, at its core, a set of chemical questions.  As chemists, we 
seek to simplify the complexity of brains, and even individual synapses, to the 
interactions between a few molecules that we can probe systematically.  I will 
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now introduce some specific ion channels and their functional environment 
(Section 1.2) and the general method—electrophysiology—that we use to study 
their function (Sections 1.3, 1.4, and 1.5).  Then I will describe the use of 
nonsense suppression, which allows us to perform structure-function studies on 
neuroreceptors (Section 1.6), and summarize my dissertation work (Section 1.7). 
 
1.2 Cell Membranes and Ion Channels 
1.2.1 Electrophysiology of Cell Membranes 
The cell membrane is permeable to a variety of ions through membrane 
spanning proteins with pores (ion channels).  In the case of LGICs, when the 
appropriate number of agonist molecules are bound, each ion channel has a 
characteristic conductance (g).  If the current that flows through the ion channel 
varies with voltage, it is called a slope conductance.  Thus the current (I) flowing 
through the channel should vary with voltage and resistance (R) as given by 
Equation 1.1. 
  
 
 
           (Equation 1.1) 
The slope conductance can be determined by making a plot of I versus V.  In 
some cases, this plot is non-linear, a phenomena called rectification.  The 
potential at which the current through the ion channel goes to 0 is known as the 
reversal potential (Vrev), and can vary with ion concentration, as given by the 
Nernst potential.  Additionally, empirical studies using the single-channel 
recording method described below have shown that the conductance of the 
muscle-type nAChR varies with the monovalent ion in the order: K+ >  Cs+ > Na+ 
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> Li+ (5, 6) .  Often, though, measurements can only be taken at a single voltage.  
In this case, conductance is reported simply with respect to the applied pipette 
potential; this value is known as the chord conductance.   
 Early studies of LGICs focused on one of many types of synapses—those 
found at the neuromuscular junction.  These studies exploited the fact that the 
synapses here are more readily amenable to electrophysiological studies, as 
they can be impaled with multiple electrodes and be easily denervated (they are 
usually innvervated by only one presynaptic neuron).  Thus, initial studies of 
synaptic transmission were done in this region, the so-called motor end plate.  
Separately, an ionic theory of membrane excitation was developed to describe 
the propagation of action potentials, with early studies of the giant squid axon 
revealing previously unknown kinetic properties of membrane permeability(7, 8).  
Further work by Katz and Miledi(9, 10) capitalized on the noise produced by 
acetylcholine-induced potentials to estimate channel open time. 
 
1.2.2 Structure and Function of the Nicotinic Acetylcholine Receptors  
Results of experiments in muscle-type and neuronal nAChRs are reported 
in this thesis.  The nAChRs are members of the ‘Cys loop’ superfamily, which 
gets its name from a loop formed by a disulphide bond between two cysteine 
residues (Figure 1.2). As with other membrane proteins, LGICs are difficult to 
crystallize, largely due to the fact that they function simultaneously in the 
hydrophobic cell membrane and hydrophilic cytoplasm and extracellular matrix.  
Consequently, structural information about nAChRs comes from a variety of 
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indirect studies.  For example, the acetylcholine binding protein (AChBP) is a 
water soluble protein with high sequence identity (15 – 28%) with the 
extracellular domain (ECD) of the LGICs, and it has been crystallized(11).  
Additionally, a cryo-EM structure of Torpedo nAChR (4 Å)(12) gives us structural 
information about the transmembrane domain (TMD), and further structural 
studies of variously modified Cys loop receptors continue(13-15).   
 
Figure 1.2. Left: nAChR pore and surrounding 5 subunits as viewed from the extracellular 
side.  Right: The topology of the transmembrane domain α-helices, including the 
disulphide link at the top.  M2 at the far right is the channel-lining helix and position L251 
is the 9‘ position (see text).  From(11) 
 
 
The four membrane spanning sections (M1 – M4) of each of the five 
subunits are α-helices (Figure 1.2).  M2 is found to physically line the ion 
channel pore, and a common numbering system(16) for LGICs denotes 0’ as the 
residue found at the intracellular end of M2 and 20’ as the residue at the 
extracellular edge of the membrane.  The 9’ position is a universally conserved 
leucine, which impacts gating of the ion channel(17, 18).  In order for the nAChR 
to open, it must first bind two molecules of agonist at binding sites far removed 
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from the pore (~ 50 Å away, in the ECD).  These two binding sites are found at 
the α1-δ and α1-γ interfaces for fetal nAChRs with subunit composition 
(α1)2β1γδ, or at the α1-δ and α1-ε interfaces for adult nAChRs with subunit 
composition (α1)2β1εδ(5).  For the neuronal α4β2 receptor, there appear to be 
two functional stoichiometries: (α4)2(β2)3 and (α4)3(β2)2(19, 20).  We term these 
A2B3 and A3B2, respectively.  There are presumably two binding sites in each 
stoichiometry, located at the α4-β2 interfaces.  This coupling of the sequential, 
bimolecular binding of small molecules (agonist) to the conformation (open or 
closed) of the channel is referred to as allostery.  In order to understand what 
happens during this allosteric transition, information beyond the static snapshots 
that structural studies provide is needed.   
 
1.3 Expression of Functional Ion Channels in Xenopus Laevis 
Oocytes 
 In order to study the function of ion channels, they need to be present in 
the cell membrane.  For the experiments described in this thesis, all channels 
were characterized by whole-cell (Section 1.4) and/or single-molecule (Section 
1.5) electrophysiology.   Electrophysiology is a functional assay of ion 
channels.  In one mode of electrophysiological recording, two electrodes are 
inserted into a cell.  One electrode monitors the potential (voltage) relative to 
ground, while the other passes current in order to maintain the cell’s membrane 
potential at a user-determined potential (voltage clamp).  This technique is 
referred to as two-electrode voltage clamp (TEVC).  Our lab has emphasized 
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TEVC, as well as Western blots and more recently microscopy(21), to make 
determinations about ion channel function and expression.  On the other hand, 
single-channel recording, as the name implies, is a single-molecule technique.  It 
provides the direct observation of the basic operational properties—opening and 
closing (gating)—of ion channels, one at a time.   
In the experiments described here, both whole-cell and single-channel 
experiments were achieved by heterologous expression of LGICs in stage V or 
VI Xenopus laevis (X. laevis) oocytes.  For expression of wild type receptors and 
conventional mutants, the RNA injected into oocytes is the mRNA for each 
subunit of the desired receptor.  For expression of LGICs with site-specific 
incorporation of unnatural amino acids, mRNA with a stop codon (UAG) is co-
injected with tRNA that has been ligated to the desired unnatural amino acid (see 
Section 1.6 for details).  The development and implementation of these oocyte 
expression methods, as they pertain to optimizing recording by both single-
channel and whole-cell methods, is covered in detail in Chapter 2.   
 The X. laevis oocyte is a particularly convenient heterologous expression 
system because the cells are large.  They are ~ 1 mm in diameter for the stage 
V/VI oocytes that we use.  RNA can be injected directly into them under a 
microscope(22).  The cell is then incubated for hours to days, depending on the 
LGIC and the specific experiment (see Figure 1.3 for description).  One 
important set of controls is monitoring channels that occur natively in oocytes(23, 
24).  Details of the procedures I developed for appropriate single-channel control 
experiments for these endogenous channels are described in Chapter 2.  
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However, for both single-channel and whole-cell experiments, it is important that 
the outermost layer of the oocyte—follicular cells—be removed before 
electrophysiology is performed, and preferably before the oocyte is injected with 
RNA.  The follicular cells themselves have channels that can interfere with 
accurate electrophysiological characterization.   
 
 
Figure 1.3.  Schematic showing details of incorporation of RNA (black squiggly line) into 
the X. laevis oocyte and subsequent protein synthesis, followed by appropriate assembly 
of the ion channel and insertion into the oocyte‘s membrane.  At right, the ion channel is 
then monitored in an electrically isolated cell-attached patch in a single-molecule 
experiment.  In our experiments, the glass needle used to inject the RNA into the oocyte is 
significantly larger than the pipette used to record single-channel activity.  Adapted 
from(25) 
 
1.4 Whole-Cell Recording of LGICs 
 Once expressed in X. laevis oocytes, LGICs can be recorded en masse by 
TEVC (Figure 1.4).  For nAChRs, typically 100,000–10,000,000 channels are 
expressed on an oocyte.  It is the sum of the current flowing through all of these 
channels that is measured in TEVC.  The relationship between the channels of 
receptors expressed and the measured whole-cell current is based on the single-
channel conductance (g) and is explored in more detail in Chapter 2.  Chapter 3 
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describes how variations in expression—measured by changes in maximal 
current, Imax—can be used to learn about channel gating and allosteric 
transitions.   
 
 
Figure 1.4. Left: TEVC on a X. laevis oocyte.  The oocyte is impaled with two separate 
electrodes, defined in the figure.  The scale bar represents ~ 1/10
th
 of a typical stage V or 
VI oocyte‘s diameter (100 µm).  Right: Sample traces from a TEVC experiment showing the 
current that must be injected into an oocyte in order to keep the oocyte at the preset 
potential (voltage clamp).  In this case 10s to 100s of nA are required when doses of 2.5 to 
25 µM are applied; the agonist is ACh.  The large downward deflections represent the 
openings of hundreds of thousands of ion channels.  Agonist is typically applied for 10 – 
20 seconds, though longer drug applications may be required for low concentrations (nM), 
when binding can be the rate-limiting activation step. 
  
The basic design of these experiments is to apply increasing 
concentrations of agonist (Figure 1.4, Right) until further increases to agonist 
concentration do not elicit further increases in the whole-cell current.  The dose-
response relation then is plotted and fitted to the Hill equation, Equation 1.2 
(Figure 1.5). 
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I is the current elicited at any given dose of agonist (A) and nH is the Hill 
coefficient.   
 
Figure 1.5. Examples of dose-response curves in which the normalized current response 
(I/Imax) is plotted against the concentration of agonist applied.  In each case, the 
concentration needed to reach the half-maximal response, EC50, is denoted with a dotted 
line.  The black dose-response curve represents a wild type (WT) ion channel.  The green 
dose-response curve represents a perturbation (typically a mutation or change in agonist) 
that caused less agonist to be needed to activate the channel.  More commonly, a 
perturbation produces a loss of function, represented by the dark pink dose-response 
curve, and corresponding increase in EC50.  Fitting the dose-response curve to the Hill 
equation also produces nH, which increases with increasing steepness of the dose-
response curve.  Since, in each case, responses are normalized, the dose-response curve 
doesn‘t give information about the number of receptors expressed on the oocyte.  That 
information is in the parameter Imax.   
 
 
1.5 Single-Channel Recording of LGICs 
1.5.1 A Brief History of Single-Channel Recording 
In 1976, Erwin Neher and Bert Sakmann published the first ever direct 
observation of current fluctuations on the order of a few picoamperes (pA) 
through denervated frog muscle fibers (Figure 1.6)(26). 
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Figure 1.6. This is the first published single-channel trace, from(27).  The recording, in frog 
muscle fiber, was obtained at a temperature of 8° C.  The membrane potential was -120 mV 
and the trace is displayed at a cut-off frequency of 200 Hz.  The white scale bars indicate 
that the trace is ~ 1 second long and that the current fluctuations are a few pA.   
 
In these experiments, highly polished glass electrodes with inner tip diameters of 
3 – 5 µm and containing Ringer’s solution with 0.2 µM suberyldicholine added 
were gently pressed against denervated frog muscle fiber within 200 µm of two 
other electrodes, which were operated in TEVC mode in order to clamp the 
membrane potential.  In doing so, Neher and Sakmann showed for the first time 
that the currents, which had been routinely observed during electrophysiology 
(i.e., on the motor endplate) were in fact comprised of unitary currents 
attributable to single ion channels.  Unfortunately, the specific electrical 
characteristics (both current amplitude and event duration) that could be 
determined from such a recording configuration were limited by the background 
noise present.  The technique became much more useful after a set of revisions 
to the method was published in 1980.  This updated technique facilitated higher 
resistance connections between the recording electrode and cell, commonly 
called gigaseals(28).  In 1981, Hamill et al.(29) outlined a set of procedures for 
obtaining high resistance seals on the order of 109 to 1011 ohms (1 – 100 gigaΩ) 
that made the technique feasible.   
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 In 1980, Hamill and Sakmann(30) also demonstrated the effect of 
membrane potential on single-channel current.  Note that the potentials for Vmemb 
and Vpipette have opposite signs (i.e., Vpipette = -Vmemb = Vout - Vin).  By convention 
in electrophysiology, currents flowing into the cell are shown as downward 
deflections.  Figure 1.7 demonstrates that the current observed increases with 
increasing polarization (more negative Vmemb).  Each ion channel is thought to 
have a characteristic conductance.  These observations were just the first of 
many as this technique, termed single-channel recording, rapidly advanced the 
characterization of ion channels in various cell preparations, as well as those 
reconstituted in liposomes and planar lipid bilayers(31, 32).  At present, the 
technique of single-channel recording is in use in hundreds of labs worldwide.   
 
 
Figure 1.7. The current through nAChR channels depends on the membrane (left) and 
pipette (right) potentials.  The current can flow either into or out of the cell or membrane 
patch, depending on the potential.  As with whole-cell data, the convention is to show 
inward currents as downward deflections.  Traces are from(33). 
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1.5.2 Single-Channel Recording and Ion Channel Kinetics 
A significant advantage over other electrophysiology measurements, such 
as TEVC to measure EC50, is the more specific models that can be developed 
from single-channel data.   EC50 is a composite of the rate at which the agonist 
associates with the receptor (binding) and as well as that agonists’ ability to 
induce the conformational change that results in current flow through the ion 
channel (gating).  For the nAChR and assuming two equivalent binding sites, we 
can write a mechanism for the interrelation of various kinetically, and presumably 
physically, distinct configurations of the receptor.  This is summarized in Model 
1.1. 
 (Model 1.1) 
Here Rc is a closed receptor and Ro is open.  As with the Hill equation for whole-
cell data, the EC50 is also related to these single-channel parameters by 
Equation 1.3(34).    

EC50 
KD
 2 1
    (Equation 1.3) 
This expression directly relates the macroscopic property of EC50 to microscopic 
rate constants since: 

KD 
k1
k1
 and, 

 


 . 
A derivation for Equation 1.3 is provided in Appendix A.  For large values of  
(>> 1), EC50 can be approximated by(35):  
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√
 . 
If the binding equilibrium is saturated, then the maximal probability that a channel 
is open (Popen,max) depends only on the gating parameters, as is shown in 
Equation 1.4. 
         
 
   
   (Equation 1.4) 
 
Single-channel data enable the detailed kinetics of binding and gating 
shown in Model 1.1 to be determined, and as such have been an influential 
technique in the formulation of models of nAChR activation and gating (36-52).  
As Equation 1.3 shows, single-channel kinetics can also be related to whole-cell 
measurements.  Significant further discussion of performing single-channel and 
whole-cell recording separately and jointly can be found in Chapter 2.  Significant 
further discussion of the theory and practice of single-channel data analysis can 
be found in Appendix B.  Specific types of analysis used are summarized in the 
relevant chapters.  
 
1.6 Unnatural Amino Acids and the Cation-π Interaction 
In order to obtain a more detailed understanding of LGICs, a common 
technique is to mutate one or more amino acids by site-directed mutagenesis.  
This technique allows for any amino acid to be converted to one of the other 19 
naturally occurring amino acids.  In most cases, these mutations produce 
significant steric and/or electronic perturbations.  As chemists, we are interested 
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in atomic-level control of LGICs.  We achieve this with a technique called 
nonsense suppression, which allows for the incorporation of a nearly limitless 
variety of unnatural amino acids.  The combination of structural changes followed 
by functional studies allows for physical organic chemistry to be performed on the 
signaling molecules that govern our thoughts and actions(53, 54).   
 
1.6.1 Incorporation of Unnatural Amino Acids 
We heterologously express ion channels of interest in X. laevis oocytes as 
described in Section 1.3(22).  Unnatural amino acids are incorporated by 
engineering the amber stop codon (nonsense suppression) in the mRNA and a 
correspondingly modified anticodon of a tRNA.  This suppressor tRNA is then 
chemically aminoacylated with the unnatural amino acid to be incorporated(55-
58).  The mRNA and tRNA are then injected into oocytes.  The technique is 
shown in Figure 1.8 and further details are described in the caption.  This 
methodology has been used to incorporate a wide range of unnatural amino 
acids and α–hydroxyacids into various ion channels (Figure 1.9)(55, 59).  Once 
successfully incorporated, protein function is studied using single-channel and 
whole-cell electrophysiology.   
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Figure 1.8. An overview of the 4-step technique for expressing ion channels with unnatural 
amino acids in X. laevis oocytes.  1) In vitro transcription is used to produce mRNA with 
the UAG stop codon at the site where the unnatural amino acid will be introduced.  2) 
Separately, suppressor tRNA is made, coupled to dCA, and chemically appended (ligated) 
to the unnatural amino acid (represented by a red asterisk, *).  This unnatural amino acid 
will be introduced site-specificlly at the UAG codon location.  3) Several ng each of the 
mRNA and tRNA are co-injected into X. laevis oocytes.  4) The oocyte is then incubated for 
several hours to several days, depending on the experiment.  During this time, the oocyte 
translates the injected mRNA into ion channels and uses the injected suppressor tRNA 
with an anticodon which recognizes the UAG stop codon.  The result is site-specific 
incorporation of the unnatural amino acid in each ion channel.  The oocyte then folds and 
assembles these mutated ion channel subunits and transports them to the cell surface, 
where they form functional ion channels.  See Chapter 2 for detailed discussion of 
methods and subsequent electrophysiology that I‘ve used to characterize these ion 
channels. 
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Figure 1.9. This figure shows many of the unnatural amino acid side chains that have been 
incorporated by nonsense suppression in the Dougherty group.  The fluorinated indoles 
(tryptophan side chains) are the ones that are predominantly used in this thesis.  They are 
in the upper right-hand corner. 
 
 
1.6.2 The Cation-π Interaction 
The electron density in the π system of aromatic rings interacts favorably 
with a positive charge.  The resulting stabilizing interaction is termed a cation-π 
interaction (Figure 1.10)(60).  The strength of the cation-π interaction can be 
modulated by altering the electron density in the aromatic ring.  Fluorinated 
tryptophans are unnatural amino acids that provide a particularly subtle 
systematic perturbation series.  Hydrogen and fluorine are relatively similar in 
size: the C—F bond is not that much longer than the C—H bond.   
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Figure 1.10. Left: A representation of the cation-π interaction—an interaction of a positive 
charge with the electron density of a π system in an aromatic ring.  Right: The side chains 
of the three aromatic amino acids: Phe, Tyr, and Trp.  Below each is the corresponding 
electrostatic potential surface.  In these plots, ‗warmer colors‘ (red and orange) represent 
regions of higher electron density, as measured by interaction with a probe positive 
charge (sodium ion).  ‗Colder colors‘ (blue) represent relatively positively charged regions.  
The cation-π binding abilities are given below (units: kcal mol
-1
).  Phe and Tyr have similar 
values, but the indole side chain of tryptophan has a significantly higher cation-π binding 
energy. 
 
On the other hand, the C—F bond is significantly more polar than the C—H 
bond, and so swapping out a single H with F on tryptophan changes the cation-π 
binding ability significantly.  The effect is cumulative, with each successive 
fluorine that is added to an aromatic ring further decreasing the electron density 
in the π system available to participate in the cation-π interaction (Figure 1.11). 
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Figure 1.11. Top: from left to right, the chemical structures of indole, monofluoro-, 
difluoro-, trifluoro-, and tetrafluoro-indole.  Middle: the calculated electrostatic potential 
surfaces for the same molecules in the same orientations.  The color scheme has the 
same meaning as in the previous figure.  Bottom: corresponding cation-π binding 
energies, in kcal mol
-1
, for each molecule   
 
At the binding site of Cys-loop receptors, an aromatic binding box is conserved, 
and for convenience the 5 residues that comprise it are often referred to based 
on their loops: TryA, TrpB, TyrC1, TryC2, and TrpD (Figure 1.12). 
 
 
Figure 1.12. The binding site of AChBP, which is thought to resemble that of nAChRs.  
Loops A–D are the four principal elements that directly define the binding site.  TrpB, 
which is the focus of studies in Chapters 3 and 5 is highlighted.  Loop C contributes two 
aromatic residues (TyrC1 and Tyr C2).  The other loops each contribute one (TyrA, TrpB, 
and TrpD).  This image is of pdb file 1I9B(11).   
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1.6.3 A Cation-π Interaction at TrpB 
The cation-π interaction is of interest in LGIC function and has wide-
ranging biological significance(60-63), including stabilization of protein secondary 
structure.  One study showed that 25% of all tryptophans in the Protein Data 
Bank (pdb) participated in a cation-π interaction(64).  In the context of the binding 
site of the muscle-type nicotinic acetylcholine receptor (nAChR), a significant 
cation-π interaction at TrpB (α1W149) was identified by our group over a dozen 
years ago (Figure 1.13)(65) using the combined techniques of unnatural amino 
acid mutagenesis and whole-cell electrophysiology.   
 
 
Figure 1.13. A ‗fluorination plot‘ at α1TrpB in the fetal, muscle-type nAChR with the agonist 
ACh.  This graph shows the relationship between the ratio of EC50s for a receptor with 
monofluoro-, difluoro-, trifluoro-, and tetrafluoro-TrpB.  Incorporated by nonsense 
suppression.  From(65) 
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The evidence for the interaction between ACh and TrpB is the strong 
correlation between nAChR channel function and the decreasing cation-π 
binding ability of a series of increasingly fluorinated tryptophans (Figure 1.13).  
Such a systematic relationship was not found at any of the other four amino acids 
of the aromatic binding box.  The functional measure used in these experiments 
was based on whole-cell electrophysiology (Section 1.5).  The value measured, 
EC50, is the concentration of agonist (A) required to elicit half-maximal current 
response.  Because of the position of the residue (TrpB), which is not only far 
away from the channel gate, but specifically is in the aromatic binding box 
(Figure 1.12), the ‘fluorination plot’ (Figure 1.13) strongly suggests that ACh 
makes a cation-π interaction to TrpB.  However, EC50 is an equilibrium 
measurement that depends on both binding and gating (Equation 1.3).  
Therefore, the increase in EC50 that occurs with increasing fluorination could not 
be definitively ascribed to either a decrease in agonist binding or a decrease in 
channel gating.   
 
1.7 Dissertation Work  
My dissertation aimed to provide even more convincing evidence for 
cation-π interactions by using single-channel recording on ion channels 
expressing unnatural amino acids.  The first step was to build an 
electrophysiology rig to perform single-channel recording, and to develop 
techniques to combine single-channel and whole-cell recording with nonsense 
suppression.  These methods are detailed in Chapter 2. 
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 Having established the feasibility of the combined use of single-channel 
and whole-cell recording, in Chapter 3 we developed a method to identify the 
functional interactions of amino acids that are physically far apart in a protein.  
This is fundamentally a whole-cell recording method to find allosteric interactions 
in ion channels.  The significance of this method is strongly supported by single-
channel measurements.  Additionally, the relationship between the single-
channel gating equilibrium constant, , and the whole-cell measurement of EC50 
is considered. 
 In Chapter 4, I describe my progress towards measuring the channel 
opening rate of the fetal and adult muscle-type receptors.  Multiple different 
agonists are used, including acetylcholine, choline, and tetramethylammonium 
(TMA).  Single-channel data are reported for the wild-type receptors as well as 
for receptors with the unnatural amino acid 5-F-Trp (monofluoro-Trp).  Data are 
reported for multiple concentrations for a mutated fetal nAChR, and QuB is used 
to fit various possible models and estimate a gating equilibrium constant, , for 
this mutant. 
 Chapter 5 describes the combined application of single-channel, whole-
cell, and unnatural amino acid mutagenesis to the specific question of how two 
molecules—nicotine and Chantix® (varenicline)—bind to the α4β2 brain receptor. 
 In Chapter 6, I describe single-channel experiments that establish a 
method for distinguishing between the two known stoichiometries of the wild type 
α4β2 receptor.    
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A note on nomenclature.  In some of the chapters of this thesis, the 
muscle-type α1 receptor is referred to simply as α.  This is based on the how the 
relevant manuscript was published and need for clarification.  When not 
specified, the muscle-type nAChR refers to the fetal receptor: (α1)2β1γδ.  In all 
cases, α4 is specified as such.  In many instances, such as throughout Chapter 
5, the receptors being studied are the α4β2 containing an L9’A mutation in the α4 
subunit.  In these cases, ‘wild type’ refers to the receptor with this pore domain 
mutation.  On the other hand, in Chapter 6, the α4β2 is the actual wild type (rat) 
receptor, with no mutation in the pore domain. 
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Chapter 2 
 
 
Methods for Combined Single-Channel  
and Whole-Cell Recording of Ion Channels  
Expressing Unnatural Amino Acids 
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2.1 Introduction 
Data from whole-cell electrophysiology can be used to compare the 
relative potencies of a series of agonists on a given ligand-gated ion channel 
(LGIC), or of a single agonist across multiple different mutated receptors.  
Frequently, the later process is accomplished by introducing a variety of 
conventional mutations at the site of interest(1) to determine how that 
perturbation impacts receptor function.  Such functional changes can be 
measured by changes in agonist potency given in the functional metric EC50, the 
effective concentration of agonist required for half-maximal response.  In order to 
determine the relationship between amino acid side chain structure and receptor 
function with enhanced control, unnatural amino acids can be introduced in 
receptors to provide systematic, subtle perturbations of receptors’ structural and 
electronic properties(2).  Such studies can also help determine whether specific 
interactions between receptor and agonist(3, 4) or between side chains primarily 
impact the binding of agonist to the receptor or gating(5-11).  Gating is the 
process by which a channel converts from a closed to an open conformation.  A 
combination of whole-cell electrophysiology and nonsense suppression to 
introduce unnatural amino acids has been common in the Dougherty group for 
over a dozen years(12-17).  This thesis describes a new methodology that 
combines the use of single-channel recording with semi-automated whole-cell 
recording in order to employ these methods synergistically and efficiently.  This 
set of techniques was further developed to combine these two types of 
electrophysiology in combination with nonsense suppression.  The techniques 
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described in this chapter, and applied throughout much of this thesis, make use 
of the rapid data collection that semi-automated whole-cell recording via the 
OpusXpress 6000A enables.  At the same time, the techniques I develop here 
make use of the detailed kinetic information that is available from single-molecule 
experiments on ion channels.  Whole-cell data can often demonstrate a 
compelling correlation in structure-function studies.  However, on its own, whole-
cell data offers an incomplete description of some key phenomena of ion 
channels because these equilibrium measurements cannot be used to 
unambiguously discriminate between binding and gating effects(6, 18).   
In short, the method considered here involves screening mutants and 
conditions (concentration, agonist, etc.) with whole-cell recording, then 
performing single-channel recording on the most interesting mutants and 
conditions.  This allows for characterization of changes in single-channel kinetics 
that correspond to changes seen in whole-cell data.  This chapter describes the 
development of this efficient methodology, outlines types of studies where it has 
been particularly useful, and describes ways in which it expands the capabilities 
of the nonsense suppression methodology.   
The receptors that were used in the studies described in this chapter are 
nicotinic acetylcholine receptors (nAChRs).  The neuronal and muscle types 
introduced in Chapter 1 are both used, including rat 42 receptors with and 
without L9’A in the 2 subunit and the mouse muscle nAChR.  Of the muscle 
nAChRs, the fetal version is comprised of 21, 1, , and , while the adult 
version is comprised of 21, 1, ε, and  subunits.  L9’S mutations were also 
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used in the muscle nAChRs, in both the β1 and δ subunits(14, 19, 20).  Most 
single-channel studies described in this chapter were performed in the presence 
of agonist in the cell-attached configuration.  However, other patch 
configurations(21, 22), and some agonist-free recordings will be reported here 
and elsewhere in this thesis. 
 
2.2 Results 
In order to efficiently combine whole-cell and single-channel recording of 
nAChRs, the first step was to construct an electrophysiology rig capable of 
regularly obtaining seals with resistances of 20-100 gΩ and RMS noise of < 0.5 
pA.  Here I will briefly summarize the capabilities of the final rig, on occasion 
illustrating them with traces and data; more data will be presented in the 
remainder of the thesis chapters which applied the methods developed and 
described in this chapter.  Details of the specific components and further 
description are provided in Materials and Methods.   
 
2.2.1 Electrophysiology Rig Components 
CV-5 100GU headstage (chosen for low noise—0.15 pA RMS with a 4-
pole Bessel filter at 5 kHz bandwidth in optimal conditions) 
GeneClamp 500B 
Avens filter 
Hum Bug noise eliminator 
Tektronix TDS 210 oscilloscope 
1320A Digidata 
Gateway computer (Windows XP) with Clampex 9.2 for recording 
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Data sampler (Axon Instruments Digidata 1320A) 
Vibration isolation workstation (Newport) 
Faraday cage (Newport) 
Lamp (Warner Instrument Corp., Sun-1) 
Dissecting microscope (Leica, GZ4) 
Fine manipulator with axial drive (Narishige Scientific Instrument Lab, 
MMO-203) 
Manipulator (custom; x, y, and z range of several cm each) 
Recording chamber (custom, volume ~ 2 ml; flow rate ~ 0.5–2 ml/min) 
Recording software: Clampex 9.2 
 
The components were arranged and connected as is described in Figure 
2.1 and the accompanying caption; see Materials and Methods for further 
description. 
 
35 
 
 
Figure 2.1. A schematic (upper, previous page) and pictorial (lower, A–C) overview of the 
electrophysiology rig (see Materials and Methods for details).  A) (from bottom) computer 
with Clampex 9.2, GeneClamp 500B, Avens filter, Hum bug, and oscilloscope (TDS 210), all 
mounted in a rack.  The Digidata 1320A is on top of the blue rack.  B) Inside the Faraday 
cage: course manipulator, headstage, recording platform with recording chamber, 
dissecting microscope, and fine manipulator (at left, unpictured).  The black line between 
A and B shows how the electrical signal is carried from the headstage out the top of the 
Faraday cage, then to the amplifier (GeneClamp 500B).  C) Recording chamber with nylon 
mesh in the bottom, bath electrode (brown), recording pipette (clear), white perfusion 
system at top, and bent aspiration tube leading to tubing at bottom left 
 
2.2.2 Overview of Experiments and Results  
Using this rig in combination with the OpusXpress, single-channel and 
whole-cell data were obtained for several different agonists and partial agonists 
of nAChRs including: acetylcholine (ACh), choline (Ch), tetramethylammonium 
(TMA), epibatidine (Epi), nicotine (Nic), and varenicline (Var).  Typical single-
channel recordings had RMS noise of 0.3–0.4 pA and gave seals with 
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resistances between 10 and 50 gΩ.  RMS noise as low as ~ 0.24 pA and a few 
seals with resistances of over 300 gΩ were obtained.  Although several seals 
that lasted > 1 hour were obtained, and 10 minute seals were common, other 
gigaseals lasted less than a few minutes.  As a whole, patch duration varied 
widely, though at the extremes, no seals could be formed on some oocytes, while 
others gave several successive high resistance seals (> 30 gΩ).  There was no 
systematic relationship between these oocytes; not even necessarily by donor 
frog.   
All of the single-channel traces displayed in this thesis are in the ‘connect-
the-dot’ trace form.  In these traces, the discrete sampled data points—20,000 to 
100,000 per second (usually 50 kHz)—are not shown, but rather a continuous 
trace which represents the individually sampled data points is shown.  Figure 2.2 
shows several examples of single-channel traces of various receptors with 
various agonists. 
Specific examples of single-channel phenomena will be shown in the 
relevant chapters.  These include: channel block (Chapter 4), desensitization 
(Chapters 3 and 4), partial agonism (Chapter 4), single-channel rectification 
behavior (Chapter 6), and patches obtained > 10 days post-injection (Chapter 6).  
Various methods and uses of characterizing the probability of a channel being 
open, Popen, will be presented throughout this thesis.  A wide range of analyses of 
single-channel data can be performed.  Examples of some of these analyses are 
given in Figures 2.3 and 2.4 and the accompanying captions. 
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Figure 2.2. Examples of data collected using the electrophysiology rig shown in Figure 2.1.  
All data were collected in the cell-attached configuration, are filtered at 4 or 5 kHz 
(Gaussian) for display, and openings are shown as downward deflections.  Recordings 
were made at pipette potentials of +50 to +70 mV.  A) Wild type muscle (α12β1γδ) nAChR 
with 50 µM ACh (approximately EC50) in the pipette.  B) α12β1L9‘Sγδ nAChR at 1.2 µM 
ACh (approximately EC50).  C) (α1W149F1W)2β1L9‘SγδL9‘S with 2.0 mM Ch in the pipette.  
D) All points histogram corresponding to the 2 seconds of data shown in C.  The open-
channel current is ~ 4.6 pA, which at the pipette potential (+70 mV) corresponds to a 
single-channel conductance of ~ 66 pS.  E) An occasional type of channel activity seen in 
these recordings.  This type of activity was most common after significantly changing the 
pipette potential (see discussion).  It is clearly qualitatively different from nAChR activity.  
F) An all points histogram of the data shown in E can be used to further verify that this 
channel activity does not exhibit the discrete openings and closings typical of nAChRs. 
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Figure 2.3. Upper) The relationship between open channel current and the open dwell time 
of single-channel events.  If events of different open dwell time were of systematically 
different current, then the events may not be long enough to reach full conductance.   A 
plot like this is used to identify whether the open dwell times are long enough to be 
properly resolved.  The increased variability in the shorter events is expected since they 
represent only a few sampled data points each.  Lower) This open dwell current histogram, 
which corresponds to the data in the upper graph, shows that all of the openings of this 
channel can be fit by a single Gaussian distribution centered at ~ 2 pA.  This channel 
therefore does not have multiple conductances. 
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Figure 2.4. An open dwell time stability plot(23).  Here, the average open dwell times of 50 
consecutive events are represented as a single data point.  Each subsequent data point 
then averages the open dwell time by moving over 25 events; for example, the first data 
point represents events 1–50, while the second data points represents events 26–76.  
Although the open dwell times do show some spread, this variation is over a fairly narrow 
range close to the mean of 0.58 ms.  The fact that the best fit line has zero slope indicates 
that the open dwell times are stable over the course of the 298 seconds that this data 
represents. 
 
 Figure 2.5 is a set of single-channel recordings from a single pipette that 
represent some of the range of capabilities of these combined techniques and 
several types of data.  First, data is obtained in the usual cell-attached 
configuration (Figure 2.5A).  Figure 2.5B then shows all of the data for the 
formation of the outside-out configuration (see figure caption) and Figure 2.5C 
and D show channel activity that is induced when agonist (in this case, 
varenicline) is added to the bath solution.  Additionally, the oocyte that was used 
to generate the cell-attached and outside-out patches shown in Figure 2.5 was 
previously recorded on the OpusXpress to verify expression level in this specific 
oocyte.   
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Figure 2.5. Single-channel traces from a single pipette in both the cell-attached (A) and 
outside-out (B–D) configurations for a 20:1 mRNA injection ratio of α4L9‘A:β2 in the 
presence of varenicline.  All data were filtered at 2 kHz for display.  The oocyte used to 
collect these data was previously evaluated on the OpusXpress (whole-cell recording) to 
verify expression.  A) Long-lived clusters of the channel are elicited by 9 nM varenicline in 
the pipette (this is approximately 10 times the macroscopic EC50 for this receptor); inward 
current is shown as downward deflections.  B) A long trace showing the conversion of the 
cell-attached patch (first 10 seconds) to whole-cell mode with the application of significant 
suction to rupture the membrane.  The pipette was then withdrawn from the oocyte and, 
over the course of ~ 10 seconds, a gigaseal forms, now in the outside-out configuration.   
The spikes that occur after this are an applied seal test to check the patch resistance.  
Shortly after that, the large baseline shift corresponds to the application of pipette 
potential (-60 mV).  Some channel activations are seen here, despite the fact that no 
agonist has been applied directly in the bath.  This is probably due to varenicline that 
leaked from the pipette prior to patch formation and during recording.  C) Patch disruption 
and subsequent channel activity was then elicited by switching to a pipette potential of 
+60 mV and adding 30 µl of 120 nM varenicline to the bath.  With an approximate chamber 
volume of 300 µl, this should produce roughly the same varenicline concentration that was 
in the pipette.  D) A 22 second expansion of some of the channel activity in the outside-out 
configuration.  It is qualitatively similar to the channel activity from the cell-attached patch 
in trace A.  In C and D, the patch configuration is inverted, so channel openings at these 
pipette potentials are seen as upward deflections.  
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The whole-cell current for this oocyte at 0.5 μM ACh was > 10 μA.  To my 
knowledge, this is the first time that such an experiment has been reported; the 
techniques that led to successfully performing both whole-cell and single-channel 
recording on the same oocyte are described later in this chapter. 
 
2.2.3 Relationships Between Single-Channel and Whole-Cell Data 
There are a number of ways in which the relationship between single-
channel and whole-cell data can be illustrated(24, 25).  In a sense, the 
relationship is very simple: whole-cell data represents the sum of thousands of 
active channels (in a typical mammalian cell) up to tens of millions of active 
channels (for some channels expressed in Xenopus laevis oocytes); see 
‘Number of Receptors for Whole-Cell and Single-Channel Recording’ in the 
Discussion section for more details. 
One useful experiment that highlights this relationship is the measurement 
of an oocyte’s membrane potentials on the OpusXpress (Table 2.1) and a 
corresponding current-voltage (I-V) relationship experiment at the single-channel 
level (Figure 2.6).  The reversal potential for a given ion is the cell membrane 
potential at which, when a channel is open, no net flow of that ion occurs in either 
direction.  Ideally, the single-channel recording solutions that are used should 
have a reversal potential of ~ 0 mV for devitellinized oocytes.  That allows the 
membrane potential of the cell-attached patch to be estimated as being equal in 
magnitude and opposite in sign to the applied pipette potential.   
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              Membrane potential (mV) 
Frog Pipette Solution Ca
2+
-free ND96 Bath Solution 
45286AZE27 -4 -12 2 
45286AZE27 -9 -15 -2 
45286AZE27 2 -5 8 
45286AZE27 -6 -11 3 
45286AZE27 -5 -8 2 
45286AZE27 -11 -10 0 
4Z56367B50 -6 -8 3 
4Z56367B50 -13 -22 2 
4Z56367B50 -4 -13 1 
4Z56367B50 -5 -11 0 
4Z56367B50 -8 -20 -4 
  
  
  
Averages -6 -12 1 
 
Table 2.1. Membrane potentials measured for devitellinized oocytes from two different 
donor frogs on the OpusXpress in three different solutions.  The pipette solution is the 
one used in the pipettes for single-channel recording.  Ca
2+
-free ND96 is the usual buffer 
used during whole-cell experiments reported in this thesis.  The bath solution is the 
solution that is used to fill the recording chamber during single-channel experiments.  
Thus, the observed average reversal potential for the oocytes in single-channel 
experiments in this bath solution is ~ 0 mV.  The standard deviations in the solutions are 4 
mV, 5 mV, and 3 mV, respectively.  Therefore, in a typical single-channel experiment at an 
applied pipette potential of +60 mV, we expect the single-channel conductance to be ±5 –
10% based on oocyte-to-oocyte variation. 
 
Figure 2.6. Graph of the relationship between current (I) and pipette potential (mV) for a 
single (α1)2β1L9‘SγD174NδD180N channel in a cell-attached patch at its macroscopic EC50 
value (160 µM ACh).  The relationship is nonlinear—this channel passes current more 
readily inward (positive pipette potentials) than it does outward (negative pipette 
potentials).  The least reliable values are at the pipette potentials that produce current 
values closest to 0 pA, since those open currents are the hardest to measure.  
Nevertheless, the reversal potential for the channel is very close to 0 mV.   
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2.2.4 Single-Channel Recording of Receptors Expressing Unnatural 
Amino Acids 
 
I will now briefly summarize the results of several techniques and 
procedures I developed in order to maximize the probability of obtaining one 
active channel in a cell-attached patch during single-channel recording, including 
of receptors expressing unnatural amino acids.  These include: control of pipette 
tip size, modulation of sylgard application to the pipette tip, the role of oocyte 
membrane health and leak currents, and the use of long incubation times.  
 
2.2.4.1 Pipette Tip Size and Sylgard Application 
Two methods of pulling pipettes were used: vertical puller and horizontal 
puller.  In both cases, details of each pipette were kept, including length of pulls, 
the bubble numbers (see Materials and Methods for definition) before and after 
polishing the pipette tip, the qualitative distance between the edge of the applied 
sylgard and the pipette tip, the resistance of the pipette in the bath solution, the 
resistance and RMS noise of a seal (if one formed), the number of hours elapsed 
between when the pipette was polished and used, the drug concentration, and 
the oocyte.  A number of relationships between these data may exist; I will now 
present one that I have evaluated: the relationship between bubble number and 
pipette resistance in solution (Figure 2.7).  The data used to produce the two 
graphs in Figure 2.7 correspond to several recording sessions in which the same 
pipette and bath solutions were used.  The average bubble number was 4.39 
before polishing and 4.13 after polishing.  The average pipette resistance in 
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solution was 13 MΩ.  18 out of 29 of the patches in these recording sessions 
formed seals, with an average seal resistance of 37 gΩ.  The average RMS 
noise for these 18 seals was 0.34 pA.  
The distance between the pipette tip and edge of the applied sylgard was 
monitored for each pipette and recorded as either close or very close.  There 
does not appear to be a relationship between the distance and quality of seal.  
The important factor is that at least a part of the pipette with sylgard is in the bath 
during recording.  Pipettes with very close sylgard coatings had ~ 10–15% 
chance of becoming covered with sylgard and therefore completely unusable.  
Therefore, I recommend only covering pipettes to the qualitatively ‘close’ level.   
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Figure 2.7. These two graphs show the relationship between measured bubble number 
during pipette fabrication, both immediately after pulling the pipette (upper graph, 
previous page) and after polishing the pipette tip in the microforge (lower graph).  The fit 
gets better after polishing, which is not surprising, since it is the polished electrodes that 
are actually used in the recordings.  Bubble numbers of ~ 4.5 before polishing and slightly 
over 4 after polishing correspond to pipette resistances of ~ 10–15, which was a useful 
range for these recordings.  The specific fit and correlation on the graph are given solely 
as a guideline to show level of variation and the overall trend.       
 
2.2.4.2 Oocyte Health and Expression Levels 
 In addition to control of the pipettes, the health and viability of oocytes was 
monitored in a variety of experiments.  These included: comparison of the whole-
cell leak current and resting potential (Figure 2.8), separation of oocytes to 
reduce collective maturation, injecting multiple batches of oocytes at the same 
time, and specific methods for keeping oocytes healthy for ≥ 10 days to increase 
expression level of some wild type channels. 
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Figure 2.8. The relationship between the initial leak current (μA) of an oocyte after being 
voltage clamped at -60 mV on the OpusXpress and the initial resting membrane potential 
(mV) just prior to voltage clamping.  Healthy oocytes generally had initial leak currents 
significantly lower than 1 μA.  These oocytes with low initial leak currents had the largest 
probability of living through an opus run, while oocytes with large initial leak currents (> 
1–2 μA) often had their leak currents increase throughout the run.  In some cases, oocytes 
with leak currents > 1 μA were analyzed and gave reliable whole-cell dose response 
relations, but this was only attempted if the maximal agonist-induced response was > 10 
times the leak current.  The specific fit and correlation on the graph are given solely as a 
guideline to show level of variation and the overall trend. 
 
 In many experiments, equal numbers of oocytes (10–30) were injected at 
the same time with the same receptor (mRNA for wild type or mRNA/tRNA mix 
for nonsense suppression) then separated into 2 or more 35 mm dishes for 
incubation in fresh oocyte incubation media at 18° C.  Sometimes, oocytes in one 
of the 2 or more dishes would be significantly less healthy than oocytes in the 
other dish(es).  Due to significant donor-to-donor variability in oocyte health and 
expression, injection of 3 batches of oocytes at the same time was found to give 
a sufficiently high chance of having oocytes with high enough expression for 
single-channel recording.  Ways to keep oocytes healthy for long periods of time 
are addressed in Materials and Methods. 
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2.3 Discussion 
2.3.1 Development of Methodology for Combined Single-Channel and 
Whole-Cell Recording of Ion Channels Expressing Unnatural Amino 
Acids 
 
One of the most important factors that had to be addressed in order to 
allow for single-channel recording on ion channels expressing unnatural amino 
acids was ensuring sufficient expression levels in X. laevis oocytes to find 
channels in cell-attached patches.  Additionally, some receptors express at low 
enough levels that even single-channel recording on wild-type or conventional 
mutants can prove difficult.  In order to optimize the control of whole-cell 
expression level for increasing efficiency of single-channel recording, I varied 
several parameters of the oocyte expression system, as is common in optimizing 
expression for new receptors in our research group: the amount of mRNA and 
tRNA injected, the relative amounts of each subunit (ratios), the number of 
injections and durations between them, the incubation time, and the incubation 
temperature.  In addition to control of pipette properties, I found four factors to be 
important tools to providing good oocyte health that is necessary for combined 
whole-cell and single-channel recording. 
The goal in these experiments was to obtain a whole-cell current that 
gives a probability of having one active channel in the patch of ~ 0.2 to 0.4; 
sometimes two or more channels will be present, while at other times, no active 
channels may be present in a given patch.  Note that I err on the low side for 
expression because although QuB can analyze multiple channels in a single 
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patch, the analysis is necessarily more complex and less intuitive; also most 
analysis presented in this thesis was performed using Clampfit.  Moreover, 
reducing expression was generally not difficult, so the data that are presented in 
this thesis generally emphasize periods during which only one channel was 
active.  In the following discussion, I will summarize my experiences with 
optimizing oocyte health, pipette properties, recording configuration, the role of 
pure populations of receptors and the number of receptors on an oocyte, the 
determination of parameters such as Popen from single-channel data and their 
relationship to whole-cell data, and the development of a method to perform 
single-channel recording on oocytes that have specifically been identified as 
having significant expression.  Several experimental controls will also be 
discussed in order to minimize the convoluting influence of endogenous channels 
in oocytes. 
 
2.3.1.1 General Oocyte Health 
The exact concentration of collagenase needed to achieve the desired 
level of defolliculation can vary significantly from lot-to-lot of collagenase, so it 
should be recalibrated for each lot.  The optimal collagenase time balances 
sufficient degradation of the follicular membrane, which impedes sorting and 
efficient injection, and actual oocyte membrane integrity/rigidity, which can 
decrease with excessive collagenase treatment.  If oocytes are slightly 
underdigested by collagenase, their follicular membranes will generally continue 
to separate over the subsequent 24 hours, in which case injecting the day after 
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frog surgery is often optimal.  On some occasions, overdigestion by collagenase 
appeared to have a significantly detrimental impact on the ability to perform 
single-channel recording due to decreased membrane rigidity, which made 
stripping the oocytes difficult, decreased the probability of forming a gigaseal, 
and decreased the percentage of seals that were of sufficiently high resistance.  
Oocytes injected at the same time and expressing the same receptor 
placed in separate dishes often displayed different levels of health.  This 
supports the general observation that oocyte membrane degradation and 
maturation appear to be random processes, at least based on visual inspection 
of the outside of the oocyte.  Once one oocyte in a dish begins to mature, others 
often follow quickly (personal communication from Bruce N. Cohen, consistent 
with personal observations).  Once they begin maturing, oocytes can rarely be 
devitellinized.  Therefore, for the purposes of this thesis, each media change was 
accompanied by careful inspection of oocytes.  Here, regularly changing oocyte 
media means changing media at: 30–60 minutes post-injection and 6–12 hours 
post-injection, then every 12–24 hours based on oocyte health as determined by 
visual inspection of oocytes.   At any media change, if oocytes in a given dish 
exhibited maturation (characteristic circular blemish developing on the cell 
membrane), those oocytes were discarded.  The remaining oocytes were rinsed 
with fresh incubation media (2–10 minutes) before being placed in separate fresh 
incubation oocyte media.  In addition, other oocytes that looked ‘dead’—as 
exhibited by disintegration/swirling of the membrane—were discarded at each 
media change. 
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 Two other general factors that were found to effect oocyte health were: the 
type of incubation dish and the components of the incubation media.  For 
incubation dishes, we’ve found that the 35 mm dishes from CELLSTAR extend 
oocyte viability and reduce oocyte adhesion to the dish (see Materials and 
Methods).  In addition, 1–2 % equine serum was found to be the optimal level in 
incubation media.  Values between 0 and 5% were incorporated.  When oocyte 
incubation media was used without equine serum, significant oocyte adhesion to 
the dish bottoms was observed; these oocytes were generally not viable for 
recording.  Faster orbital shaking sometimes offset this effect, but may decrease 
overall oocyte health and on many occasions led to oocytes clumping at the edge 
of the dish.  5% equine serum prevented oocyte adhesion to the dish no better 
than 2%, while 5% equine serum increased the probability that the oocyte 
incubation media would become contaminated and unusable.  
 
2.3.1.2 Receptor-Dependent Effects on Oocyte Health 
Two factors that impact oocyte health but can vary from receptor-to-
receptor are constitutive activity and overexpression. Constitutive activity, 
sometimes called spontaneous opening for LGICs, occurs when the receptor 
enters the activated conformation even in the absence of agonist.  As is the case 
with cells that have high leak currents, it is observed that oocytes expressing 
constitutively activated receptors, such as nAChRs with mutations of hydrophobic 
residues to hydrophilic residues in the pore (L9’S)(14, 19, 26), are generally less 
healthy.  On the other hand, these oocytes sometimes display significantly larger 
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agonist-activated whole-cell currents as well (see Chapter 3 for further 
discussion).  One strategy that can be employed to address oocyte health when 
expressing constitutively active receptors is to incubate the cells with a channel 
blocker that can be washed off prior to recording, such as QX314 or QX222(27).  
This may be advisable when two or more L9’S mutations are used in the muscle 
nAChR, but does not appear to be necessary for L9’A mutations in the α4β2 
receptor.   
For receptors that routinely express > 40 µA in oocytes, the current signal 
can reach saturating values for the opus for some oocytes.  At these high whole-
cell currents, the opus can struggle to maintain the voltage at the clamped 
voltage value, and so the opus traces show increased variability.  40 µA 
corresponds to ~ 17,000,000 channels for muscle nicotinic receptors (see 
calculation below); this is significantly more receptors than is needed for whole-
cell recording, which can be accomplished with two orders of magnitude fewer 
channels, or single-channel recording, which can be accomplished with as few as 
~ tenfold fewer channels.  In these cases, decreasing the number of expressed 
receptors may both increase oocyte health and increase the fidelity of the 
recordings—both whole-cell and single-channel.  Expression can be decreased 
by injecting less mRNA—sometimes 10- or 100- fold less, or by using 
significantly shorter post-injection incubations(28).  However, additional methods 
for controlling the number of channels being monitored are available.   
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2.3.1.3 Number of Receptors for Whole-Cell and Single-Channel 
Recording 
 
  The X. laevis oocyte is ~ 1000 µm in diameter, thus if it were a perfect 
sphere, it would have surface area of π*d2 = 3,142,000 µm2.  The oocyte 
membrane actually contains a significant number of invaginations, which greatly 
increase the surface area.  Assuming a twofold increase in surface area from 
these invaginations, the oocyte surface is actually ~ 6,300,000 µm2.  Thus, for a 
pipette with tip diameter of 1.0 µm (A = 0.785 µm2), there are ~ 8,000,000 pipette 
tip-sized patches per membrane.  However, as was observed by Sigworth and 
Neher(29), the capacitance of the membrane in the gigaseal of a patch is actually 
about 5–10 times larger than that indicated by the area of the pipette tip.  This 
may be due to a significant additional portion of oocyte membrane actually 
entering the pipette tip, as is often pictured (Figure 2.12, below).  Assuming a 
conservative estimate of 5 times the membrane, there are ~ 1,600,000 patches 
per oocyte.   
 We routinely observe whole-cell currents of 1 µA up to 50 µA at Vmemb = -
60 mV, which corresponds to a conductance (g) of 16.7 µS up to 830 µS (g = 
I/V).  Since the embryonic muscle nAChR (α12β1γδ) has a single-channel 
conductance of ~ 40 pS, a whole cell current of 6 µA (100 µS at -60 mV) 
corresponds to 1.0*10-4 S per cell / (4*10-11 S per channel) = 2,500,000 channels.  
Thus, there would be an average of 1 channel per patch if the whole cell 
current were ~ 4 µA. 
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For (α1)2β1γδ, a signal-to-noise ratio of > ~ 3–5 can be achieved for 
receptors (or mutants/agonists) that produce Imax of ≥ ~ 100 nA; this is 
considered ‘sufficient expression’ for whole-cell expression, but will vary with a 
variety of properties.  For these specific channels with single-channel 
conductance (gchannel) of ~ 40 pS (with Na
+ as the permeant ion), 100 nA at a 
potential of -60 mV corresponds to ~ 40,000 receptors on the ooycte’s surface 
(goocyte = I/V = 100 nA/0.06 V = 1.7*10
-6 S; goocyte/gchannel = ~ 40,000).  Receptors 
with a lower gchannel may be defined as having sufficient expression for Imax values 
proportionally lower than 100 nA, provided that Imax can be determined, given the 
signal-to-noise ratio of the current responses.  These calculations illustrate a 
significant difference in expression levels of channels for the two methods being 
combined in this thesis: single-channel and whole-cell recording. 
A separate way to increase the probability of observing single-channel 
events is to increase the patch size.  Two common ways to do this are: (1) to use 
larger pipette tips for the single-channel recordings and (2) to record in the 
outside-out configuration instead of the cell-attached configuration. 
 Throughout this thesis, several attempts were made to systematically vary 
the size of pipette tips, as measured by bubble number after pulling the pipette 
and pipette resistance.  Although there is a clear relationship between the ‘quick 
and dirty’ bubble number and the pipette resistance in the final recording solution 
(Figure 2.4), the control of these parameters during the pipette pulling process 
proved more difficult.  This was true for both of the pipette pulling procedures 
used: (a) a custom pipette puller (courtesy of Bruce N. Cohen), which allowed for 
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the position of the pipette glass during the second pull to be set manually, and (b) 
an automatic puller, a Flaming/Brown P-97.  In many cases, larger pull-to-pull 
variation in bubble number was seen than variation observed after systematically 
varying the program parameters (pressure, heat, pull, velocity, and delay).  The 
Sutter Instrument Pipette Cookbook (2010 Rev F.) provided useful information on 
designing programs for the P-97. 
 Several alternatives exist to the cell-attached patch recording 
configuration emphasized in this thesis, including: whole-cell, outside-out, inside-
out, and perforated patch.  The whole-cell method is not effective in oocytes 
given the electrical components of the electrophysiology rig; it also loses much 
kinetic information.  The opus recordings provide whole-cell data as needed.  On 
the other hand, each of the other pipette configurations offers distinct benefits, as 
have been previously summarized(21, 30).  One of these configurations, outside-
out, offers a method for increasing the area of oocyte membrane analyzed in 
single-channel recording.  It also allows for multiple different concentrations to be 
readily applied to the same channel/patch of membrane, though this has also 
been done in the cell-attached configuration(31).  See Figure 2.5 for an example 
of how an outside-out patch was obtained and a description of the related 
channel events. 
This data appear qualitatively similar to the data analyzed elsewhere for 
this receptor at similar concentrations; in this case the outside-out configuration 
did not appear to alter channel kinetics.  Moreover, loss of cytosolic 
components—in the outside-out configuration the inside of the patch now faces 
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the pipette solution instead of the oocyte’s cytosol—didn’t qualitatively change 
channel activation.  This rig was not designed to emphasize recording in the 
outside-out patch configuration; however, with modifications to the perfusion 
system, regular outside-out recording with various concentrations of agonist—or 
even multiple agonists—on a single channel is well within the capability of our rig.   
For one key set of receptors that might be pursued in the Dougherty 
group, α4β2, some other experimenters have reported rundown and other 
experimental difficulties in single-channel recording of these neuronal 
receptors(32) (Cynthia Czajkowski and Joe Henry Steinbach, personal 
communications).  Rundown is a phenomena in which the current being 
measured decreases over the course of an experiment.  In some single-channel 
experiments, the channel activity can disappear completely.  It is possible that 
under our specific recording conditions and with oocytes, these problems could 
be addressed.  A single outside-out patch of α4L9’Aβ2 A3B2 (20:1) (Figure 2.5) 
seemed to show similar behavior to a cell-attached patch of the same channel 
and agonist, although detailed kinetic analysis was not performed. 
Another specific type of experiment that could make use of cell-detached 
configurations is the investigation of the relationship between specific cytosolic 
molecules—such as the polyamine spermine—and inward rectification(32, 33).  
See Chapter 6 for further discussion.  
 A method of obtaining the inside-out configuration is exposure to: (a) air or 
(b) hexadecane(21).  If using inside-out patches, I suggest avoiding introducing 
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hydrophobic molecules such as hexadecane, which may partition into the bilayer 
and thereby change the bilayer properties and impact channel kinetics.   
 
2.3.1.4 Pure Populations of Receptors 
 
When unnatural amino acids are used, read-through and reaminoacylation 
control experiments can be used to verify a sufficiently pure population of 
receptors if they show that the desired receptor is overwhelmingly or solely 
present after extended incubations (> 48 h–72 h).  Such a determination is made 
by comparison of Imax values that show < 5% -- 10% current when oocytes are 
injected with, for example, 76mer tRNA. 
 The procedure developed and used here involves performing all single-
channel recording within 48 h of the most recent tRNA injection (72 h if opus 
recording at 72 h showed < 5–10% read-through or reaminoacylation current).  In 
some cases, in order to increase expression, oocytes were injected initially with 
mRNA + tRNA, then injected again 24 h–72 h later with mRNA + tRNA (on rare 
occasions, just tRNA was injected during the second injection).  Data collected > 
48 h (> 72 h) post-tRNA injection, were only used in the analysis when 2 or more 
patches recorded at < 48 h (or < 72 h) showed qualitatively and quantitatively 
similar single-channel activity.  In these cases the low measured level of 
contamination, by read-through/reaminoacylation, indicates a high likelihood (> 
90–95%) of getting the right channel in the patch.  This is true except in the case 
that the single-channel conductance of the contaminating channel is significantly 
lower than the single-channel conductance of the desired channel.  In addition to 
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being unlikely, this difference is readily monitored by quantitative comparison of 
the single-channel conductance of data collected pre- and post-48 h (or 72 h), 
and never interfered with data analysis.  Moreover, channels with significantly 
lower conductance than the channels studied in this thesis are not problematic to 
analyze because the signal-to-noise ratio of those events is so low that they 
couldn’t be analyzed, even if we wanted to. 
 
2.3.1.5 Single-Channel and Whole-Cell Recording on the Same Oocyte 
When a specific receptor being expressed in a given batch of oocytes 
(specific donor frog) gave primarily significant whole-cell responses, it was often 
true that any oocyte from that donor frog had a significant chance of producing 
patches with single-channel activity.  Specifically, if ≥ 6 of 8 oocytes in a given 
opus expression test or run were expressing at sufficient levels, then chances of 
finding channels on any oocyte from that donor frog injected with the same 
mRNA/tRNA within the first few patches were high (>> 50%).   
However, a limitation of this technique of modulating channel density on 
oocytes is that biological variation can be significant.  During several recording 
sessions, I observed whole-cell Imax values that varied over at least 1 order of 
magnitude for a specific receptor, yet the cells gave similar EC50 values.  
Attempts to address this variability in the number of receptors expressed from 
oocyte-to-oocyte by separating injected oocytes that visibly ‘leaked’ more or less 
immediately after injection did not reveal an obvious correlation between the two 
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groups.  Rather, the difference is more likely inherently at the biological level and 
varies oocyte-to-oocyte.   
Although it was not the main purpose of any experiments reported here to 
perform both single-channel recording and whole-cell recording on the same 
oocyte, I began developing this technique in order to mitigate the frustrating 
impact of oocyte-to-oocyte variation in expression levels.  This enhances our 
ability to combine the techniques of single-channel and whole-cell recording in a 
targeted, efficient way and reduced the frustration associated with performing 
single-channel recording on an oocyte that may—due essentially to bad luck—be 
expressing much less receptor than the average oocyte from that donor frog.  
Such enhanced targeting of resources is even more desirable when these 
techniques are additionally combined with incorporation of unnatural amino 
acids, since the tRNA required is used as a stoichiometric reagent.  To my 
knowledge, no similar experiments have been reported for oocytes, so their 
execution is briefly summarized in the methods section. 
 Note that these experiments are far more likely to succeed if whole-cell 
recording precedes single-channel recording due to the significant membrane 
damage that is introduced by whole-cell recording and the fact that the oocyte 
must be devitellinized prior to single-channel recording.  This damage is more 
extreme for whole-cell recording performed with the OpusXpress, even when 
physically smaller electrodes with resistances towards the high end of the 
permitted range on the OpusXpress (3 MΩ and 10 MΩ, for current and voltage 
electrodes, respectively) are used.  In these cases, no obvious qualitative 
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difference in channel activity was seen between oocytes recorded on the 
OpusXpress and those not.  I therefore conclude that whole-cell recording on the 
OpusXpress–and the corresponding large electrodes and significant changes to 
membrane potential—do not appear to significantly impact subsequent single-
channel events or kinetics.    
Note that in some cases even oocytes that showed expression on the 
opus did not give active channels in cell-attached patches.  This effect appeared 
to increase with increasing time delay between opus recording and single-
channel recording, yet oocytes must be given at least 1 hour after whole-cell 
recording for their membranes to heal.  A recovery time of 2–10 hours post opus 
recording seemed ideal. 
 
2.3.2 Applicability of the Technique to Various Receptors and 
Agonists  
 
 In order to demonstrate the broad applicability of combined single-channel 
and whole-cell recording, including on channels expressing unnatural amino 
acids, the various types of channel activations possible should be considered.  
Issues of single-to-noise, which may allow for measurements on channels with 
lower conductances, are addressed in the Methods section.   Recording on 
channels with different levels of expression has been extensively addressed 
above.  However, we must also consider recording onto channels with different 
level of activation or with agonists that activate channels to different extents.  
Some of these broad quantitative issues are addressed below, in addition to 
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specific discussion and analysis in the appropriate chapters.  Note that I did not 
attempt to design single-channel experiments for the recording of GPCRs(6, 34). 
 
2.3.2.1 Quantitative Relationships Between Whole-Cell and Single-
Channel Data 
 
As in most experiments on LGICs, information from macroscopic 
experiments is usually limited by the speed of the solution change.  The solution 
exchange time for the OpusXpress has been estimated at ~ 1–2 seconds for flow 
rates similar to those used in the experiments reported here(35).  These are 
much slower than nAChR kinetics at most concentrations I used, but faster than 
the kinetics of some receptors (i.e., 1 GABAA).  In the rare cases where 
activation/deactivation kinetics can be resolved by the OpusXpress, the sampling 
and filtering characteristics must first be optimized.  Use of an analog-to-digital 
sample rate ≥ 2.5 times the analog filter’s cut off frequency avoids aliasing(36).  If 
low concentrations of agonist (nM or lower) are used, then one component of the 
opus trace activation is expected to be the association rate, assuming that this 
rate is diffusion limited. 
 
2.3.2.2 NPopen, Popen, Efficacy, and the Possibility of Multiple Channels in a 
Patch 
 
In the ideal single-channel experiment, there is one active channel in a 
patch, and for at least some concentrations, clusters of activity are seen with high 
enough NPopen to establish that those events are arising from the same channel 
and therefore represent Popen for the channel.  In NPopen, N indicates that the 
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probability of being open being reported reflects an unknown number of 
channels, N.  At concentrations where the binding equilibrium is saturated, a 
measured Popen value would be Popen,max and is a measure of efficacy—the ability 
of the agonist to open the channel.  Single-channel recording allows for direct 
determination of this parameter, while whole-cell recording allows for 
determination of the relative efficacy of two or more agonists.  In addition, 
measurements of efficacy from single-channel data are often reported to 2–3 
significant figures(5, 10, 34, 37), which is probably better resolution than is 
obtainable based on variation in whole-cell current measured on the 
OpusXpress.  Chapter 4 describes the development of a proposed model for a 
mutated nAChR and a resulting measurement of efficacy by fitting single-channel 
data to multiple ACh concentrations using QuB(38-41).  
In all cases, the assignment of which agonist(s) are full agonists requires 
single-channel measurement to verify, at a minimum, that Popen,max is ~ 1.  That is 
to say, clusters of activity—channel activations that end in desensitization—must 
occur in which the probability of the channel being open is nearly one if an 
agonist is a full agonist.  A fact that appears to be underappreciated is that, in 
cases where desensitization is fast(42, 43) or the rate of exit from the 
desensitized state back to the open channel is very slow, it may be difficult to 
unambiguously assign full or partial agonism at either the whole-cell or single-
channel level.  Until recently a partial agonist has been defined as a molecule 
that produces a relatively lower gating equilibrium constant, , where  is the 
channel opening rate (β) divided by the channel closing rate (α).  In these cases, 
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 must be < ~ 10–30 for an agonist to be considered a partial agonist(44).  
Recently, different models, invoking a pre-opening conformational change, have 
been proposed to explain why some molecules are only able to partially activate 
receptors(45-47). 
Some analysis software, such as QuB, can be used to analyze single-
channel recordings even when multiple channels are simultaneously active.  
However, unambiguous assignment of the number of channels in a patch is 
difficult and even with such analysis, it is impossible except in regions of 
extended very high Popen for full agonists at saturated binding.  This ambiguity is 
summarized in the representation of many measured Popen values as NPopen.  
Indeed, calculations of NPopen for 1–40 channels show that a measured NPopen 
value of ~ 0.01, was consistent with many different numbers of channels present, 
with Popen getting correspondingly smaller to represent larger—but still very 
small—values of NPopen.   
 On the other hand, when Popen is significantly greater than 0.5, overlapping 
channel events may readily be seen if multiple channels are active.  Figure 2.9 
shows what these overlapping events would look like when artificially 
superimposed on a trace with very high Popen (> 0.9) and compares them to 
observed brief current deflections from the open state. 
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Figure 2.9. Upper) A single-channel record in which downward deflections represent an 
open channel.  At the start, the channel is mostly closed, with brief openings, then the 
channel is primarily open.  In order to examine the resolution limit for brief openings that 
my analysis can detect from the open state, current transitions (baseline shifts) of 5 ms, 2 
ms, 1 ms, 0.5 ms, 0.3 ms, 0.2 ms, and 0.1 ms have been added.  Both qualitatively and 
quantitatively, openings > 0.3 ms can clearly be discerned from noise.  The result is that 
this record appears to have a single channel that switches between low and high Popen, 
rather than multiple channels, since they don‘t appear to open as overlapping events.  
Lower Left) A high resolution trace of a separate record with actual brief openings from 
both the closed and open state.  Lower Right) For comparison, a high resolution trace of a 
0.5 ms current transition added to the open state.  Comparison of the real opening (left) 
and added one (right) once again demonstrate that 0.5 ms openings overlaid on the high 
Popen sections of data can readily be assigned. 
 
A minimum number for N can be assigned based on the largest number of 
overlapping (simultaneous) channel openings.  For data analyzed in this thesis, I 
confine my analysis to patches with either no or very few (<< 5%) overlapping 
channel events.  In the few cases where records with overlapping channel events 
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were analyzed, patches exhibiting this behavior were quantitatively compared to 
those with that displayed only opening of a single channel at any given time.  The 
resulting data were only included in the analysis if they quantitatively agreed with 
patches that displayed no overlapping openings.  Further discussion of multiple 
channels and analysis of NPopen is given in Chapter 5.  As is described there, 
other parameters, such as the length of time that a channel spends open, τopen, 
can often be used to clarify results(48), though a full treatment of overlapping 
events is complex(49). 
 
2.3.3 Control Experiments for Single-Channel Recording in Oocytes 
 
Channels that are believed to be endogenous to oocytes were observed in 
some single-channel recordings.  These channels generally exhibited kinetics 
that were different from nAChRs kinetics, a different current (at the recording 
pipette potentials), and were often mechanosensitive(50, 51).  Although these 
parameters generally made the identification and separation of these events from 
channel activity from the desired, exogenously expressed channel of interest, 
possible, it took some skill to do so.  Therefore, and in order to ensure the 
applicability of characterization of unnatural amino acids expressed in oocytes by 
single-channel recording to a broad range of receptors, a method was 
developed, in conjunction with Shawna Frazier (Lester lab), that seemed to 
decrease the occurrence of these extraneous current events. 
In addition to the obvious controls of recording on uninjected oocytes and 
recording on channels with no agonist in the pipette, three variables were 
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investigated to identify and/or eliminate endogenous channel activity: the time 
between stripping an oocyte and recording on it, the use of suction during 
recording to identify mechanosensitive channels, and the use of glass dishes to 
incubate oocytes.  In early experiments, recording on oocytes began as soon as 
the stripped oocyte was placed in the recording chamber.  Reasoning that the 
transition from incubation media to hypertonic solution to bath solution, as well as 
removal of the vitelline membrane, all caused significant stress to the oocyte, we 
decided to delay recording of the stripped oocyte after being placed in the 
chamber in order to allow it to equilibrate.   
 A second method, which allowed for the identification of the presence of 
mechanosensitive channels, was to apply suction to the oocyte after a few 
minutes of recording on the channel of interest.  When suction is applied, the 
channel is probably not mechanosensitive if its activity (Popen, τopen, conductance, 
etc.) continues at the same level.  The presence of a mechanosensitive channel 
in the patch could often be identified if activity could be induced by suction in a 
record with no activity (or a desensitized channel).  Popen for these 
mechanosensitive channels varied with applied suction: ~ 0.5 with light suction 
and nearly 1 with moderate suction.  In addition to this characteristic, these 
channels were generally easy to distinguish from exogenously expressed 
channels due to their raggedy openings and closings.  On several occasions, 
light suction was applied during channel openings; nAChRs did not display a 
qualitatively different Popen or conductance when suction was applied in this way. 
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Anecdotally, I do not notice that oocytes that spend 30 or more minutes in 
the stripping solution exhibit more endogenous channel activity, especially when 
this procedure was followed.  Nevertheless, the time in the stripping solution 
should be no more than is necessary to exhibit significant separation between 
the oocyte membrane and the vitelline membrane.   
The third variable we considered, incubation of oocytes in glass dishes 
instead of plastic dishes, did not appear to significantly decrease the occurrence 
of these extraneous channel events.   
 In addition to endogenous oocyte channels, it is important to be aware of 
other potential contaminants of the single-channel signal.  These include: 
receptor heterogeneity (such as a receptor with an omitted subunit), spontaneous 
openings, voltage-gated channels, and patching to something other than the cell.  
Channels with omitted subunits can form functional receptors, and these 
have been characterized, including at the single-channel level(52, 53).  The 
relationship between receptors lacking a subunit and spontaneous openings has 
been at least partially explored(53).  One type of subunit omission experiment is 
fairly straightforward: one (or more) of the mRNAs coding for a subunit of the 
receptor is simply not included in the mRNA mix.  If subsequent whole-cell 
experiments reveal no agonist-induced activation, or only activation at several 
orders of magnitude higher concentration than the channel’s EC50, then it is 
unlikely that the signal from this receptor will impact whole-cell data or single-
channel analysis.  If the whole-cell leak currents for these channels are 
systematically higher than for oocytes expressing receptors with all subunits, this 
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could indicate that a receptor is being expressed that can open spontaneously, 
even though it may not bind agonist with nearly as high affinity as the full 
receptor.  Thus, in order to quantitatively examine any potential impact on single-
channel analysis, recording should be performed on several patches from 
multiple oocytes from different donor frogs.   Both agonist-induced and 
spontaneous single-channel events from receptors lacking a subunit can then be 
quantitatively analyzed and compared to single-channel recording of the receptor 
of interest.  Events with characteristics of the undesired receptor can then be 
analyzed separately in subsequent analysis. 
 The only time that nAChRs gave significant single-channel currents in the 
absence of agonist was when 2 or more L9’S mutations were included (Chapter 
4).  As with the subunit omission experiments, understanding the spontaneous 
openings of a channel is valuable because some mutations (such as the L9’ 
mutations) may increase the rate of spontaneous opening.  If they increase it 
significantly, then any kinetic analysis should take into account these unliganded 
(usually brief) openings(54). 
Channels that were likely voltage-gated were only present in records on 
rare occasions.  They most often appeared after significant changes to the 
applied pipette potential and at high voltage (> +120 mV applied pipette 
potential).  These events were of variable, but generally high conductance (> 100 
pS) and irregularly shaped as opposed to the square, discrete openings of 
nAChRs. 
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A previous report demonstrated that it was possible to obtain current 
transitions when patching onto sylgard(55).  Although the recording conditions 
are significantly different (higher salt and larger pipette potential), on a few 
occasions I did deliberately patch onto sylgard.  High resistance seals did form 
readily, but I did not observe current transitions or channel-like activity. 
 
2.3.4 Miscellaneous Recording Advice for Single-Channel Recording 
My success rate for obtaining gigaseals of ~ 40% is similar to the 40–50% 
success rate that more experienced labs have reported (Bruce Cohen, personal 
communication).  Several of the key factors in obtaining high rates of gigaseals 
are outlined in the Materials and Methods section.  At one point, I had several 
consecutive recording sessions where the probability of obtaining a gigaΩ seal 
went down significantly (to < 20%) and when seals did form, they were of 
significantly lower resistance.  At this point, I implemented the additional step of 
refiltering the pipette solutions at the start of each recording session as well as 
additional rinsing of the recording chamber at the end and beginning of each 
session.  These measures restored the gigaseal rate and resistances.   
Oftentimes, a patch, particularly with high resistance (> 50 gigaΩ), will not 
contain any channels.  This may be disproportionately true for high resistance 
seals, since they are more likely to result from smaller pipettes, which in turn are 
less likely to contain a large enough section of membrane to have an ion 
channel.   
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As has been previously reported(21), I find that unpolished pipettes do not 
form seals nearly as readily as polished pipettes, though unpolished pipettes can 
be used in a pinch.  The role of glass cleaned with chromic/sulfuric acid versus 
uncleaned glass was not investigated. 
Sometimes (~ 20% of the time), when stripping an oocyte, the vitelline 
membrane was significantly thicker and less translucent than usual.  This was 
usually true of most/all or none of the oocytes from a particular donor frog.  The 
recording sheets contain a note when oocytes with this property were used for 
single-channel recording, though qualitatively I did not observe differences in the 
records from these oocytes.  As always, these oocytes were only used for single-
channel recording if the vitelline membrane could be completely removed. 
  
2.4 Conclusions 
 Calculations shown in the discussion section of this chapter and data 
collected and reported throughout the rest of this thesis indicate that the oocyte 
expression system can be used for single-channel characterization of many 
receptors in which the DAD group has incorporated unnatural amino acids.  The 
unique aspects and control experiments developed to perform single-channel 
recording on ion channels expressing unnatural amino acids were discussed 
above.   
When a dozen or more rates are measured in a single-channel 
experiment, one or more are almost invariably seen to vary between mutants or 
agonists.  By developing a technique in which we first perform whole-cell 
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recording, we verify that the changes to these receptor properties are ones that 
meaningfully impact overall receptor function, as opposed to minor and/or 
potentially compensating changes in binding and gating.  We consequently 
advance the view that screening receptors by whole-cell recording, followed by 
targeted single-channel recording of high expressing wild type receptors, 
conventional mutants, unnatural mutants, or partial agonists, is a particularly 
efficient way to obtain kinetic information on key mutants while minimizing the 
tendency towards over interpretation of detailed single-channel kinetic analysis.  
Specific examples of the various ways in which we productively combined these 
techniques are described throughout this thesis.   
 
2.5 Future Studies 
It is perhaps underappreciated, but important to understand, that analysis 
of single-channel data can rarely be considered ‘complete’.   So, for much of the 
single-channel data presented in this thesis, the analysis is necessarily partial.  
An exhaustive detailing of future studies available just by analyzing data that I’ve 
already collected could occupy an entire additional thesis.  I have left some of 
these ideas with the group separate from my thesis.  In the future studies 
sections of each chapter, I will generally restrict myself to the most interesting 
experimental single-channel studies.  In this chapter, I outline analysis of the data 
I’ve collected about pipettes that could be done in order to continue optimizing 
this important and time-consuming process (see Table 2.2), as well as control 
experiments on endogenous and mechanosensitive channels. 
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 Singles Opus 
Pipette preparation 
  Clean glass 0.25 NA 
Prepare sylgard 0.25 NA 
Pull pipettes 0.5 0.5 
Sylgard pipettes 2 NA 
Polish pipettes 2.5 NA 
Fill pipettes  2 0.25 
Pipettes per session 36 20 
Attrition rate (estimated) 40% 10% 
TOTAL pipette preparation 378 17 
   Solution preparation 15 40 
Rig/Opus set up 30 15 
Plate drugs, impale oocytes NA 15 
Strip oocyte and rinse for recording 40 NA 
TOTAL Preparation Time 463 87 
   Recording 
  Average per patch/run 30 60 
Patches/runs per mutant 20 5 
Clean up  20 20 
TOTAL recording 620 320 
   Analysis (opus) 
 
30 
SCR analysis 
  Initial screen of file 10 
 Filtering 3 
 Remove Electrical Interference 2 
 Baseline correction 10 
 All points histograms 5 
 Event detection (automatic) 0.5 
 Analysis of preliminary statistics 10 
 Manual event detection 30 
 Fit dwell time histograms 20 
 τcrit(s) 15 
 # of interations per file 2.5 
 Analysis time per file 264 
 Analysis time per mutant 2110 150 
 
 
Table 2.2. This table gives estimates for the amount of time spent on several of the main 
aspects of preparing for, executing and analyzing data for single-channel and whole-cell 
(opus) experiments.   All values are in minutes. 
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When pulling pipettes on the custom vertical pipette puller, detailed notes 
were kept on the heat used and the duration of each pull.  This could be 
compared to the final solution resistance of pipettes to determine which 
parameters or combination thereof, if any, correlate to achieving pipettes of the 
desired size.  As of yet, this data from the manual, vertical puller have not been 
converted to electronic form for analysis because the P-97 provides much more 
rapid pipette production, with only slightly higher—and sometimes lower—pipette 
attrition rates (e.g. pulled glass that does not make it to the recording stage, in 
this case due to being significantly too small or big based on bubble number).  In 
the case that particularly expensive pipette glass is used, a more efficient method 
based on analysis of existing data may be warranted.  Additional dependencies 
may be worth considering.  For example, there may be dependence on other 
factors, such as the lot of KG-33 glass used and/or how long the glass is cleaned 
in chromic/sulfuric acid.  Since pipette resistance and seal quality (RMS noise 
and seal resistance) were also recorded for each pipette, analysis of the full, 
broader data set would allow for comparison of the probability of getting a seal, 
as well as seal quality, to the above parameters.  Examination of these data 
could provide useful information going forward concerning combined optimization 
of pipette characteristics to maximize probability of getting a high resistance seal 
with the desired number of active channels.  Another parameter that could be 
analyzed to optimize seal resistance and probability of formation is the time delay 
between polishing the pipette tip and using that pipette to form a patch.  I 
hypothesize that as the length of this time delay increases (average was a few 
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hours), the probability of forming a gigaseal will decrease, but the effect could be 
on the quality of the seal and may be non-linear versus time. 
 A standard error for the seal resistances and RMS noise for patches I 
obtained is not available, but could be calculated from existing data by 
transcribing all lab notes (recording files) into electronic files.   
 In dozens, and perhaps hundreds, of single-channel records, suction was 
applied at the end of the record—and in some cases during active channel 
events.  This suction rarely impacted Popen (see Materials and Methods); 
however, in some cases it induced new channel events.  These were often 
raggedy events that were qualitatively different from the channel of interest, but 
they were not quantitatively characterized.  However, qualitatively, the Popen of 
these mechanosensitive, presumably endogenous, channels often appeared to 
increase with increasing suction(50).  Using data I’ve already collected, this 
behavior could be further characterized, along with the impact on channel 
kinetics. 
 
2.6 Materials and Methods 
The combined single-channel and whole-cell recording of X. laevis 
oocytes expressing LGICs with unnatural amino acids requires several distinct 
steps and significant preparation.  This Materials and Methods section will 
describe: (2.1) general molecular biology methods, (2.2) site-directed 
mutagenesis and transcription, (2.3) preparation of tRNA for incorporation of 
unnatural amino acids, (2.4) expressing LGICs in X. laevis oocytes, (2.5) whole-
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cell recording with the OpusXpress 6000A, (2.6) single-channel recording on a 
custom-built electrophysiology rig, (2.7) combined single-channel and whole-cell 
recording performed on a single oocyte, and (2.8) analysis of the resulting single-
channel and whole-cell data.  Note that, in practice, several steps are often 
completed in parallel.   
 
2.6.1 Molecular Biology Methods; Preparations and Precautions 
2.6.1.1  General Materials and Methods 
Throughout these studies, unless otherwise stated, the water used was 
Millipore-filtered water with resistivity  17.5 M-cm.  The 0.2 µm filters used are 
Nalgene (Cat # 450-0020, Thermo Fisher Scientific, Inc., Wilmington, DE).  For 
all molecular biology reactions, reagents were combined in an appropriately 
sized Eppendorf tube (usually > ~ 3 times the reaction volume), mixed by 
pipetting for 30 s, vortexed for 3 s, then microcentrifuged for 1–3 s, unless 
otherwise specified.  Whenever possible, all RNA (here mRNA and tRNA) was 
handled at a dedicated RNA lab bench that was cleaned with ethanol before 
each use and kept clear of RNAses at all times.  The RNA was pipetted with a 
set of pipettes that were never used with RNAses.  Unless otherwise noted, 
mRNA and tRNA were kept up to ~ 1 year at -80° C, and stored in aliquots for a 
few injections (~ 2–8 µl) in order to minimize freeze-thaw cycles.   
All agarose gels were 1%, generally made by dissolving 0.60 g agarose 
(Cat #15510-019, Invitrogen, Carlsbad, CA) in 60 mL of 1x Tris/acetic acid/EDTA 
(from 1 part 50x TAE, Cat #161-0743, Bio-Rad Laboratories, Hercules, CA, 
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diluted with 49 parts water).  Gels were prepared as needed by boiling the 1% 
agarose in 1x TAE (heated for 1 minute in a microwave in an Erlenmeyer flask 
with a Kimwipe to prevent boiling over) and pouring the solution into a gel mold 
with a comb with the desired number of lanes (typically 8–16 lanes).  This was 
stored at 4° C for 1–12 hours until use.  The running buffer for the gel was 1x 
TAE; typically gels were run for ~50 minutes at 110 V, 400 milliamperes.  Gels 
were visualized by bathing in ethidium bromide (0.1%) for 15 minutes followed by 
UV imaging (AlphaImager 3400, Alpha Innotech/Cell Biosciences, Santa Clara, 
CA).  Typical exposure times were 1–2 seconds.   
 
2.6.1.2 Buffers and Oocyte Incubation Media 
The compositions of commonly used solutions are briefly defined here; all 
recording solutions were stored at 4° C with parafilm around the cap.  Whole-cell 
drug solutions were stored up to 14 days at 4° C, while single-channel drug 
solutions were stored up to several months at -20° C, while attempting to 
minimize the number of freeze thaw cycles.  ND96 solution consisted of 96 mM 
NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5 mM HEPES, with pH set to 7.5 
with NaOH.  Ca2+-free ND96 solution consisted of 96 mM NaCl, 2 mM KCl, 1 mM 
MgCl2, 5 mM HEPES, with pH set to 7.5 with NaOH.  The resulting solutions 
were filtered with a 0.2 µm filter and stored at 4° C.  Usually, 1–4 liters were 
made at a time.  Frequently, it was convenient to prepare a concentrated (20x) 
stock solution of ND96 and Ca2+-free ND96 in order to quickly prepare the large 
volume of buffers used in semi-automated electrophysiology.  These solutions 
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can be kept for 6–12 months at 4° C if parafilmed, as long as no solid is found in 
the bottle.  I strongly recommend filtering all recording solutions (0.2 µm), 
including stock solutions, every few months, especially for cell-attached single-
channel recording (where it is desirable to perform all of a given set of 
experiments with a given batch of pipette solution so that single-channel 
conductances are more comparable—same osmolarity, pH, etc.).    
To obtain oocyte incubation media from ND96, 138 mg sodium pyruvate 
(Sigma; P2256-25G; final concentration 2.5 mM) and 60 mg theophylline (Sigma 
T1633-50G; final concentration 0.67 mM) was added to 500 ml of 1x ND96 
solution and filtered with a 0.2 µm filter.  500 µl of 10 mg/ml gentamicin solution 
(Sigma G1397-10 ml; final concentration ~ 0.021 mM) was added.  1–2% equine 
serum (Hyclone, #SH30074.03, 500 ml) was added, and stored at 4° C, then 
used within 10 days.  The osmolarity of the resulting incubation media was tested 
on a freezing point osmometer (Precision Instruments, Inc.; Osmette) and should 
be in the range of 190–230 osmol/L.  I prefer values on the lower end of this 
range (190–200), especially for whole-cell experiments on the OpusXpress 
6000A (Molecular Devices Axon Instruments, Sunnyvale, CA), as it seems to 
increase oocyte health during the runs.  It is especially important that parafilm be 
used to seal the cap of the bottle containing the oocyte incubation media.   
Oocyte stripping solution consisted of: 196 mM NaCl, 2 mM KCl, 1 mM 
MgCl2, 5 mM HEPES, pH to 7.5.  Note that this high salt solution was found to be 
preferable to an alternative hypertonic solution that contained a high 
concentration of sucrose; the later solution quickly became moldy even at 4° C.  
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Bath solution consisted of: 120 mM KCl, 5 mM HEPES, 1 mM MgCl2, and 2 mM 
CaCl2, pH to 7.4.  In our experiments, this solution gives a reversal potential for 
agonist-induced currents of devitellinized oocytes of ~ 0 mV (see Table 2.1).  
Therefore, with an applied pipette potential of +100 mV, the transmembrane 
potential of a cell-attached patch is ~ -100 mV.  Pipette solution consisted of: 100 
mM KCl, 10 mM HEPES, 1 mM MgCl2, 10 mM K2EGTA, pH = 7.4.   
 
2.6.2 PCR-Based Site-Directed Mutagenesis and mRNA Transcription 
 Mutagenic primers of 25–45 bases were designed with 50–55% GC 
content and Tm  78° C.  They were terminated with one or more C/G at the 3’ 
end and designed to avoid primer dimers.  For each conventional mutation 
described here, forward and reverse (complementary sequence) primers were 
ordered (Integrated DNA Technologies).  For each mutation, polymerase chain 
reaction (PCR) was performed using the Stratagene QuickChange method.  50 l 
reaction mixtures containing 5 l 10x polymerase buffer, 1 l circular dsDNA 
template (5–50 ng), 1.25 l of both mutagenic primers (~ 125 ng each), 1 l 25 
mM dNTP mix, 39.5 l RNAse-free H2O (Ambion Nuclease-Free Water, 
Cat #AM9932), and 1 l Pfu Turbo Hotstart DNA polymerase were used with a 
10 minute extension time in each thermocycle.  Annealing temperatures were 
modified as required for successful incorporation of the mutation (iCycler, Bio-
Rad Laboratories, Hercules, CA).  10 l of each PCR reaction mixture were 
removed for a gel screen against the corresponding circular DA (control) in 
neighboring lanes to verify amplified linear product. 
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1.5–3 hour digestions of the remaining PCR reaction were performed with 
DpnI to eliminate methylated template DNA from the PCR product, leaving the 
desired mutated DNA.  The PCR products were amplified by electroporation 
(Electroporator 2510, Eppendorf, Hamburg, Germany) of Super Competent Top 
10 Escherichia coli cells at 1800 V, followed by ~ 12 hours of growth on 
agar/Luria broth/ampicillin plates in an incubator with orbital shaking at 37° C.  
Single colonies were selected and amplified separately in 4 ml liquid Luria broth 
(Difco, #240230) + 4 l ampicillin (Sigma, A9518-25G) or 4 ml liquid 2xYT 
Medium (Difco, #244020) + 4 l ampicillin with orbital shaking (300 rpm) at 37° C 
for ~ 12 hours. 
Using a QIAPrep Miniprep kit (Cat #27106, Quiagen, Valencia, CA), DNA 
from each bacterial sample was isolated as follows.  DNA was pelleted by 
centrifuging at 2100 g for 5 minutes at 4° C and resuspending in 250 l chilled 
buffer P1 in a 1.5 ml Eppendorf tube.  250 l buffer P2 were added and mixed by 
inverting 6 times; 350 l buffer N3 were then added and mixed immediately by 
inverting 6 times.  Following 10 minutes of microcentrifuging at 13,000 rpm, the 
supernatant was pipetted onto a QIAprep spin column, centrifuged 1 minute and 
the flow-through discarded.  The QIAprep spin column was washed with 0.5 ml 
buffer PB, centrifuged for 1 minute and the flow-through was discarded.  This 
rinse was repeated with 0.75 ml Buffer PE.  Residual buffer was removed with an 
additional 1 minute microcentrifuging.  DNA was then eluted with 30–50 l water 
into a fresh 1.5 ml Eppendorf tube with 1 minute microcentrifuging.  The amount 
of DNA solution recovered from the spin column was tracked by drawing a line 
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on the Eppendorf tube at a level corresponding to volume of water used in the 
final DNA elution step.  In some cases, several additional 1–2 minute 
microcentrifugations were needed to recover this total volume from the column.  
The concentration of the resultant DNA was quantified by measurement either on 
a UV-vis (SQ2802; Daigger) or NanoDrop-1000 (Thermo Scientific, Inc., 
Wilmington, DE).   
 DNA was then sequenced to verify the successful incorporation of the 
mutation at the selected site.  The 1-subunit cDNAs used in these experiments 
encode an HA epitope in the M3-M4 cytoplasmic loop for Western blot studies 
(not described).  The HA epitope provides an independent way of determining if a 
mutation(s) giving no current is not functional or is not being assembled, 
transported, and inserted into the cell membrane.  Control experiments show that 
this epitope does not significantly alter EC50. 
DNA for each of the muscle and neuronal nAChR subunits (wild type or 
mutated) in expression vector pAMV were individually linearized by adding 50 g 
(~ 50–100 l) to 20 l 10x buffer, 20 l NotI (New England Biolabs, Ipswich, MA). 
RNAse-free water was added to a final reaction volume of 200 l, followed by 
incubation for 8–16 hours in a 37° C water bath.  Complete linearization was 
verified by running an agarose gel of ~ 2 l reaction mixture against 2 l of 
circular DNA.  If the linearization reaction was not complete, additional NotI 
enzyme was added for up to an additional 24 hours of incubation.  Once fully 
linearized, the DNAs were then transcribed using mMESSAGE mMACHINE T7 
kits (Cat #AM1344M, Applied Biosystems, Foster City, CA) individually for each 
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subunit required for the receptor to be expressed.  Typically transcription was 
performed by combining, in the following order: 6 l 10x transcription buffer, 30 l 
2x NTP mix, 8 l RNAse-free water, 10 l (~ 10 g) linearized plasmid DNA, 6 l 
T7 enzyme mix.  The resulting transcription reaction mixture was incubated for 
3–4 hours in a 37° C water bath.  Transcription was stopped by adding 3 l 
DNAse and incubating at 37° C for an additional 1 hour.   
The resulting mRNA was purified using an RNeasy Mini kit (Cat #74104, 
Quiagen, Valencia, CA).  First, the reaction volume was adjusted to 100 l by 
adding 37 l RNase-free water, then 350 l buffer RLT (with 1% -
mercaptoethanol previously added to buffer RLT), was added, vortexed 5 
seconds and microcentrifuged 10 seconds.  250 l of 100% ethanol were added 
and the resulting solution was mixed with gentle pipetting.  The entire 700 l 
sample was then applied to an RNeasy column placed in a 2 ml collection tube 
and microcentrifuged for 15 seconds at 14,000 rpm.  The flow-through was 
discarded and the column was placed in a new 2 ml collection tube where it was 
washed with 500 l diluted buffer RPE (4:1, 100% ethanol: RPE concentrate) by 
15 seconds of microcentrifuging at 14,000 rpm.  The flow-through was discarded 
and the washing process repeated with 500 l diluted buffer RPE and 2 minutes 
microcentrifuging.  The column was then transferred to a new 2 ml collection tube 
and microcentrifuged for 1 minute at 14,000 rpm to ensure dryness and minimize 
ethanol carryover.  The column was then transferred to a final 1.5 ml Eppendorf 
tube, and, depending on desired final concentration, 30–60 l RNase-free water 
were pipetted directly onto the silica-gel membrane of the column, followed by 
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elution with 1 minute microcentrifuging at 14,000 rpm.  The eluent was reapplied 
to the silica-gel of the column and re-eluted to increase concentration.  On some 
occasions, a second re-elution was performed, which appeared to further 
increase concentration.  As above with DNA, the final volume of eluted RNA 
solution recovered here was roughly verified by drawing a line on the Eppendorf 
tube at a level corresponding to the volume of water used in the final elution step.  
Additional spins were used after final reapplication of eluent, if necessary, to 
recover approximately this total volume from the column.  The concentration of 
mRNA was determined as described above for DNA (UV-vis or NanoDrop).   
 
2.6.3 Preparation of tRNA Ligated with Unnatural Amino Acids for 
Incorporation by Nonsense Suppression 
 
The nitroveratryloxycarbonyl (NVOC)-protected cyanomethyl ester forms 
of unnatural amino acids were used as previously synthesized by various 
Dougherty group members.  These were coupled to the dinucleotide dCA, and 
enzymatically ligated to 74-mer THG73 tRNACUA as previously described(2).  
Successful ligation was verified by MALDI-MS.   
 
2.6.4 Expression of Ligand-Gated Ion Channels in X. Laevis oocytes 
2.6.4.1 Preparation of Solutions and Injection Needles 
Drug solutions were prepared in Ca2+-free ND96 by supplementing with 
the desired concentration of drug within 12 hours prior to recording.  For 
acetylcholine (ACh) chloride (A6625, Sigma), typical stock solution concentration 
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was 1.00 M in water and was immediately stored at -80° C in aliquots of 100–500 
µl for  3 freeze-thaw cycles.  Stock concentration varied for other agonists.  
Drug solutions for recording were prepared from stock solutions by first making 
the highest 3–4 concentrations—however, many concentrations were to be used 
per order of magnitude in concentration.  Serial dilutions of these upper 
concentrations were performed by adding 5.00 ml to a final volume of 50 ml in 
Ca2+-free ND96.  ~ 10 doses over ~ 3 orders of magnitude of agonist 
concentration centered on the anticipated EC50 value is a good starting point.  
However, if the receptor was known or suspected to have a low Hill coefficient, 
nH, (< ~ 1.2), then concentrations over 4 orders of magnitude were appropriate 
for initial runs in order to maximize the chance of seeing low concentrations with 
no response and a plateau  in the dose-response at the highest concentrations.  
In addition, 4 doses per order of magnitude were used if there was reason to 
suspect multiple populations of receptors may have been present in a single 
oocyte in order to more definitively detect and characterize a possible biphasic 
dose-response behavior in which each component represents a different receptor 
population.   
Injection needles were pulled from 8-inch-long glass with an outer 
diameter of 1.14 mm and an inner diameter of 0.53 mm (Cat #3-000-210-G8, 
Drummond Scientific, Broomall, PA) in groups of 10 or more on a Flaming/Brown 
P-97 horizontal pipette puller (Sutter Instrument Co., Novato, CA). 
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2.6.4.2 Isolation of X. Laevis Oocytes 
Oocytes were isolated from X. laevis frogs by lab technicians in Professor 
Henry Lester’s lab according to their standard operating procedure.  Briefly, 
female Xenopus laevis frogs were purchased from Nasco (Cat # LM00535MX) 
and shipped during non-extreme temperatures.  Frogs were allowed > 28 days to 
acclimate to their new environment, which consisted of charcoal-filtered tanks at 
17° C ± 1° C with a light cycle of 12 hours full spectrum fluorescent light (8:00 
am–8:00 pm) and 12 hours dark.  After anesthetizing the frog for surgery (12–15 
minutes in a solution of 1 g tricaine methanesulfonate and 1.7 g sodium 
bicarbonate in 1 l of frog tank water), a number of oocytes proportional to the 
number ordered for that day were removed from one side of the frog.  No more 
than two-thirds of the oocytes were removed in any given surgery and surgeries 
for a given frog were performed on alternating sides.  The harvested oocytes 
were separated into clumps of ~ 30 oocytes each and transferred into solution of 
0.03% collagenase (Sigma, Cat#: C9891) in OR-Mg (2 mM KCl, 20 mM MgCl2, 
82 mM NaCl, 5 mM  HEPES, pH = 7.4) in 15 ml tubes for ~ 80–100 minutes with 
slow, gentle partial inversion (~ 20 cycles per minute).  The oocytes were then 
visually inspected.  Healthy, spherical, stage V–VI oocytes of ~ 1 mm diameter 
were sorted into 60 mm dishes (Greiner Bio-One, CELLSTAR), rinsed twice with 
OR-Mg, then placed in fresh 60 mm dishes in oocyte incubation media.  
Subsequent to the first surgery for a given frog, the frog was allowed to recover 
for 14 days in an individual cage with 0.01 % gentamycin.  A maximum of six 
surgeries per donor frog, 3 on each side, were performed, after which the frog 
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was euthanized. 
2.6.4.3 Injection of Xenopus laevis Oocytes 
Immediately prior to working in the injection station, all surfaces—including 
gloves—were sprayed with 95% ethanol and allowed to dry.   The injection 
station consisted of: a microscope (Leica S6E, Spectra Services, Ontario, NY) 
with 20x eyepiece and adjustable objective (~ 0.5x–4 x), a flexible light source 
that had multiple lighting levels (Dolan-Jenner Industries, Inc., #3100, Lawrence 
MA), and x, y, z manipulator on a stable base (Nanoject Support Base, Cat #3-
000-025-SB, Drummond Scientific, Broomall, PA).  A 10 µl microdispenser (Cat 
#3-000-510-X, Drummond Digital Microdispenser) was used to control volume of 
injected solutions to within a few nl. 
Wild type or mutant receptors were expressed by preparing solutions of 
mRNA with a total mRNA concentration of ~ 1–2 ng/nl for the desired ion channel 
subunits.  In order to incorporate unnatural amino acids with the nonsense 
suppression technique, the unnatural amino acid-conjugated tRNA was 
deprotected with ~ 5–7 minutes photolysis using a 1 kW Hg(Xe) arc lamp with 
WG-335 and UG-11 filters.  Within 15 minutes of deprotection, this tRNA was 
mixed with ~ 5–25 ng mRNA of the desired mRNA containing the UAG mutation 
at the site of interest and ~ 25 ng deprotected tRNA-amino acid and the two were 
co-injected as described below. 
Injection of wild type receptors, receptors with conventional mutations, and 
receptors expressing unnatural amino acids then proceeded in similar ways, as 
follows.  Freshly flame-sterilized Inox forceps (No. 5, Dumont, Foster City, CA) 
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were used to break a previously pulled injection needle to a tip diameter of ~ 10–
20 m at the injection station.  This injection needle was then completely back 
filled with mineral oil, loaded onto the 10 µl microdispenser, and placed in the 
injection manipulator.  mRNA (or mRNA + tRNA) solution, typically 1–3 l, was 
placed on a clean coverslip and drawn into the injection needle.  Once the mRNA 
(or mRNA + tRNA) solution was placed on the coverslip, and especially under the 
light source, the amount of time that these small volumes were left on the 
coverslip was minimized since evaporation could rapidly change the RNA 
concentration.  The amount of solution actually drawn up into the injection needle 
was compared to the amount deposited on the coverslip in order to verify that the 
volume had not been significantly altered. 
 Defolliculated stage V–VI X. laevis oocytes (Nasco, Fort Atkinson, WI) 
were injected by lining them up in a custom made dish with ridged bottom, 
pressing the injection needle through the cell membrane until the membrane 
visibly bounced back, then expelling ~ 50–70 nl of the combined mRNA (or 
mRNA + tRNA) solution into the cell.  The overall injection volume was kept to 
less than 10% of the oocyte (e.g. < ~ 100 nl) in order to avoid damaging the 
oocyte membrane.  Injected oocytes were placed in 35 mm dishes (Cat #627160, 
Greiner Bio-One, CELLSTAR) with fresh incubation media.  10–40 oocytes were 
stored per 35 mm dish.  The oocyte incubation media was changed 30–60 
minutes after injection, and oocytes were incubated at 172° C with orbital 
shaking.  Subsequently oocytes were examined 6–12 hours later, then every 12–
24 hours.  During these checks, oocytes that were damaged or had begun the 
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maturation process (showing an expanding circle of degenerating membrane) 
were discarded and the media was changed.  In some cases, the health of 
injected oocytes was improved by using a new 35 mm dish each time the oocyte 
incubation media was changed. 
 
2.6.4.4 Controlling Expression Levels 
 Several ways to control the number of receptors on the oocyte surface 
were covered in the discussion section.  For receptors which commonly exhibited 
very low expression level (especially wild type α4β2), long incubation times were 
employed in order to obtain sufficiently high expression for single-channel 
recording.  Oocytes were carefully examined at each media change as described 
above, which allowed them to be kept healthy and viable for successful recording 
(single channel and whole cell) for 6–10 days post-injection and 8–15 days after 
surgical removal from the donor frog.  Since expression can vary significantly 
between oocytes from different donor frogs and waiting ~ 1 week before knowing 
expression levels is inefficient, multiple batches of oocytes were frequently 
injected in parallel.  Injecting 3 batches of oocytes was found to be the optimal 
number, though if a given receptor or mutant is reliably expressing, fewer 
batches may be sufficient for high chance of successful single-channel recording.   
 
2.6.5 Whole-Cell Recording with the OpusXpress  
Semi-automated whole-cell voltage clamp recordings of X. laevis oocytes 
expressing LGICs were performed with the OpusXpress 6000A (Molecular 
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Devices Axon Instruments, Sunnyvale, CA).  Varying types and levels of 
maintenance procedures were developed in the group in order to accommodate 
the high level of regular use of our OpusXpress 6000A (60–100 hours per week).  
The key aspects of the most common maintenance procedures are briefly 
summarized here; keep in mind that the timeline is not exact and, in many cases, 
specific aspects of the maintenance listed below were also performed as needed.    
 
2.6.5.1 Maintenance of the OpusXpress 
Weekly maintenance: The electrode holders are cleaned by completely 
disassembling and rinsing in water with stirring for 30–60 minutes.  The brass 
pin, threaded Teflon collar, and electrode wire with nylon sleeve and silicone seal 
were not rinsed.  Each piece is then dried thoroughly and carefully inspected for 
any use-related wear.  Damaged or overly worn pieces are replaced at this time; 
the most common are: electrodes losing their chloride coating, broken or missing 
AgCl pellets, cracks in the electrode holder threading, and corroded brass pins.  
Electrodes are then reassembled.  Debris is removed from solution filters by 
sonicating them in water for 10 minutes.  Headstages are inspected for corrosion 
and chambers are inspected for damage; chambers are rinsed individually by 
pipetting several ml of water to remove debris.  The liquid handler nozzles and 
headstages are wiped with a moistened Kimwipe, then allowed to dry before use. 
Monthly maintenance: In addition to the weekly maintenance, the 
headstage are sprayed tracks with Inox lubricant and fluorocarbon gel (Cat 
#911–1, The SmartGrease Co., Fairhaven, MA) is applied to the driving 
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assembly shafts; gloves are required.  Also approximately each month, all 
peristaltic tubing on pumps A, B, and the aspirator pump are replaced.  The new 
peristaltic tubing is primed by rinsing with 70% isopropanol for 10 minutes, 
followed by rinsing with water for 10 minutes.  In each case a flow rate of  
1 ml/minute is used for pump A and B and  4 ml/minute for the aspirator pump.  
It is important that the aspirator pump rate be large enough to ensure that there 
is no overflow of isopropanol or water in the chambers.  It is crucial that such 
overflow be avoided because several electrical circuit boards for the opus are 
located directly under the chambers and there is not a water-tight seal between 
the chambers and electronics.  This type of overflow generally results from 
insufficient aspiration, which can arise for several different reasons even if the 
aspiration rate is larger than the sum of pump A + pump B flow rates.  
Obstruction of the aspirator (in chamber) can be overcome by removing the 
aspirator and blowing air through it to remove any physical debris, such as 
decomposing oocyte membrane; Iight should be visible through the aspirator in 
order for it to function effectively.  The lines that lead from the chambers to the 
aspirator tubing can become disconnected even during normal usage; these 
should be checked and all appropriate washers should be used at each junction.  
A third issue affecting aspiration is that the aspirator pump itself may not 
efficiently grip the tubing.  In many cases, the ability of the pump to efficiently grip 
the peristaltic tubing to pump buffer can be greatly enhanced by the use of a 
material with moderate static friction (e.g., lab tape).   
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2.6.5.2  OpusXpress Recording Session 
A typical OpusXpress recording session is now described.  Recording 
electrodes were pulled on a Flaming/Brown P-97 horizontal puller starting with 
borosilicate glass with length 15 cm, outer diameter of 1.5 mm, and inner 
diameter of 1.17 mm (Cat #BF 150–117–15, Sutter Instrument Co., Novato, CA).  
20–30 electrodes are generally pulled in a batch before the puller filament is 
allowed to cool for 10–30 minutes. 
In order to begin preparation for a recording session, these electrodes, 
which may be pulled days or weeks in advance, were back filled with 3.0 M KCl.  
Bubbles in the electrode tip were removed by flicking and the electrodes were 
placed in electrode holders.  One of each of these holders with electrode was 
placed on each of the 16 OpusXpress headstages.  The electrodes were then 
lowered into Ca2+-free ND96 solution in the recording chambers.  Electrodes with 
resistances initially in the ranges: 0.3–3 M for current (I) electrodes and 0.3–
10 M for voltage (V) electrodes, were used for repeated experiments (multiple 
runs) as long as their resistances were still in range, they did not show drift, and 
they continued to be free of significant oocyte membrane (as indicated by visual 
inspection).  Electrodes were usually replaced every 1–2 days.  96 well drug 
plates were filled with increasing concentrations of agonist in Ca2+-free ND96 
buffer, starting with 0 and continuing to concentrations of > 10 times EC50, or 
where channel block was evident in the opus waveforms (traces) for receptors 
with Hill coefficients of ~ 2.  If the Hill coefficient of the receptor being studied is 
significantly less than 2, then the highest agonist concentration may need to be 
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closer to ~ 100 times EC50.  In all cases it is important that the dose-response 
relation when plotted on a semi-log scale (normalized current response on the y-
axis and log of concentration of agonist on the x-axis) ‘turns over’, meaning that 
there are at least a few data points at the upper concentrations that exhibit a 
normalized response of ~ 1.  Similarly, it is important that at two or more of the 
lower concentrations no activation above baseline is seen in the opus 
waveforms; one of these should be the 0 concentration.   
One oocyte was placed in each of the 8 recording chambers and impaled 
individually.  In order to maximize oocyte health, and especially if subsequent 
single-channel recording on a given oocyte is desired, oocytes should be impaled 
to the least extent, and shortest duration, possible (see Section 2.7 for further 
details).  Common recording parameters were: capacitance neutralization (0.0), 
output gain (1), ultra-high DC gain (on), and initial recording gain (1500).  
Recording gain was then optimized by increasing or decreasing gain individually 
on each impaled oocyte to achieve maximally square current responses to test 
pulses with minimal ringing (usually gain values of 3000–6000 for healthy 
oocytes).  Oocytes were then voltage clamped at a holding potential between -
40 mV and -80 mV, most typically at -60 mV.  Larger holding potentials were 
used when necessary to increase Imax.  This can be used to increase the signal-
to-noise ratio if it is too low in order to regularly and consistently determine the 
maximal response at each concentration from the opus trace.  However, this 
should be balanced against the observation that higher holding potentials often 
decrease oocyte viability over the course of an entire run.  Imax comparisons, for 
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example for relative efficacy experiments, are made at the same holding 
potentials and after similar incubation times, temperatures, and parallel treatment 
of oocytes. 
 A typical opus run was performed by applying each concentration of drug 
solution (1 ml) for 15 seconds followed by a 130 second wash with Ca2+-free 
ND96 solution between each applied drug concentration.  During drug 
application, oocytes were superfused with a flow rate of 4 ml/min; during wash, a 
flow rate of 3 ml/min was used.  Data were sampled at 125 Hz and filtered at 50 
Hz.  The run was initiated and dose-response data for all prepared agonist 
concentrations was collected for ≥ 5 oocytes with sufficient expression for each 
mutant.  It is advisable to apply at least two control doses (Ca2+-free ND96 with 
no added agonist) during each run to verify non-response as well as to 
differentiate from leak current, spontaneous openings, and fluidics effects (such 
as oocyte shearing and other membrane damage that can occur during 
recording).  For each mutant, recordings were performed on oocytes from ≥ 3 
different donor X. laevis frogs. 
 
2.6.5.3 Control Experiments for Unnatural Amino Acid Incorporation 
The fidelity of unnatural amino acid incorporation at each new site was 
verified with a ‘wild type recovery’ experiment and ‘read-
through/reaminoacylation’ tests.  In the ‘wild type recovery’ experiment, UAG 
mutant mRNA and tRNA charged with the amino acid that is present at this site 
in the wild type receptor are co-injected.   Generation of receptors that are 
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functionally indistinguishable from the wild type receptor (similar EC50 and nH) 
indicates that the residue carried by the suppressor tRNA was successfully and 
exclusively integrated into the receptor.  For the ‘read-through/reaminoacylation’ 
tests, the UAG mutant mRNA was introduced with (1) no tRNA, (2) tRNA THG73 
that is not charged with any amino acid, or (3) tRNA THG73 enzymatically ligated 
with dinucleotide dCA, but not coupled to any amino acid.  Lack of currents in 
these experiments validates the reliability of the nonsense suppression 
experiments for the corresponding specific sites. 
 
2.6.6 Single-Channel Recording (Patch Clamp) 
2.6.6.1 Building an Electrophysiology Rig for Single-Channel Recording 
(with Bruce N. Cohen) 
 
The electrophysiology rig was designed and built with emphasis on single-
channel recording of X. laevis oocytes in the cell-attached configuration.  
Mechanical stabilization, high signal-to-noise, and minimal electrical interference 
(noise) were important design factors, while the rig was not designed for fast 
perfusion.  The components listed in the results section were assembled as 
described for data acquisition, conditioning, sampling, and data storage.  Some 
of the key considerations and resulting approach are summarized here and in the 
next section. 
The CV-5 100GU headstage (gain 100 mV/pA) was equipped with a 
pipette holder that was modified with a small hole (~ 1 mm) into which a metal 
tube was inserted.  This tube was connected to a manual pressure modulator 
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(mouth pipette)—ideally the tube of a 3 ml plastic syringe with bypass valve.  
Since many components were extra, unused components (HAL lab, or 
sometimes DAD lab), each part was thoroughly dusted (Kimwipes and can of air) 
prior to use.  Dirt in the recording solutions or in the pipette tip can be fatal to 
single-channel experiments.  Additionally, all components were cleaned of any 
salt residue.  Electrical components for the rig were purchased at the Caltech 
Electrical Engineering shop (i.e., BNC cables, soldering iron and solder, heat-
activated insulator, Q-dope, etc.) or C&H Supply in Pasadena (i.e., capacitor, 
pump, miscellaneous hardware, etc.).  All other materials were obtained from the 
Caltech Biology stockroom (i.e., syringes, beakers, glass vials, tygon tubing, 
etc.), were custom made by the instrument shop (fine manipulator holder, rod to 
mount solution bottles), or purchased from commercial suppliers. 
 
2.6.6.2 Minimizing Electrical and Mechanical Noise; Grounding (with Bruce 
N. Cohen and Pam Fong) 
 
 In order to ensure that each component has the same electrical frame of 
reference, we connected all of these to a single power strip, which is preferably 
configured with no resistors in-between outlets.  Shorter cables with minimal 
looping were emphasized since extraneous current flow is more easily induced in 
looped cables.  Monitors sometimes produce high frequencies, so an LCD was 
used for the computer display.  Care was taken to route the video cable well 
away from other cables and electrical components.  Whenever possible, the 
computer hard drive is defragmented once per month.  The doors to the Faraday 
cage were grounded to the vibration isolation workstation.  In order to inhibit salt 
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accumulation from disrupting the solder connections used for grounding, these 
connections were coated with Q-dope.   
Certain configurations of the rig components resulted in increased noise.  
These were generally found and corrected by trial and error.  For example, when 
the Hum Bug was directly touching the GeneClamp 500B, a significant noise 
transient was observed.  Placing the Hum Bug on top of the filter eliminated this 
noise.  Several modifications and additions were required in order to obtain the 
level of mechanical stability and low noise required for cell-attached single-
channel recording.  A faraday cage, which is open on one side (for the vibration 
isolation workstation) and has hinged doors on one other side for general access, 
encased the following items: the recording chamber (on raised platform; 
Newport), course manipulator (for initial positioning of pipette), light, and 
dissecting microscope—which were all mounted on a leveled Newport vibration 
isolation workstation.  The fine manipulator (Narishige) was mounted separately 
in the cage, but not connected directly to the table.  No cables (headstage to 
GeneClamp 500B), grounding wires, bath electrode, or power cable for light were 
allowed to touch the table—they were either suspended from the top of the cage, 
or connected to the side of the cage.  Where possible, the overall center of mass 
of the components on the table was kept as low as possible.  To enhance this 
goal, and to generally dampen vibrations caused by motions in the rig room or 
nearby, 2 30-pound lead bricks were added to the table top.   
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2.6.6.3 Single-Channel Electrophysiology Rig Maintenance 
Similar maintenance was implemented for this electrophysiology rig as the 
above described for the opus, as applicable.  Also important are rinsing the 
perfusion lines and chamber after each use with water, regular maintenance of 
electronics, and frequent checking of the wiring/cables for salt buildup, fraying, 
and proper grounding.  Additionally, every few months the pipette holder was 
cleaned with ethanol and sonicated for 15 minutes to remove oil and dirt buildup 
that can increase noise.  Annual maintenance included deconstruction of the 
majority of the components on the table, cleaning, and reassembly. 
 
2.6.6.4 Preparation of Solutions for Single-Channel Recording 
Within 12 hours prior to recording, the recording pipette solution with the 
desired concentration of agonist was made from pipette solution.  For extended 
recording sessions, drug solutions were stored at 4° C (or on ice) if not being 
used for extended periods of time.  These solutions were moved to room 
temperature ~ 1 hour prior to use. 
 
2.6.6.5 Preparing Pipettes for Single-Channel Recording 
2.6.6.5.1 Cleaning the Pipette Glass 
KG–33 glass with I.D. = 0.80 mm +/- 0.05 mm, O.D. = 1.60 mm +/- 0.05 
mm, length = 75.0 mm +/- 3 mm (Garner Glass Company; lots: 2544, 5596, 
7687, and 8286) was cleaned by complete submersion in chromic-sulfuric acid 
(Fisher, SC88-1) for ~ 12–36 hours, followed by rinsing ≥ 4 times each with 
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alternating water and methanol, then bathing ≥ 16 hours in methanol and drying 
≥ 12 hours at ~ 110° C.  Cleaned glass was stored for ~ 6–12 months in an 
airtight container.   
 
2.6.6.5.2 Pulling Pipettes 
Pipettes with final resistances of ~ 8–25 M, were pulled from cleaned 
KG-33 glass in two stages.  Pipettes were made using two different pullers: a 
vertical puller and a horizontal Flaming/Brown P-97 electrode puller (Sutter 
Instrument Company, Novato, CA); the latter, once available, proved significantly 
more efficient. 
Vertical puller (Figure 2.10A):  This custom-built puller had a variable-
current power supply.  The filament used was a nichrome heater coil (David 
Kopf, #710).  The first pull was used to thin the glass over a length of several mm 
to a width of ~ 200 µm, this was achieved with heat of ~ 24 amperes through a 
nichrome wire looped 2.5 times with diameter of ~ 10 mm.  The glass was then 
repositioned so that the middle of the thinned portion was approximately 
centered in the filament.  Pipette tip size can be controlled by varying the precise 
positioning after the first pull and the current during the second pull.  The current 
for the second pull was adjusted—generally between 13.5 and 14.0 amperes—to 
yield pipette openings of the desired size.  A crude estimate of pipette tip size 
was regularly made and recorded for each pipette after pulling and again after 
polishing (see below).  
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Figure 2.10. Preparation of pipettes for single-channel recording.  A) The custom vertical 
puller on which some pipettes were pulled.  B) The process of applying sylgard to the 
pipette tip after pulling electrodes at 80x magnification.  The picture shows the use of the 
tip of a small needle to apply the sylgard, which is visible as globs over the entire visible 
pipette shaft.  This coating with a material of high dielectric constant increases the 
electrical isolation of the pipette tip.  The sylgard coating is also hydrophobic, so it 
prevents water from creeping up the tip when in solution.  Pictures C, D, and E are shown 
at 900x magnification.  C) A ―good‖ pipette tip (shown near a filament).  D) A pipette tip 
that has been covered in sylgard; it is unusable.  E) A pipette tip that has significant dirt 
near the tip.  If polishing on the microforge in the subsequent step doesn‘t remove this 
dirt, then the pipette should not be used.  F) Microforge used for polishing the pipette tip.  
The pipette tip is lowered near the filament, and current is passed through the filament to 
polish the pipette tip. 
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The tip size was estimated as follows: A 10 ml syringe was fitted with 
silicon tubing (here the silicon piece from Drummond Microcaps and Tygon 
tubing was used) and the back end of the pipette was placed firmly in the tubing.  
The pipette tip was then submerged in 95–100% ethanol and the plunger 
depressed slowly until bubbles were seen coming from the pipette tip.  The 
syringe reading at this time was recorded and is termed the bubble number.  
Depression until the reading is ~ 4.0 to 4.5 ml (i.e. depression of ~ 5.5 to 6.0 ml) 
typically corresponded to pipettes of ~ 10–20 M in our recording solutions.  The 
size was never directly measured, but based on viewing at high magnification 
and the resistances, the pipette tips in this range were probably ~ 0.5–3 µm in 
diameter.  
Horizontal puller: The ramp value was determined, and the program 
developed, as outlined in the Sutter Instrument Pipette Cookbook (2010 Rev F.).  
The most recently used parameters were: P = 500, heat = 510 (ramp = 520), pull 
= 000, velocity = 24, delay =1. 
For either puller, it was generally easiest to obtain a pipette tip with the 
desired size by systematically adjusting the appropriate parameters for the 
second pull.  Because, unlike whole-cell opus recording, these single-channel 
pipettes will not be inserted into the oocyte, the overall pipette morphology is less 
important than the pipette tip size and physical characteristics (such as defects) 
immediately in the vicinity of the pipette tip.  Thus, the main pipette morphology 
concern was to make pipette tips that could be filled with recording pipette 
solution as easily as possible.  Consequently, one of the key benefits of the 
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horizontal puller was that the pipettes it produced were symmetrical and almost 
always both could be used, while for the vertical puller, the pipettes were 
asymmetrical and the lower pipettes generally had long, thin tips that made them 
nearly impossible to remove bubbles from for recording.  Also, for both the 
vertical and horizontal pullers, significant variation in pipette-to-pipette tip size 
was common, even when identical settings were used.  In order to maximize 
filament life, and diminish pipette-to-pipette size variation, no more than several 
successive pulls were performed on either puller, generally corresponding to 5–
10 pipettes at a time.  A break of 10–30 minutes of non-use of the puller was 
generally sufficient to prevent overheating and increase consistency in pipette tip 
size. 
 
2.6.6.5.3 Applying Sylgard and Polishing the Pipette Tip 
Sylgard (World Precision Instruments, SYLG184) was then applied to 
within ~ 20–100 µm of the pipette tip using the tip of a 23 gauge needle (Becton 
Dickinson & Co).  The Sylgard was cured by ~ 10–20 seconds of gentle rotation 
of the pipette, with freshly coated tip up, in a stream of hot air from a heat gun. 
Pipettes at this stage can be stored for ~ 14 days in an air-tight container.  
Pipette tips were polished for ~ 15–30 seconds on a microforge with a compound 
microscope providing 900x magnification (15 x eyepieces, 60 x objective, NA 
0.70), usually immediately before recording and preferably no more than several 
hours before use.  At this magnification, openings in tips of pipettes with bubble 
number ~ 4.4 or larger are clearly discernible.  After polishing the pipette tip, the 
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bubble number was again tested and recorded.  The bubble number should be 
measurably lower than it was after being initially pulled; in my experience, a 
decrease of ~ 0.2 to 0.5 ml best facilitates gigaseal formation.  This level of 
decrease in bubble number is often accompanied by a visible change in the 
pipette tip morphology—the tip becomes slightly darker and tapers to a narrower 
diameter.  If there was no change in the bubble number or no change in the 
pipette tip, the pipette tip was polished a second time.  Pipettes were then stored, 
coated tip up, in a closed plastic box (Biology stockroom) affixed in clay to 
prevent contamination.  The high magnification of the microforge allowed for 
unsuitable pipettes to be identified and discarded before attempting to record 
with them.  For example, in some cases, sylgard accidentally covered the pipette 
tip making it unusable (Figure 2.10D).  In other cases, dirt near the tip was 
readily visible (Figure 2.10E).  If this dirt did not disappear with polishing, then 
the pipette was discarded.  These factors, in addition to the occasional breakage 
of the pipette tip and small pipettes/overpolishing (which lead to pipette tips that 
cannot be filled) contributed to the overall 40% attrition rate (Table 2.2). 
 
2.6.6.6 Single-Channel Recording 
2.6.6.6.1 Preparing the Oocyte for Single-Channel Recording 
 One to three oocytes were placed in hypertonic solution (oocyte stripping 
solution) for 15–30 minutes.  After this incubation, the oocyte(s) were visually 
inspected to determine if the vitelline membrane (Figure 2.11) had separated 
from at least part of the oocyte.  Since the hypertonic solution doesn’t cause the 
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vitelline membrane to swell, but rather causes the oocyte’s cell membrane to 
shrink, the oocyte generally appeared dimpled or slightly creased in one or more 
regions when it was ready to have its vitelline membrane stripped.  When this 
was the case, the vitelline membrane was generally visible as a translucent, 
colorless membrane that was separated from the oocyte membrane by up to 
~50–100 µm.    
 
Figure 2.11. A schematic of a stage V or VI oocyte from a Xenopus laevis frog ovary.  This 
cell has an approximate diameter of 1 mm.  The outermost, irregular follicular cell layer is 
removed during the initial oocyte preparation by digestion with collagenase and 
subsequent orbital shaking for 12–24 hours.  Here the vitelline membrane is shown as a 
thick black layer that surrounds the entire oocyte.  In hypertonic solution, the oocyte‘s 
membrane shrinks away from the vitelline membrane allowing the vitelline membrane to 
be manually stripped from the oocyte.  The oocyte is bipolar with a darker animal pole 
(upper) and lighter vegetal pole (lower).  This is of practical application in single-channel 
recording because it is often easier to record on the animal pole, since positioning of the 
pipette over this pole allows for maximal contrast between the pipette tip and easy pipette 
manipulation while minimizing the chances of accidentally touching the oocyte 
prematurely.  Some oocytes also display a lighter color band around the hemisphere 
between the animal and vegetal poles.  (From The Axon CNS Guide, 3rd Edition) 
 
The oocyte’s vitelline membrane was then gently stripped using 2 pairs of 
jeweler’s forceps (Dumont, No. 5). This step takes some practice; it was usually 
easier to strip the vitelline membrane from oocytes that had been allowed to 
recover 1–2 hours after whole-cell recording (see discussion section on ‘Single-
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Channel and Whole-Cell Recording on the Same Oocyte’ for details).  Oocytes 
should not be left in the hypertonic solution for more than ~ 1 hour because the 
oocytes osmoregulate over time and return to their normal volume, at which point 
stripping the vitelline membrane becomes very difficult.   
I developed the following procedure for stripping the vitelline membrane 
with a high level of success (80–90%).  It involved gripping the vitelline 
membrane with one pair of sharp-tipped jeweler’s forceps (Dumont No. 5) and 
pulling slightly (~ 200 µm, or 1/5th the diameter of the oocyte) away from the 
oocyte; only the vitelline membrane should move.  Using a second pair of 
jeweler’s forceps, part of the vitelline membrane that was now being pulled away 
from the oocyte was grasped.  The two forceps were then slowly pulled away 
from each other.  In the ideal case, the oocyte rolls out of the vitelline membrane, 
which comes off in a single piece.  But, in some cases, the vitelline membrane 
comes off the oocyte in a few separate pieces, so it is important to keep track of 
the vitelline membrane to ensure that all of it has been removed.  Vitelline 
membrane that remains on the oocyte can interfere with gigaseal formation and 
recording.  The devitellinized oocyte was then transferred to a separate 35 mm 
dish with bath solution for 1-2 minutes, then transferred to the recording chamber 
which was filled with bath solution (~ 1 ml).  Once devitellinized, it is important to 
avoid contact with the air-water interface, which can cause the oocyte membrane 
to rupture.  The two forceps are wiped gently with a moistened Kimwipe after 
each use and not used for any other purpose in order to ensure that the tips stay 
sufficiently sharp for grasping and removing the vitelline membrane. 
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2.6.6.6.2 Final Pipette and Rig Preparation for Single-Channel Recording 
The tips of sylgarded, polished pipettes were filled by submerging them in 
the drug pipette solution and applying suction to the back of the pipette for ~ 30–
60 seconds. The same 10 ml syringe used to test the ‘bubble number’ can be 
used to apply this suction, provided that it is kept dry.  During this time, the 
progress of filling the pipette tip was monitored by viewing the pipette against a 
strong light source for contrast.  The back end of the pipette was then fire 
polished for ~ 3–5 seconds in the flame of a small butane torch (~ 2-cm-long 
flame) until the back end of the pipette ass visibly smooth and rounded.  This 
step is important to reduce the extent to which the pipette scratches chloride off 
of the AgCl wire for the pipette (see below).  Once cooled to room temperature, 
the pipette is then back filled with the same drug solution as was used to fill the 
tip, using a 28 gauge syringe needle (World Precision Instruments, MF28G-5) 
and 1 ml syringe with attached 0.2 µm nylon filter and flicked until all bubbles 
have been removed from the tip.  This sometimes took up to a few minutes of 
intermittent flicking and vertical standing (in clay), especially for smaller pipette 
tips—with polished bubble number < 4.0—that may not have been significantly 
filled with the suction step for tip filling.  Since sylgard applied near the pipette tip 
sometimes made it hard to unambiguously identify bubbles as opposed to 
uneven sylgard distribution, as pipettes were filled they were again viewed 
against a strong light source to aid in identification of bubbles.  A single-channel 
pipette with a bubble cannot be used for recording.   
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Once prepared, the pipette was loaded into the electrode holder with AgCl 
wire.  I re-chlorided the silver wire prior to each recording session and any time 
that silver is visible on the wire (shiny as opposed to dull brown) by submersion 
in household bleach for 15–30 minutes, until dull brown in color.  Do not chloride 
the entire length of the wire, as the non-pipette end must make electrical contact 
with the brass pin that connects to the headstage in the pipette holder.  Ag wires 
can generally be re-chlorided 3–5 times.  Sometimes, Ag wires were cleaned in a 
flame, but these often proved difficult to re-chloride evenly.  Once the pipette is 
secured on the headstage, positive pressure is applied and the solution level in 
the chamber is reduced to ~ 1–2 mm above the oocyte by gently sucking off the 
top layer of solution with a Pasteur pipette.  In our rig, this leaves ~ 300 µl of bath 
solution in the chamber.  It is important not to disrupt the oocyte membrane at all 
at this stage to minimize the occurrence of events from mechanosensitive 
channels (see Section 2.6.6.6.4 for further details).  The application of positive 
pressure to the pipette and aspiration of the top layer of solution are important 
steps to prevent clogging of the pipette tip before a gigaseal is formed with the 
oocyte.  An additional precaution taken was to refilter the drug solutions (0.2 µm 
nylon filter) before each recording session, especially if gigaseal formation was 
problematic.   
The pipette was introduced into the recording bath at a steep angle of 60–
70°.  This, in addition to prior reduction of the bath solution volume, minimized 
the length of the pipette in contact with the solution and the resultant noise.  The 
course and fine manipulators were then adjusted to place the tip of the pipette 
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within ~ 200 μm of the oocyte without touching it.  All unnecessary AC electronics 
(especially lights) were then turned off and the pipette resistance was tested and 
recorded as the solution resistance.  Final approach to the oocyte occurred with 
the fine manipulator (Narishige) while applying a 100 µV seal test.  Contact with 
the oocyte was recognized as a small baseline deflection on the oscilloscope 
accompanied with a 1.5- to 3-fold increase in the pipette resistance.   
 
2.6.6.6.3 Obtaining the Cell-Attached Configuration for Single-Channel 
Recording 
 
 Once the pipette was in contact with the oocyte membrane, data 
acquisition was initiated, then gentle suction was applied by mouth as soon as 
possible in order to minimize channel activity that might be missed as channels 
desensitize (Figure 2.12).  Often, gigaseal formation occurred nearly 
instantaneously, but sometimes took as many as several minutes with 
intermittent gentle suction.  In other cases, success in forming a gigaseal was 
achieved after additional advancement of the pipette and application of moderate 
suction.  In some cases, small negative pipette potentials (-5 to -50 mV) 
facilitated gigaseal formation, though this process was often slow.  Once a 
gigaseal of several to hundreds of gΩ was formed, the desired pipette potential 
was applied.   
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Figure 2.12. A diagram of the physical and electrical connection between the recording 
pipette and the oocyte membrane.  As is described in text, the gigaseal is formed by 
pressing the pipette tip against the oocyte, then applying suction.  This process results in 
an electrically isolated patch of membrane that is believed to be partially sealed to the 
inside of the pipette in addition to the rim, producing an ‗omega‘-like shape in the pipette 
tip.  VCMD controls the applied pipette potential through the AgCl wire. (Adapted from 
Sigworth and Neher, 1980(29)) 
 
Data were collected using a GeneClamp 500B amplifier (Axon 
Instruments) at full bandwidth (50 kHz; 4-pole Bessel, -3 dB) with a CV-5 100GU 
headstage.  The signal was then low-pass filtered (Avens Signal Equipment, 
AP220, 20 kHz; 8-pole Bessel, -3 dB), sampled with a Digidata 1320A (50 kHz), 
and acquired in Clampex 9.2 (Axon Instruments).  Channel openings and 
closings were observed as nearly discrete changes in the measured current 
when the signal was large enough with respect to the noise (usually ~ 3–10-fold).  
Once the gigaseal was lost, sufficient data (number of events) were collected, or 
further channel activity seemed unlikely due to channel desensitization or 
inactivation, the data acquisition was stopped.  In some cases, recordings were 
performed at multiple pipette potentials on a single patch in single or multiple 
recording files (see Figure 2.6). 
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2.6.6.6.4 Controls for Single-Channel Recording 
 Where appropriate, several single-channel controls, whose purpose was 
described in more detail in the discussion section, were performed.  These 
included: recording in the cell-attached configuration in the absence of agonist, 
recording with and without agonist on uninjected oocytes, recording after 
deliberately patching onto an oocyte-sized blob of sylgard, and applying gentle, 
moderate, and significant suction to the patch during recording. 
The key additional step that we added, which seemed to significantly 
reduce the occurrence of endogenous channel events, was to allow the oocyte to 
sit in the recording chamber for 15 minutes after stripping the oocyte’s vitelline 
membrane.  15 minutes in the chamber was generally sufficient, though this time 
length can readily be extended if endogenous activity is still seen. 
 
2.6.6.6.5 Outside-Out Configuration for Single-Channel Recording 
 Attempts were made to achieve the outside-out patch configuration using 
both common methods to obtain the intermediate whole-cell configuration: 
significant suction and large voltage pulses(21).  Though development of this 
recording configuration was not pursued extensively, my qualitative observation 
from trying each method a few times was that the suction method gave a better 
chance of obtaining the necessary intermediate whole-cell mode.  Subsequent 
withdrawl of the pipette from the oocyte produced the outside-out patch 
configuration on some occasions.  One of the best examples was shown in 
Figure 2.5.  Since the outside-out configuration allows for multiple 
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concentrations, or even multiple agonists, to be applied to the same channel(s), it 
may be worth pursuing for single-channel dose-response studies.  Also, the 
outside-out patch configuration could prove useful for receptors that are low 
expressing, since it often monitors a larger patch of membrane than the cell-
attached method. 
 
A useful overview and tutorial for many aspects of single-channel 
recording of ligand-gated ion channels is available(56). 
 
2.6.7 Combined Single-Channel and Whole-Cell Recording of Single 
X. Laevis Oocytes 
 
 Oocytes were first recorded, as described in Section 2.5, on the 
OpusXpress.  Extra care was taken to use opus electrodes that were as small as 
possible (toward the high ends of the respective resistance ranges) and the 
amount of time that oocytes spent impaled and voltage clamped was minimized.  
Immediately at the conclusion of the run, the electrodes were slowly removed 
(not using the ‘home’ function; instead by slowly backing the electrodes out).  
The oocytes were then gently removed from the opus chambers and transferred 
to individual wells of 12 well plates with fresh oocyte incubation media.  Each well 
was labeled to indicate which recording chamber the oocyte came from for future 
correlation of the whole-cell and single-channel data.  The oocytes were allowed 
to heal for 1–10 hours at 18° C with orbital shaking; usually a minimum of 3 hours 
was necessary before the next step.  
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Once visual inspection of the oocytes revealed that the membrane 
appeared to have healed—no remaining gashes from the whole-cell electrodes—
an oocyte was transferred to hypertonic stripping solution.  These previously 
opus-recorded oocytes were monitored carefully when they were in the 
hypertonic stripping solution.  In some cases, oocyte health rapidly declined 
leading to disintegrating oocytes, especially if the oocyte membrane had not 
completely recovered after the whole-cell recording.  In other cases, opus-
recorded oocytes appeared not to display the characteristic shrinking in 
hypertonic stripping solution.  Nevertheless, in several cases, cells that were 
opus recorded (often after expression tests—one or two high doses of agonist—
and/or voltage ramps; see Chapters 5 and 6 for methods description) were 
successfully stripped and single-channel recording was performed as described 
in Section 2.6.6.6.  One example was shown in Figure 2.5, in both the cell-
attached and outside-out configurations for an oocyte that was previously 
recorded on the OpusExpress.  With proper attention to the above details, 
success rates of ~ 30–50% should be possible.   
 
2.6.8 Data Analysis  
2.6.8.1 Analysis of Whole-Cell Data 
Each opus data file (trace) was opened in Clampfit (Axon Instruments, 
Union City, CA) and the baseline was defined.  A baseline current that is non-
zero can be of two different categories: (1) leak current and (2) constitutive 
activity.  Leak current occurs when current that is not flowing through ion 
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channels is measured.  This is correlated to the property of initial membrane 
potential at the start of an opus run, as was shown in Figure 2.8, and so appears 
to be related to general oocyte health.  Constitutive activity was addressed in the 
discussion.  Baseline was defined as the average current of a 10 second period 
before the drug was applied and was corrected for significant slope, as 
necessary.  Peak response was measured as the largest current deflection from 
baseline.  This process was carried out in parallel for all oocytes in a given run, 
then repeated for the current traces at each concentration.  EC50 and the Hill 
coefficient (nH), with standard errors for each, were determined by fitting the 
normalized current responses versus agonist concentration to the Hill equation 
(Equation 2.1)(57).  In this equation, I is the measured current at a given agonist 
concentration, [A], Imax is maximal response, EC50 is the effective concentration 
that produces the half-maximal current response, and nH is the Hill coefficient.  
Briefly, each oocyte’s normalized current response and corresponding drug 
concentration were plotted on a semi-log scale.  The absence of current 
response to control dose (no drug) was verified.  When oocytes could live 
through long runs the control doses were done as both the first dose and last 
dose to ensure reversibility.  Larger standard error values were frequently 
observed for the regions of the dose-response curve that are near EC50. 

I /Imax 1/ 1
EC50 
[A]






nH







   (Equation 2.1) 
 To determine whether or not a dose-response relation has multiple 
components, as opposed to having a low nH, the F-test was used to determine 
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whether 1 component (monophasic) or 2 components (biphasic) best fits the 
dose-response data, while accounting for the fact that increasing the number of 
components increases the degrees of freedom and so necessarily produces a 
better fit. 
On occasion, additional analysis of opus traces was performed.  For 
example, whole-cell activation and deactivation kinetics were sometimes 
determined by fitting the rising and falling currents in opus traces, as previously 
described(35).   
 
2.6.8.2 Analysis of Single-Channel Data 
 A wide variety of different analyses of single-channel data was performed, 
as dictated by the goals of each project in this thesis.  Details for each are given 
in the appropriate chapters.  In each case, methods are presented for the 
combined analysis and interpretation of single-channel and whole-cell data, often 
including channels expressing unnatural amino acids.  Most analysis was done in 
Clampfit 9.2 using the single-channel search function (event detection); some 
analysis was done in QuB.  Key parameters analyzed were: single-channel 
conductance, NPopen, τopen, and τclosed (especially to determine τcrit and allow for 
estimation of Popen).  In favorable cases, and when using QuB to fit single-
channel data across multiple concentrations(38-41), I made some progress 
towards determining specific rate constants, such as the channel closing rate (α) 
and apparent opening rate (β’).   
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 A general method for ‘cleaning up’ single-channel data prior to analysis 
has been proposed(58).  We feel that the addition of the steps presented in the 
discussion section on ‘Controls for Single-Channel Recording’ and Appendix B 
make our data clean up and subsequent analysis more robust and reproducible.  
The extent to which our analysis is robust is demonstrated in many ways, 
including that on two occasions when a single-channel record was analyzed 
separately by two members of the lab (Shawna Frazier and Jai Shanata in one 
case; Ximena Da Silva and Jai Shanata in the other), quantitatively 
indistinguishable results were achieved for Popen calculations. 
 
2.7 References 
1. Hutchison, C. A., 3rd, Phillips, S., Edgell, M. H., Gillam, S., Jahnke, P., 
and Smith, M. (1978) Mutagenesis at a specific position in a DNA 
sequence, J Biol Chem 253, 6551-6560. 
2. Nowak, M. W., Gallivan, J. P., Silverman, S. K., Labarca, C. G., 
Dougherty, D. A., and Lester, H. A. (1998) In vivo incorporation of 
unnatural amino acids into ion channels in Xenopus oocyte expression 
system, Methods in enzymology 293, 504-529. 
3. Papke, R. L., Millhauser, G., Lieberman, Z., and Oswald, R. E. (1988) 
Relationships of agonist properties to the single channel kinetics of 
nicotinic acetylcholine receptors, Biophys J 53, 1-10. 
4. Blum, A. P., Lester, H. A., and Dougherty, D. A. (2010) Nicotinic 
pharmacophore: the pyridine N of nicotine and carbonyl of acetylcholine 
hydrogen bond across a subunit interface to a backbone NH, Proc Natl 
Acad Sci U S A 107, 13206-13211. 
5. Chakrapani, S., Bailey, T. D., and Auerbach, A. (2004) Gating dynamics of 
the acetylcholine receptor extracellular domain, The Journal of general 
physiology 123, 341-356. 
6. Colquhoun, D. (1998) Binding, gating, affinity and efficacy: the 
interpretation of structure-activity relationships for agonists and of the 
effects of mutating receptors, Br J Pharmacol 125, 924-947. 
7. Gleitsman, K. R., Shanata, J. A., Frazier, S. J., Lester, H. A., and 
Dougherty, D. A. (2009) Long-range coupling in an allosteric receptor 
revealed by mutant cycle analysis, Biophys J 96, 3168-3178. 
113 
 
8. Grosman, C., Salamone, F. N., Sine, S. M., and Auerbach, A. (2000) The 
extracellular linker of muscle acetylcholine receptor channels is a gating 
control element, The Journal of general physiology 116, 327-340. 
9. Grosman, C., Zhou, M., and Auerbach, A. (2000) Mapping the 
conformational wave of acetylcholine receptor channel gating, Nature 403, 
773-776. 
10. Lee, W. Y., and Sine, S. M. (2005) Principal pathway coupling agonist 
binding to channel gating in nicotinic receptors, Nature 438, 243-247. 
11. Xiu, X., Hanek, A. P., Wang, J., Lester, H. A., and Dougherty, D. A. (2005) 
A unified view of the role of electrostatic interactions in modulating the 
gating of Cys loop receptors, J Biol Chem 280, 41655-41666. 
12. Dougherty, D. A. (2008) Physical organic chemistry on the brain, J Org 
Chem 73, 3667-3673. 
13. Hanek, A. P., Lester, H. A., and Dougherty, D. A. (2008) A stereochemical 
test of a proposed structural feature of the nicotinic acetylcholine receptor, 
J Am Chem Soc 130, 13216-13218. 
14. Kearney, P. C., Zhang, H., Zhong, W., Dougherty, D. A., and Lester, H. A. 
(1996) Determinants of nicotinic receptor gating in natural and unnatural 
side chain structures at the M2 9' position, Neuron 17, 1221-1229. 
15. Lummis, S. C., Beene, D. L., Lee, L. W., Lester, H. A., Broadhurst, R. W., 
and Dougherty, D. A. (2005) Cis-trans isomerization at a proline opens the 
pore of a neurotransmitter-gated ion channel, Nature 438, 248-252. 
16. Xiu, X., Puskar, N. L., Shanata, J. A., Lester, H. A., and Dougherty, D. A. 
(2009) Nicotine binding to brain receptors requires a strong cation-pi 
interaction, Nature 458, 534-537. 
17. Zhong, W., Gallivan, J. P., Zhang, Y., Li, L., Lester, H. A., and Dougherty, 
D. A. (1998) From ab initio quantum mechanics to molecular neurobiology: 
a cation-pi binding site in the nicotinic receptor, Proc Natl Acad Sci U S A 
95, 12088-12093. 
18. Colquhoun, D., and Hawkes, A. G. (1982) On the stochastic properties of 
bursts of single ion channel openings and of clusters of bursts, 
Philosophical transactions of the Royal Society of London 300, 1-59. 
19. Filatov, G. N., and White, M. M. (1995) The role of conserved leucines in 
the M2 domain of the acetylcholine receptor in channel gating, Mol 
Pharmacol 48, 379-384. 
20. Leonard, R. J., Labarca, C. G., Charnet, P., Davidson, N., and Lester, H. 
A. (1988) Evidence that the M2 membrane-spanning region lines the ion 
channel pore of the nicotinic receptor, Science 242, 1578-1581. 
21. Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. 
(1981) Improved patch-clamp techniques for high resolution current 
recording from cells and cell-free membrane patches, Pflugers Arch. 391, 
85-100. 
22. Dascal, N. (1987) The use of the Xenopus oocyte system for the study of 
ion channels, CRC Crit. Rev. Biochem. 22, 317-387. 
23. Weiss, D. S., and Magleby, K. L. (1989) Gating scheme for single GABA-
activated Cl- channels determined from stability plots, dwell-time 
114 
 
distributions, and adjacent-interval durations, The Journal of 
neuroscience: the official journal of the Society for Neuroscience 9, 1314-
1324. 
24. Hille, B. (2001) Ion channels of excitable membranes, 3rd ed., Sinauer, 
Sunderland, Mass. 
25. Mathie, A., Cull-Candy, S. G., and Colquhoun, D. (1987) Single-channel 
and whole-cell currents evoked by acetylcholine in dissociated 
sympathetic neurons of the rat, Proceedings of the Royal Society of 
London. Series B, Containing papers of a Biological character 232, 239-
248. 
26. Labarca, C., Nowak, M. W., Zhang, H., Tang, L., Deshpande, P., and 
Lester, H. A. (1995) Channel gating governed symmetrically by conserved 
leucine residues in the M2 domain of nicotinic receptors, Nature 376, 514-
516. 
27. Charnet, P., Labarca, C., Cohen, B. N., Davidson, N., Lester, H. A., and 
Pilar, G. (1992) Pharmacological and kinetic properties of a4b2 neuronal 
nicotinic acetylcholine receptors expressed in Xenopus oocytes, J Physiol 
450, 375-394. 
28. Gleitsman, K. R., Kedrowski, S. M., Lester, H. A., and Dougherty, D. A. 
(2008) An intersubunit hydrogen bond in the nicotinic acetylcholine 
receptor that contributes to channel gating, J Biol Chem 283, 35638-
35643. 
29. Sigworth, F. J., and Neher, E. (1980) Single Na+ Channel Currents 
Observed in Cultured Rat Muscle-Cells, Nature 287, 447-449. 
30. Molleman, A. (2003) Patch clamping: an introductory guide to patch clamp 
electrophysiology, J. Wiley, New York. 
31. Auerbach, A. (1991) Single-channel dose-response studies in single, cell-
attached patches, Biophys J 60, 660-670. 
32. Haghighi, A. P., and Cooper, E. (2000) A molecular link between inward 
rectification and calcium permeability of neuronal nicotinic acetylcholine 
a3b4 and a4b2 receptors, J Neurosci 20, 529-541. 
33. Nishino, A., Baba, S. A., and Okamura, Y. (2011) A mechanism for graded 
motor control encoded in the channel properties of the muscle ACh 
receptor, Proc Natl Acad Sci U S A 108, 2599-2604. 
34. Colquhoun, D. (2006) Agonist-activated ion channels, British journal of 
pharmacology 147 Suppl 1, S17-26. 
35. Wang, J., Lester, H. A., and Dougherty, D. A. (2007) Establishing an ion 
pair interaction in the homomeric rho1 gamma-aminobutyric acid type A 
receptor that contributes to the gating pathway, J Biol Chem 282, 26210-
26216. 
36. Sakmann, B., and Neher, E. (1995) Single-channel recording, 2nd ed., 
Plenum Press, New York. 
37. Mukhtasimova, N., and Sine, S. M. (2007) An intersubunit trigger of 
channel gating in the muscle nicotinic receptor, J Neurosci 27, 4110-4119. 
38. Qin, F., and Li, L. (2004) Model-based fitting of single-channel dwell-time 
distributions, Biophys J 87, 1657-1671. 
115 
 
39. Qin, F. (2004) Restoration of single-channel currents using the segmental 
k-means method based on hidden Markov modeling, Biophys J 86, 1488-
1501. 
40. Qin, F., Auerbach, A., and Sachs, F. (2000) Hidden Markov modeling for 
single channel kinetics with filtering and correlated noise, Biophys J 79, 
1928-1944. 
41. Qin, F., Auerbach, A., and Sachs, F. (2000) A direct optimization approach 
to hidden Markov modeling for single channel kinetics, Biophys J 79, 
1915-1927. 
42. Changeux, J. P., and Edelstein, S. J. (2005) Allosteric mechanisms of 
signal transduction, Science 308, 1424-1428. 
43. Rayes, D., Spitzmaul, G., Sine, S. M., and Bouzat, C. (2005) Single-
channel kinetic analysis of chimeric alpha7-5HT3A receptors, Mol 
Pharmacol 68, 1475-1483. 
44. Kalbaugh, T. L. (2004) Ligand-binding residues integrate affinity and 
efficacy in the NMDA receptor, Mol Pharmacol 66, 209-219. 
45. Lape, R., Colquhoun, D., and Sivilotti, L. G. (2008) On the nature of partial 
agonism in the nicotinic receptor superfamily, Nature 454, 722-727. 
46. Lape, R., Krashia, P., Colquhoun, D., and Sivilotti, L. G. (2009) Agonist 
and blocking actions of choline and tetramethylammonium on human 
muscle acetylcholine receptors, J Physiol 587, 5045-5072. 
47. Sivilotti, L. G. (2010) What single-channel analysis tells us of the activation 
mechanism of ligand-gated channels: the case of the glycine receptor, J 
Physiol 588, 45-58. 
48. McManus, O. B., Blatz, A. L., and Magleby, K. L. (1987) Sampling, log 
binning, fitting, and plotting durations of open and shut intervals from 
single channels and the effects of noise, Pflugers Arch 410, 530-553. 
49. Fredkin, D. R., and Rice, J. A. (1991) On the Superposition of Currents 
from Ion Channels, Philos T Roy Soc B 334, 347-356. 
50. Reifarth, F. W., Clauss, W., and Weber, W. M. (1999) Stretch-independent 
activation of the mechanosensitive cation channel in oocytes of Xenopus 
laevis, Biochim Biophys Acta 1417, 63-76. 
51. Silberberg, S. D., and Magleby, K. L. (1997) Voltage-induced slow 
activation and deactivation of mechanosensitive channels in Xenopus 
oocytes, The Journal of physiology 505 (Pt 3), 551-569. 
52. Charnet, P., Labarca, C., and Lester, H. A. (1992) Structure of the 
gamma-less nicotinic acetylcholine receptor: learning from omission, Mol 
Pharmacol 41, 708-717. 
53. Jackson, M. B., Imoto, K., Mishina, M., Konno, T., Numa, S., and 
Sakmann, B. (1990) Spontaneous and agonist-induced openings of an 
acetylcholine receptor channel composed of bovine muscle alpha-, beta- 
and delta-subunits, Pflugers Archiv: European journal of physiology 417, 
129-135. 
54. Jackson, M. B. (1984) Spontaneous openings of the acetylcholine 
receptor channel, Proc Natl Acad Sci U S A 81, 3901-3904. 
116 
 
55. Sachs, F., and Qin, F. (1993) Gated, Ion-Selective Channels Observed 
with Patch Pipettes in the Absence of Membranes - Novel Properties of a 
Gigaseal, Biophysical Journal 65, 1101-1107. 
56. Mortensen, M., and Smart, T. G. (2007) Single-channel recording of 
ligand-gated ion channels, Nat Protoc 2, 2826-2841. 
57. Weiss, J. N. (1997) The Hill equation revisited: uses and misuses, Faseb J 
11, 835-841. 
58. Elenes, S., and Auerbach, A. (2002) Desensitization of diliganded mouse 
muscle nicotinic acetylcholine receptor channels, J Physiol 541, 367-383. 
 
 
117 
 
 
Chapter 3 
 
Long-Range Coupling in an Allosteric Receptor 
Revealed by Mutant Cycle Analysis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sections 3.1 through 3.8 of this chapter are reprinted from Biophysical Journal, 96. Kristin Rule 
Gleitsman, Jai A.P. Shanata, Shawnalea J. Frazier, Henry A. Lester, and Dennis A. Dougherty.  
Long-Range Coupling in an Allosteric Receptor Revealed by Mutant Cycle Analysis, 3168–178. 
Copyright (2009) with permission from Elsevier.  
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3.1 Abstract 
 The functional coupling of residues that are far apart in space is the 
quintessential property of allosteric proteins.  For example, in Cys-loop receptors 
the gating of an intrinsic ion channel is allosterically regulated by the binding of 
small molecule neurotransmitters 50–60 Å from the channel gate.  Some 
residues near the binding site must have as their primary function the 
communication of the binding event to the gating region.  These gating pathway 
residues are essential to function, but their identification and characterization can 
be challenging.  The present work introduces a simple strategy, derived from 
mutant cycle analysis, for identifying gating pathway residues using macroscopic 
measurements alone.  In the exemplar Cys-loop receptor, the nicotinic 
acetylcholine receptor, a well-characterized reporter mutation (βL9’S) known to 
impact gating was combined with mutations of target residues in the ligand-
binding domain hypothesized or previously found to be functionally significant.  A 
mutant cycle analysis of the macroscopic EC50 measurements can then provide 
insights into the role of the target residue.  This new method—elucidating long-
range functional coupling in allosteric receptors (ELFCAR)—can be applied to a 
number of reporter mutations in a wide variety of receptors to identify both 
previously characterized and novel mutations that impact the gating pathway.  
We support our interpretation of macroscopic data with single-channel studies.  
ELFCAR should be broadly applicable to determining functional roles of residues 
in allosteric receptors. 
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 3.2 Introduction 
 Cys-loop receptors mediate fast synaptic transmission throughout the 
central and peripheral nervous systems.2-5  These pentameric, ligand-gated ion 
channels are prototypical allosteric receptors,6 in that the activation (gating) of an 
intrinsic ion channel is allosterically regulated by the binding of small molecule 
neurotransmitters (acetylcholine (ACh), serotonin, GABA, or glycine).  While 
valuable structural insights for Cys-loop receptors have appeared in recent 
years,1, 7 detailed conformational mechanisms linking neurotransmitter binding to 
channel gating remain elusive.  
 Structurally, Cys-loop receptors have two principal functional domains 
(Figure 3.1).  The extracellular domain, rich in β-sheet structure, contains the 
agonist binding sites.  Each subunit also contains a transmembrane domain 
comprised of four membrane-spanning helices, one of which (M2) lines the ion 
channel.  While the precise location of the channel gate has been debated, the 
consensus positions it at or below the middle of the M2 helix.  This puts the 
channel gate some 50–60 Å away from the agonist binding sites.  
Neurotransmitter binding events must therefore be communicated over this 
distance to the channel gate.  
 In terms of function, such a clear demarcation of domains is less evident.  
For a given residue, if a mutation at the site leads to a change in receptor 
function, this could be because the binding of agonist or the gating of the channel 
(or both) has changed.  It seems safe to say that residues in the middle of the 
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transmembrane domain do not contribute directly to agonist binding, and so 
residues in the transmembrane domain that contribute to function are typically 
described as ‘gating’ residues.  In contrast, one expects to find residues in the 
extracellular domain with varying functional roles.  Some residues will primarily 
facilitate agonist binding, either by directly contacting the agonist or by refining 
the shape or electronic properties of the agonist binding site. However, to 
achieve the long-range communication that is fundamental to Cys-loop receptor 
function, other extracellular domain residues must be involved in communicating 
the binding event to the channel gate, serving an instrumental role in the gating 
pathway. These gating pathway residues are in some ways the most interesting, 
but their identification and characterization can be challenging. 
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Figure 3.1. Residues considered here.  Shown are two adjacent subunits of the cryo-EM 
structure of the Torpedo nAChR (pdb 2BG9).
1
  The reporter residues in the transmembrane 
domain are shown as cyan and are labeled.  Residues in the extracellular domain are in 
two classes:  those with no long-range coupling (purple) and the five residues that show 
significant long-range coupling (orange).  One non-coupling residue (γE168) is not defined 
in the EM structure and so is not shown. 
 
 One strategy for determining whether a given residue primarily contributes 
to agonist binding or channel gating involves single-channel recording on 
appropriate mutants, followed by kinetic analysis.  However, in some Cys-loop 
122 
 
receptors (such as 5-HT3)
8, single-channel conductances are too small for 
reliable kinetic analyses;9, 10 in many other Cys-loop receptors, single-channel 
kinetics are complex or nonstationary, again vitiating single-channel kinetic 
analysis.11, 12  Also, in other ion channels13 and in allosteric receptors in general, 
single-channel studies are often not possible. 
 A more broadly applicable approach, allowing one to efficiently evaluate a 
number of mutants in search of unusual behavior, is to measure macroscopic 
currents across multiple concentrations.  This produces the EC50 value, the 
concentration that induces half-maximal current in response to applied agonist, 
along with comparative measurements of maximal agonist-induced currents.  In 
the case of ligand-gated ion channels, EC50 is a composite value, being 
responsive to both changes in agonist binding and channel gating behaviors.  As 
such, it can be challenging to interpret shifts in EC50.  Here we describe an 
approach to use the readily obtained EC50 values to identify residues that 
substantially impacting receptor gating.  We refer to the method as ELFCAR 
(elucidating long-range functional coupling of allosteric receptors).  The basic tool 
involves mutant cycle analysis of EC50 values for distant pairs of mutation sites.  
Complementary observations concerning mutational effects on receptor efficacy 
and the effects of partial agonists support the basic methodology.  Thus, 
ELFCAR provides an efficient strategy for identification of key gating pathway 
residues that may otherwise evade detection, without performing single-channel 
studies. 
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 Key to the approach is the definitive feature of allosteric proteins–action at 
a distance.  When a mutation in the transmembrane domain that is 
unambiguously associated with channel gating is paired with various mutations in 
the extracellular domain, the observation of non-multiplicative EC50 shifts for the 
two mutations signals a functional coupling between the two residues, and thus 
identifies the extracellular domain mutation as influencing gating.  We show that 
this behavior derives from the typical allosteric kinetic scheme for Cys-loop 
receptors, suggesting the approach could provide a general probe of allosteric 
receptors. 
 
3.3 Results 
 The prototypical and most-studied Cys-loop receptor, the muscle nicotinic 
acetylcholine receptor (nAChR), was used in this study.  It is important to 
appreciate that the method is directly applicable to other Cys-loop receptors, and, 
in favorable cases, to other allosteric proteins as well.  Here we have employed 
the muscle-type nAChR as a well-established system that allows us to evaluate 
the methodology. 
 The muscle nAChR is a heteropentamer with subunit composition (α2βγδ).  
Two non-equivalent binding sites are located in the extracellular domain at the αδ 
and αγ subunit interfaces.  Nearly all Cys-loop receptors, including all nAChRs, 
contain a conserved leucine residue in the hydrophobic, pore-lining M2 helix of 
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each subunit (Figure 3.1).  Mutating this residue, termed L9’, to serine lowers the 
EC50.
14, 15  Structural studies place L9’ near the middle of the M2 helix, in the 
region of the occlusion of the closed channel, and while it can be debated 
whether L9’ constitutes a literal gate of the channel, there can be no doubt that it 
is a crucial gating residue.  In the present work, the L9’S mutation in the β 
subunit was used as a reporter to evaluate mutations of residues in the 
extracellular domain that may function as binding residues or as gating pathway 
residues. 
 
3.3.1 βL9’S as a Reporter of Functional Role for Extracellular 
Residues 
 Agonist occupancy at both binding sites is required for efficient opening of 
the channel pore.  Scheme 3.1 shows a simplified kinetic model for activating the 
nAChR, leading to an expression for EC50 (Equation 3.1; see Appendix A for 
derivation),16 where A is the agonist; RC and RO denote the closed and open 
states of the receptor; k1 and k-1 are forward and reverse rate constants for 
agonist binding; KD is the dissociation constant for the agonist; and  is the 
gating equilibrium constant, given by the ratio of the channel opening rate, β, to 
the channel closing rate, α.  It is well understood that the actual kinetic model for 
the nAChR is likely more complicated, and that different Cys-loop receptors may 
show kinetic schemes that differ in detail.  In addition, a strong gating mutation 
could enable spontaneous openings of the channel when no agonist is bound.  
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This could compromise the kinetic model discussed here.  However, the βL9’S 
mutation alone does not lead to extensive spontaneous openings, and the types 
of mutations emphasized here, if they impact gating at all, discourage channel 
opening (decrease ), suggesting that spontaneous openings will not produce a 
major perturbation to the system.  Scheme 3.1 is typical for an allosteric 
receptor, capturing the essence of the situation: function depends on binding of 
an allosteric effector as well as signal transduction (gating).  For ligand-gated ion 
channels, this means that EC50 depends on both KD and , where  is a 
measure of receptor efficacy.  The graphical representation of the relationship 
between EC50 and , based on Equation 3.1, is shown in Figure 3.2.  
Simulations of more complex kinetic schemes produce qualitatively similar plots.  
For full agonists (FAs), that is, those that produce a large , the plot is linear with 
a negative slope.  We will refer to this as the ‘high slope’ region of the plot.  For 
smaller values of , such as would be associated with partial agonism, the plot 
approaches an asymptote.  We will refer to this as the ‘plateau’ region.17  
,     Scheme 3.1 
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 A defining feature of allosteric proteins is that an allosteric effector shifts 
the equilibrium between two states, historically termed tensed and relaxed.  
However, binding of the allosteric effector itself does not define the exact state as 
tensed or relaxed, rather it produces a shift in the equilibrium distribution 
between these states.  Consequently, once the allosteric signal is saturated, this 
equilibrium distribution depends only on the equilibrium constant governing 
tensed-relaxed interconversion.  In the case of ligand-gated ion channels, such 
as the nAChR studied here, different allosteric effectors—i.e., different ligands for 
ligand-gated ion channels—produce different closed-open equilibria, 
characterized by .  Thus, while FAs ( >> 1) cause the channel to be mostly 
open when agonist is bound, partial agonists influence this allosteric transition to 
a lesser extent, resulting in a smaller perturbation of the gating equilibrium.  It is 
the varying extent to which ligand binding can bias the equilibrium that produces 
the general shape of the relationship between EC50 (function) and , seen in 
Figure 3.2. 
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Figure 3.2. Black line: the relationship between EC50 and Θ as given in Equation 3.1.  Red 
line: the same equation, but with a larger KD.  For both plots, in the negative slope region 
changes in Θ produce significant changes in EC50, as shown when the reported effect is 
added to the wild type receptor.  However, when beginning with Θ in the low slope region, 
a much smaller shift in EC50 occurs for equivalent shifts in Θ.  
 
 Previous studies15, 18-20 have shown that polar mutations at L9’ 
substantially increase , causing a corresponding drop in EC50.  Our goal was to 
determine whether it was possible to use a reporter mutation such as βL9’S to 
evaluate whether the shift in EC50 from mutation at a target residue is primarily a 
result of changes in binding (KD) or gating () (see the Supporting Material, 
Figure 3.8).  Consider such a target mutation in the extracellular domain that 
only increases KD, i.e., a pure binding mutation.  This has the effect of raising the 
EC50 versus  curve, but maintaining its shape (Figure 3.2, red line).  Addition 
128 
 
of the βL9’S mutation then causes a comparable increase in , lowering EC50 by 
the same factor as in the wild type.  The pairing of an extracellular domain 
binding mutation with the reporter transmembrane domain mutation results in a 
multiplicative shift in EC50; the two mutations are independent.  
 Now, consider the consequences of an extracellular domain target 
mutation that affects gating, and not binding.  Deleterious mutations (increase in 
EC50) will cause a drop in , and if the effect is large enough, the agonist 
employed will now be a partial agonist.  The EC50 versus  relationship for this 
mutant will now lie in the plateau region of Figure 3.2.  As a result, the 
subsequent increase in  caused by adding the βL9’S mutation will induce a 
much smaller drop in EC50.  The pairing of these mutations will no longer give a 
multiplicative shift in EC50, and therefore the two mutations are functionally 
coupled.  Thus, the βL9’S gating mutation acts as a reporter to identify a target 
mutation that is substantially loss-of-function (decreasing ).  It is clear from 
Figure 3.2 that a gain-of-function gating mutation (lower EC50; increasing ) will 
still be in the high slope region and so will be additive with the βL9’S mutation. 
This method cannot detect gain-of-function gating mutations.  
 For many mutations in the extracellular domain, the βL9’S mutation is 
indeed multiplicative, producing a consistent 40-fold shift to lower EC50 (Table 
3.1).15, 21, 22  We now report the first examples of mutations closely associated 
with the agonist binding site for which the effect of βL9’S is substantially less than 
40-fold, indicating non-multiplicative behavior (Figure 3.1).  Four of these are 
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conventional mutants: αY190F, γD174NδD180N, γW55YδW57Y, and αD200N.  
Others have probed these sites, and they are generally considered to primarily 
influence gating.23-29  As such, these studies validate the ELFCAR method.  The 
fifth, a novel mutant, replaces αS191 with its α-hydroxy analogue, which we 
abbreviate Sah (for serine α-hydroxy), converting the backbone amide that links 
αY190 and αS191 to a backbone ester.30, 31  
 
3.3.2 Mutant Cycle Analysis Suggests Long-Range Coupling 
 The typical way to analyze a system in which two mutations are evaluated, 
both individually and in tandem, is by mutant cycle analysis (Figure 3.3).  Briefly, 
if a mutation at one site has no structural or energetic impact at a second site, 
then the effect of simultaneous mutations at both sites will simply be 
multiplicative (Figure 3.3).  In the parlance of mutant cycle analysis, the coupling 
parameter, Ω, will be unity.  In contrast, if two residues interact, the simultaneous 
mutation at both sites will lead to an effect that is either greater or less than the 
product of their individual effects, producing an Ω value that significantly deviates 
from unity.  This approach has been broadly applied to a wide range of systems, 
including Cys-loop receptors, where several investigators have used mutant 
cycle analysis of EC50 values to determine functional coupling between 
neighboring residues of the extracellular domain.32-34 
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Figure 3.3. Scheme for double mutant cycle analysis where A and B represent amino acid 
positions and A’ and B’ represent mutations at these sites.  The coupling parameter, Ω, is 
calculated from the given equation.   
 
 As could be anticipated from the EC50 values in Table 3.1, the vast 
majority of mutations made in the extracellular domain of the nAChR produce an 
Ω for coupling to βL9’S of ~ 1, indicating the functional independence of these 
residues.  However, the five mutations noted above—αY190F, γD174NδD180N, 
γW55YδW57Y, αD200N, and αS191Sah—produced larger Ω values.  We 
consider a value of Ω > 2 to signify a meaningful coupling (Figure 3.4).  
Phenomenologically, this establishes a long-range coupling between these 
extracellular domain sites and the βL9’ site, as one would expect for an allosteric 
receptor.  Typically, an Ω that deviates significantly from a value of 1 is 
interpreted to indicate a direct interaction between the residues, such as a 
hydrogen bond or a salt bridge.   
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Target 
Mutation 
WT 
EC50 
EC50 with Reporter 
Mutation 
Ratio 
    L9'S     
wild type 46 1.2 38 1.00 
D174ND180N 590 160 3.7 11 
Y190F 1200 520 2.3 17 
W55YW57Y 180 24 7.5 5.1 
D200N 130 29 4.5 8.6 
S191Sah 300 50 6.0 6.4 
E45W 120 3 40 0.96 
Y93Yah 39 1 39 0.98 
N94Nah 87 2.2 40 0.97 
D97E 3.3 0.09 37 1.0 
M144L 15 0.37 41 0.95 
M144Lah 50.4 1.3 39 0.99 
K145Q 170 8.1 21 1.8 
L146Lah 26 0.5
*
 52 0.74 
T148Tah 33 1.3 25 1.5 
αW149Wah 36 0.72 50 0.77 
W149 5-F-Trp 200 4.7 43 0.90 
W149 5-Br-
Trp 
88 2 44 0.87 
L199Lah 11 0.18 61 0.63 
T202Tah 24 0.48 50 0.77 
Y203Yah 39 0.62 63 0.61 
F205Yah 67 1.4 48 0.80 
F205Y 90 1.5 60 0.64 
V206Vah 170 3.1 55 0.70 
L36L39Lah 28 0.63 44 0.86 
I56I58Iah 33 0.83 40 0.96 
A121A124Aah 25 0.66 38 1.0 
E168QE175Q 42 1.2 35 1.1 
    L9'S     
wild type 46 4.5 10 1.0 
D174ND180N 590 244 2 4.2 
Y190F 1200 650 2 5.5 
W55YW57Y 180 74 2 4.2 
    L9'S     
wild type 46 1 46 1.0 
D174ND180N 590 140 4 11 
Y190F 1200 370 3 14 
W55YW57Y 180 16 11 4.1 
    L9'S     
wild type 46 0.35 131 1.0 
D174ND180N 590 65 9 14 
Y190F 1200 223 5 24 
W55YW57Y 180 7.5 24 5.5 
    V13'S     
wild type 46 0.1 460 1.0 
D174ND180N 590 8.9 66 7 
Y190F 1200 32 38 12 
W55YW57Y 180 1.5 120 3.8 
    L16'S     
wild type 46 0.47 98 1.0 
D174ND180N 590 59 10 10 
Y190F 1200 190 6 15 
W55YW57Y 180 8.5 21 4.6 
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Table 3.1. (Previous page). EC50 values with and without βL9’S reporter mutation for 
coupled and non-coupled residues.  Values for the 3 coupled residues are also given for 
reporter mutations in all other subunits (γ, δ, and α) and positions (9’, 13’, and 16’).  The 
ratio of EC50s: target/(target with reporter) and resultant calculated Ω values are also 
reported.  The standard error for all EC50 values was < 10%, except for *, which had 
standard error of 20%.  Data at sites α148(51), α149(22), and αS191(45) have been reported 
previously. 
 
 
Figure 3.4. Values of Ω (coupling to βL9’S) for mutations considered here.  The standard 
40-fold shift expected for a βL9’S mutation produces an Ω value of one (horizontal gray 
line).  5-F-Trp is 5-fluorotryptophan and 5-Br-Trp is 5-bromotryptophan.  For α-hydroxy 
acids (Yah, Nah, Lah, Tah, Wah, Vah, Iah, and Aah), a 3-letter abbreviation is used: the 1-
letter code for the parent amino acid is followed by ah; thus Yah is the α-hydroxy acid of 
tyrosine. 
 
In the present case, though, such a direct interaction is clearly impossible.  We 
feel the interpretation of Figure 3.2 is much more palatable.  Significant coupling 
is seen because both the βL9’S mutation and the particular extracellular domain 
mutation disrupt the gating pathway. 
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3.3.3 Single-Channel Recording Supports Whole-Cell Mutant Cycle 
Analysis Conclusions 
 The most convincing way to evaluate the impact of a particularly 
interesting mutation is by single-channel analysis.  To test our interpretation of 
the mutant cycle analyses using EC50 values, we chose three extracellular 
domain mutants which ELFCAR identified as gating pathway residues (αY190F, 
γD174NδD180N, and γW55YδW57Y) for single-channel studies.  From these 
recordings, the open probability in the patch, NPopen was obtained.  N is the 
number of channels in the patch, which often cannot be precisely determined. 
Popen is derived from Scheme 3.1 and depends only on  at equivalent points on 
the dose-response relation.  The NPopen measurements reported were obtained 
using the macroscopic EC50 concentration of ACh, and thus represent 
0.5(NPopen,max).  Each of the three target mutations produces a very large 
decrease in NPopen (Figure 3.5; Table 3.2) compared to the wild type value of 
~0.5 (data not shown); they are substantially deleterious gating pathway 
mutations. Also consistent with the model, adding the βL9’S mutation 
substantially increases NPopen. The single-channel analysis thus supports the 
interpretation of the macroscopic EC50 data.  
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A 
B 
C 
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Figure 3.5. (Previous page). Single-channel currents for select mutants.  In each case, ACh 
is applied at the macroscopic EC50 value (Table 3.1), and the left panel has no reporter 
mutation while the right panel is for receptors with the βL9’S reporter mutation.  For each 
of the 6 receptors, the lower trace (5s) depicts an expansion of the section of the upper 
trace indicated with a line.  Records were obtained in the cell-attached configuration with a 
pipette potential of + 100 mV and are shown at 5 kHz bandwidth.  Channel openings are 
shown as downward deflections.  (A) αY190F.   (B) γD174NδD180N.   (C) γW55YδW57Y. 
 
Mutant  Imax ratio NPopen 
 
NPopen L9’S 
 Y190F 17 11 0.0026 ± 
0.0006 
 
0.18 ± 0.04 
D174ND180N 11 13 0.0007 ± 
0.0005 
 
0.08 ± 0.06 
W55YW57Y 5 12 0.018 ± 
0.005 
0.26 ± 0.06 
 
Table 3.2. Coupling parameter, Ω, and Imax ratio from whole-cell data.  NPopen values (± 
SEM) at respective macroscopic EC50 values (Table 3.1) from single-channel data   
 
3.3.4 Other Reporter Mutations Support Gating Pathway Assignments  
 An implication of this experimental strategy is that other residues in the 
transmembrane domain that substantially increase  could act as reporters for 
extracellular domain residues; we are not limited to the β subunit or the well-
characterized L9’ position.  To test this notion, L9’S mutations were made in the 
α, γ, and δ subunits, and two other Ser mutations were made in the M2 helix of 
the α subunit at positions V13’ and L16’ (Figure 3.1).  All of these mutations 
lower EC50 significantly, and all positions are confidently ascribed to be gating 
residues.  As shown in Figure 3.6, the extracellular domain mutations that give 
significant Ω values with βL9’S also show significant Ω values with L9’S 
mutations present in the other subunits.  Recalling that there are two α subunits, 
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we find that there is a general coupling parameter sequence of β   δ > α > γ.  
Thus, subtle asymmetries between subunits exist regarding the L9’ residues’ 
contribution to gating, which are also reflected in the EC50 values of the various 
L9’S mutants (Table 3.1).  If one considers positions other than 9’, all the 
mutated gating pathway residues again produce meaningful Ω values, and the 
magnitude of their effect is consistently α9’ > α16’ > α13’ (Figure 3.6). 
 
Figure 3.6. Values of Ω for various reporter mutations.  For each of the three extracellular 
domain mutations, results for six different reporter mutations are shown.  Reporter 
mutations are identified by their location; in each case, the mutation is of a hydrophobic 
residue to serine. 
 
3.3.5 The Reporter Mutation βL9’S Systematically Increases Imax for 
Gating Pathway Residues 
 This interpretation of the mutant cycle analysis data predicts other 
behaviors for extracellular gating pathway residues.  For example, to produce a 
significant mutant cycle analysis coupling to L9’ (Ω > 2), the mutation in the 
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extracellular domain must convert ACh to a partial agonist, such that the target 
mutation is now in the plateau region of Figure 3.2.  Due to this decrease in , 
the maximal current observed in response to saturating concentrations of ACh 
(Imax) should diminish.  In general, interpreting differences in Imax can be 
challenging due to variations in whole-cell current among oocytes, which can 
stem from a variety of sources that may or may not relate to the actual mutation 
in question.  However, use of a reporter mutation can assist in the interpretation 
of Imax differences.  For mutations that render ACh a partial agonist, increasing 
efficacy through a reporter mutation produces a significant systematic increase in 
Imax.  We find that these increases are larger and more consistent than the typical 
variability in Imax in conventional mutagenesis studies.  Thus, if a receptor with a 
target mutation shows a large increase in mean Imax on introduction of a reporter 
mutation, the mutation likely affects gating.  This is shown in Figure 3.7 for 
mutations with large Ω values, along with several examples with Ω near one.  
Recovery of Imax by introduction of the reporter mutation confirms the gating 
pathway residue assignments made by mutant cycle analysis.  Moreover, the 
single-channel observations support this interpretation, in that the increase in 
NPopen is the microscopic correlate of the macroscopic observation of recovery of 
Imax (Table 3.2).  
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Figure 3.7. Variation in Imax in response to introduction of a βL9’S reporter mutation 
 
3.3.6 Experiments with the Partial Agonist Succinylcholine Support 
Gating Pathway Assignments  
 Given the argument that a substantially deleterious mutation of a gating 
pathway residue converts the full agonist ACh to a partial agonist, which 
manifests as a diminished Imax, it is interesting to consider the behavior of an 
inherent partial agonist, such as succinylcholine (SuCh).35  The relative efficacy, 
ε, of a partial agonist can be defined as the ratio of the maximal current elicited 
by a partial agonist (PA) to the maximal current elicited by a full agonist (FA; 
Equation 3.2).  At saturating doses of agonist, all the receptors are presumed to 
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be in a diliganded state (A2R), meaning that differences in Imax for the
 two 
agonists are due to differences in the probability that a single channel is open 
when the binding equilibrium is saturated, Popen,max.  For wild type muscle nAChR, 
SuCh is a partial agonist with ~ 4% efficacy relative to ACh.  

 
Imax,PA
Imax,FA

Popen,max,PA
Popen,max,FA ,   

Popen,max 

 


1      (Equation 4.2) 
 In the presence of an αL9’S mutation alone, SuCh becomes a full agonist. 
Three of the five gating pathway residues were characterized using the partial 
agonist SuCh.  Unlike what is observed for binding mutations, when αY190F, 
γD174NδD180N, and γW55YδW57Y contained a LS mutation at either the  9’ 
(α or β), 13’ (α), or 16’ (α) site, the recovery of SuCh toward full agonism is 
blocked.  As before, the magnitude of the effect follows the trend α9’ > α16’ > 
α13’ (data not shown).  This is interpreted as further evidence that mutation of 
these extracellular domain residues drastically impairs normal gating function.  
Note that the efficacies of SuCh for the gating pathway mutants without the L9’S 
reporter mutation are not dramatically different from that of wild type (0.04 ± 0.02 
for wild type, 0.04 ± 0.01 for αY190F, 0.02 ± 0.01 for γD174NδD180N, and 0.01 ± 
0.0009 for γW55YδW57Y).     
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3.4 Discussion 
 In this work we propose that appropriately designed double mutant studies 
can provide valuable insights into the mechanism of action of an allosteric 
receptor.  We begin with a mutation at a site whose function is unambiguous.  
Here, this reporter residue can be one of several sites in the transmembrane 
region of a ligand-gated ion channel, far removed from the agonist binding site.  It 
is assumed that mutations at this site primarily, if not exclusively, perturb the 
gating of the receptor, and this view is supported by detailed studies of the 
reporter mutations.  A second site, the target site, can then be probed by 
combining mutations there with a reporter mutation.  Here we consider a number 
of target sites that are far removed from the reporter residue.  Analysis of the 
results can proceed along several lines.  The classical tool is a mutant cycle 
analysis.  Indeed we find that, while most pairings of remote residues produce 
independent behavior (Ω ~ 1), for select target residues a mutant cycle analysis 
produces strong coupling parameters.  Typically, such coupling is interpreted to 
indicate a direct interaction between the residues.  However, in all cases here the 
residues are much too far apart to accommodate a direct structural interaction.  
As such, we have an allosteric coupling between remote residues, which 
manifests in a mutant cycle analysis just as if the two were structurally coupled.  
Of course, such action at a distance is the definitive feature of an allosteric 
system, but there are few cases where such pairwise interactions have been 
seen.  Since the reporter mutation influences gating, coupling requires that the 
target residue also impact gating, allowing an apparent long-range interaction to 
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be revealed in the mutant cycle analysis.  We have labeled such residues as 
being on the ‘gating pathway’, with the understanding that any mutation that 
preferentially stabilizes one state of the receptor could produce a positive result 
in ELFCAR, regardless of its location in the receptor.  The particular residues 
studied here, however, do lie in regions of the receptor that have been 
considered to be part of the primary structural transduction from binding site to 
channel gate. 
 A less phenomenological analysis can be made with reference to Figure 
3.2.  The key here is that if the mutation at the target site perturbs gating by 
decreasing , moving the system to the left along the EC50 versus  curve, and if 
the effect is large enough, the system will now be in the plateau region.  Then, 
when the reporter mutation is added, its effect on EC50 will be diminished relative 
to what is seen in the receptor that is wild type at the target site.  To be 
informative, the mutation at the target site must be loss-of-function (diminished 
) and must have a substantial effect on gating.  If  is diminished only slightly 
by the target mutation, or if  is increased (gain-of-function) the system will 
remain in the region of high slope, and the reporter mutation will have its normal 
effect.  Also, when we do see significant coupling, that does not rule out the 
possibility that KD has changed in addition to ; ELFCAR can only establish that 
a significant decrease in  has occurred.  At the same time, when a target 
mutation produces a large shift in EC50 but a conventional 40-fold additional shift 
on adding the βL9’S reporter mutation, it is tempting to conclude that the target 
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mutation exclusively impacted KD.  However, changes in  that are significant but 
not large enough to move the system into the plateau region of Figure 3.2 could 
be involved in addition to or instead of a KD change.  For example, the K145Q 
mutation has been reported to impact gating,26 but without moving  into the 
plateau region.  In the present work, K145Q shows a marginal functional coupling 
with L9’S, with an Ω value near the cut off for significance (1.8  0.2).  As such, 
ELFCAR is best suited to identifying mutations that strongly perturb gating (Ω > 
2); negative results should be interpreted cautiously.  Note that in receptors for 
which the wild type  is smaller than in the muscle-type nAChR, ELFCAR would 
be expected to be more sensitive to small changes in . 
 Several additional observations support our analysis of the results seen 
here.  First, in a typical mutant cycle analysis, Ω values less than 1 can be 
observed and are functionally significant.  However, in the present context, the 
model of Figure 3.2 allows only for Ω > 1, which is consistent with our data.  
Importantly, three mutations shown here to impact gating by the ELFCAR 
approach have been confirmed to be gating mutations by single-channel 
analyses.  The single-channel values we report are NPopen.  The true probability 
that a single channel is open at these concentrations, Popen, is increased by a 
factor of N, where N is the number of channels in the patch.  Because the 
measured probability that the channel is open is very low (< 2%) for the gating 
pathway mutations without the reporter mutation, the number of channels in the 
patch cannot be exactly determined.  However, if there are actually multiple 
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channels in these patches, our NPopen values would be overestimates of Popen.  
The measured NPopen values are substantially diminished upon addition of each 
of the three target residues we tested (αY190F, γD174NδD180N, and 
γW55YδW57Y), such that the modest perturbation of EC50 associated with the 
target mutations can be primarily ascribed to dramatic changes in the gating 
pathway.  Other single-channel studies of residues considered here are also 
consistent with our findings. 
 Other observations support our general model.  If a target mutation 
substantially reduces , then ACh should become a PA at the receptor.  This 
should lead to reduced maximal currents from whole-cell recordings, and just 
such an effect is seen.  Also, an inherent PA should be sensitive to the 
consequences of the target mutation, and we find that is indeed the case for 
SuCh. 
 It is interesting to consider the residues that have been probed here; 
Figure 3.1 highlights them all.  The considerable distance between the reporter 
residues and the target residues is clear from this image.  Concerning the target 
residues, those with no strong coupling (purple) are dispersed throughout the 
extracellular domain, and, although only five have been identified so far, the 
same is true of the gating pathway residues (orange).  There is no simple pattern 
that distinguishes the two classes.   
 The agonist binding site of the nAChR is an ‘aromatic box’, shaped by five, 
conserved aromatic residues: αY93 (A), αW149 (B), αY190 (C1), αY198 (C2), 
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and γW55/δW57 (D).7, 36  The letter designations signify the ‘loop’ of the 
extracellular domain that contains the particular residue37.  Because all the 
natural agonists of Cys-loop receptors have a cationic group, the presence of the 
aromatic box suggested that a cation-π interaction contributes to agonist 
binding.38, 39  Indeed, αW149 (B) and the aligning residues have been shown to 
contribute to agonist binding through a cation-π interaction in both the nAChR 
and the 5-HT3 receptors.
22, 40  We find Ω ~ 1, consistent with a binding role for 
this residue.  Note that subtle mutations have been employed at this site, taking 
advantage of the power of unnatural amino acid mutagenesis.  We cannot rule 
out the possibility that more disruptive mutations at this and other sites would 
impact receptor gating.  Indeed, the αW149F mutation has been probed, and it 
impacts both binding and gating.41  Most of the mutations in Table 3.1 are, by 
conventional standards, relatively subtle, and we would argue that some caution 
must be employed in interpreting the consequences of more severe mutations.  
 The residue analogous to αY198 (C2) has been shown to bind serotonin 
through a cation-π interaction in the MOD-1 receptor42.  Previous studies in the 
nAChR show that mutations at this site exhibit normal coupling to L9’S 
mutations.43  Single-channel studies of the αY198F mutant indicate only modest 
changes in gating24 that would be outside the limits of detection for ELFCAR.  
 The residue αY93 (A) has been extensively probed.  In the GABAA 
receptor the analogous residue makes a cation-π binding interaction to the native 
agonist.44  In the nAChR, side chain mutations at this site strongly impact 
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channel gating.  However, the mutation studied here—αY93Yah—is a backbone 
mutation.  Our finding of Ω ~ 1 indicates no strong perturbation of gating by a 
backbone mutation in this region.  This conclusion is supported by the similar 
result at the adjacent residue (αN94Nah).   
 The remaining two box residues, αY190 (C1) and γW55/δW57 (D), have 
never been shown to make a cation-π interaction with an agonist.  Both are 
clearly assigned as gating pathway residues according to the ELFCAR method. 
αY190 has been extensively studied.  That αY190F strongly impacts gating is 
unambiguously established by the single-channel records of Figure 3.5A.  Other 
workers have also found strong perturbations to gating for mutations at this 
site.25, 26  Some studies have also found a contribution to binding, but, as 
discussed above, the present work does not address this issue.  The important 
point is that the finding of a large Ω value in ELFCAR is fully supported by single-
channel studies.  In addition, a backbone mutation at the adjacent residue, 
αS191Sah, also produces a large Ω value in ELFCAR.  We have recently shown 
that this residue makes a strong hydrogen bond to a side chain from the 
complementary subunit (γ/δ), and that the hydrogen bond contributes 
significantly to gating.45  Most gating models for the nAChR invoke considerable 
movement of loop C,7, 46, 47 and the finding of large Ω values for these two loop C 
residues is consistent with these models. 
 The final binding box residue, γW55/δW57 (D), shows a large Ω value for 
the Tyr mutant.  Our single-channel studies (Figure 3.5C) clearly establish an 
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impact on gating for this mutation.  Previous single-channel studies of the Phe 
mutant show a small effect on binding (3.4-fold) and a very large effect on gating 
(50-fold),48 consistent with the present results.  There is reason to anticipate that 
loop D may also undergo significant rearrangements during gating.  In Unwin’s 
image of the Torpedo nAChR,1 with no agonist bound, TrpD is flipped out away 
from the box that is so well formed in AChBP (with or without agonist bound).  
This again suggests that movement of TrpD occurs on ligand binding, consistent 
with it being a gating pathway residue.  
 The fifth gating pathway residue we identified, αD200, is not part of the 
aromatic binding box, but appears to lie outside the box.  However, it is part of a 
triad of residues that includes αY190 and αK145 and that has been suggested to 
undergo significant rearrangement on gating.26  Previous single-channel studies 
have shown that mutation at this site perturbs gating.23, 26  As such, the large Ω 
seen here with ELFCAR is fully consistent with other studies.   
3.5 Conclusions 
In this work, we have developed an efficient strategy for identifying 
mutations that impact receptor function by significantly impeding the gating 
pathway.  The method involves combining mutations of extracellular domain 
residues proposed to be functionally important with a known gating pathway 
(reporter) mutation.  For interesting sites, ELFCAR can provide guidance for 
more focused, advanced studies, such as detailed unnatural amino acid 
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mutagenesis of putative binding residues or single-channel analysis, where 
possible, for gating residues (Figure 3.8). 
 The kinetic model of Scheme 3.1 refers to the nAChR, but it contains the 
essential features of any allosteric system.  There is a binding interaction with an 
allosteric effector and an intrinsic conformational change associated with the 
signaling event.  The former is a bimolecular association, and so is saturable at 
high ligand concentration.  However, the conformational change is unimolecular, 
and so it is an intrinsic property of the system.  It is the combination of these two 
processes that produces the curvature of Figure 3.2 and thus allows for the 
specific application of mutant cycle analysis presented here.  As such, we 
anticipate that the same approach could be applied to other allosteric systems, 
allowing a facile means to identify the roles of particular residues in a complex 
protein system.  Thus, while this study has focused exclusively on a single Cys-
loop receptor, we believe the approach is broadly applicable to other Cys-loop 
receptors and to allosteric receptors in general.  Certainly, comparable reporter 
residues can be found in the other Cys-loop receptors; the L9’ residue is highly 
conserved and it seems likely to play an important gating role throughout the 
family.  We emphasize that, although all members of the Cys-loop family are 
genetic orthologs, functional paralogs, and structural homologs, there is growing 
evidence that the detailed mechanisms of action will vary from system to 
system.39  Thus, the present approach, based on the readily obtained EC50 
measure, offers a robust and efficient way to search for such variations in gating 
mechanism. 
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3.6 Materials and Methods 
3.6.1 Site-Directed Mutagenesis  
 Fetal mouse muscle nicotinic acetylcholine receptor (nAChR) α-, β-, γ-, δ-
subunits were utilized in the experiments.  Each subunit was expressed in pAMV 
vectors.  Mutations were made at the site of interest using a standard Stratagene 
QuikChange protocol.  For the incorporation of unnatural residues, the site of 
interest was mutated to the amber stop codon.  In addition, the α-subunits 
contain an HA epitope in the M3-M4 cytoplasmic loop for Western blot studies. 
Control experiments show that this epitope does not detectably alter EC50.  
Primers were designed to fulfill the established criteria and were ordered from 
Integral DNA technologies.  Polymerase chain reactions (PCRs) reactions were 
carried out using a high fidelity Pfu DNA polymerase, and a 10 min extension 
time was used in each thermocycle.  Annealing temperatures were modified as 
required for successful incorporation of the mutation.  DpN1 digestion was used 
to eliminate methylated template DNA from the PCR products.  After PCR 
purification (Qiagen standard protocol), amplification of the PCR product was 
conducted by electroporation with Super Competent Top 10 E. coli, followed by 
12 h of growth on agar/LB/ampicillin plates.  Single colonies were selected and 
amplified in liquid LB/ampicillin culture.  The DNA was isolated from the bacteria 
(Qiagen, miniprep kit), and sequenced to verify the successful incorporation of 
the mutation at the selected site. 
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 The circular bacterial plasmid of the mutation-containing DNA was 
linearized using a Not1 restriction enzyme.  Linearized plasmids were used as 
the DNA template for in vitro transcription using T7 mMessage mMachine 
enzyme kits (Ambion) to make mRNA.  Quantification of mRNA was determined 
using a NanoDrop spectrophotometer (NanoDrop Technologies, Thermo 
Scientific, Wilmington, DE).  
 For conventional mutations, the stoichiometry of subunits was 2:1:1:1 of 
α:β:γ:δ by mass with a total mRNA concentration of ~ 2 μg/μL.  For unnatural 
mutations,49 a total of 40 ng of mRNA in a 10:1:1:1 α:β:γ:δ subunit ratio was 
coinjected with the synthetic α-hydroxy acids conjugated to the dinucleotide dCA 
and ligated to truncated 74-nucleotide tRNA, as previously described.  Ratios of 
mRNA to tRNA were typically 1:1. 
 Stage V–VI oocytes of Xenopus laevis (Nasco, Fort Atkinson, WI) were 
injected with 50 nL of the mRNA or mRNA/tRNA mixture.  The oocytes were 
incubated in culture media containing 1–2% horse serum at 18 ˚C. 
 
3.6.2 Whole-Cell Electrophysiology 
 Whole-cell electrophysiological recordings were performed on injected 
Xenopus laevis oocytes after 12–36 h incubation.  Recording was done in two-
electrode voltage clamp mode using the OpusXpress 6000A (Axon Instruments, 
Union City, CA).  Oocytes were superfused with Ca2+-free ND96 solution (in mM: 
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96 NaCl, 2 KCl, 1 MgCl2, 5 HEPES) at flow rates of 4 mL/min during drug 
application (15 s) and 3 mL/min during wash (130 s).  Macroscopic agonist-
induced currents were recorded in response to bath application of the indicated 
agonist concentrations at -60 mV or -80 mV.  Data were sampled at 125 Hz and 
filtered at 50 Hz.  ACh chloride and SuCh chloride were purchased from 
Sigma/Aldrich/RBI (St. Louis, MO).  Agonist solutions ranging from 0.0100 to 
5000 μM were prepared in Ca2+-free ND96 from a 1.00 M stock solution.  Dose-
response relations were constructed for each mutation using data from > 5 
oocytes.  Dose-response relations were fitted to the Hill equation (Equation 3.3) 
to determine the EC50 and the Hill coefficient. 

I
Imax
 1
(1 (EC50 [A])
nH )            (Equation 3.3) 
Here, I is the current for agonist concentration [A], Imax is the maximum current, 
EC50 is the concentration to elicit half maximal response, and nH is the Hill 
coefficient.  The dose-response relations of individual oocytes were examined 
and used to determine outliers.  The reported EC50 values are from the curve fit 
of the averaged data.   
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3.6.3 Single-Channel Characterization of Selected Gating Pathway 
Residue Mutants 
 Single-channel recording was performed in the cell-attached configuration 
on devitellinized oocytes 24–60 h after injection at 20 ± 3C with an applied 
pipette potential of +100 mV, as described previously.50  Pipettes were fabricated 
from thick-walled (I.D. = 0.80 mm, O.D. = 1.60 mm) KG-33 glass (Garner Glass 
Company, Claremont, CA) and coated with sylgard (World Precision Instruments, 
Sarasota, FL); they had resistances of 8–25 MΩ.  The bath solution contained, in 
mM, 120 KCl, 5 HEPES, 1 MgCl2, 2 CaCl2, pH = 7.4, so that the transmembrane 
potential of the patch was -100 mV and the reversal potential for agonist-induced 
currents was ~ 0 mV.  The pipette solution contained, in mM, 100 KCl, 10 
HEPES, 1 MgCl2, 10 K2EGTA, pH = 7.4 and was supplemented with the 
indicated concentrations of ACh using a 1.00 M stock solution.   
 Before single-channel recording, whole-cell expression levels were 
determined with 100–1000 μM ACh doses using the whole-cell recording 
conditions on each mutant.  When whole-cell expression exceeded ~ 300 nA for 
receptors with the target mutation alone and ~ 3 μA for receptors with both a 
target mutation and a reporter mutation, oocytes were typically incubated 4–10 
additional h prior to single-channel recording.  Data were collected using a 
GeneClamp 500B amplifier (Axon Instruments, Union City, CA) with a CV-5 GU 
headstage at full bandwidth (4-pole Bessel, -3 dB, 50 kHz).  The signal was then 
low-pass filtered (8-pole Bessel, -3 dB, 20 kHz) and sampled with a Digidata 
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1320A and Clampex 9.2 (Axon Instruments, Union City, CA) at 50 or 100 kHz.  
Only recordings that showed no simultaneous activations were included in NPopen 
analysis.  In this manner ≥ 3 patches at EC50 were analyzed for all mutants, 
except for the αβγD174NδD180N and αβL9’SγD174NδD180N mutants for which 
2 patches each were obtained.  Data were filtered offline (Gaussian, -3 dB, 5 
kHz) and electrical interference at harmonics of 60 Hz was removed, if 
necessary.  Event transitions were detected with Clampfit 9.2 (single-channel 
search).  A dead time, τd, of 40 μs was applied to all events.  The time-average 
probability that exactly one channel in the patch is open (NPopen) was calculated 
as the total open time divided by the total closed time.  
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3.8 Supporting Material 
 
Figure 3.8. Experimental outline for applying the ELFCAR methodology introduced here to 
identify mutations that affect the gating pathway 
 
3.8.1 The relationship between Ω, Imax, and NPopen 
In < 10% (2 of > 20) of patches obtained for single-channel recordings of 
the three target mutations shown in Table 3.2, a higher Popen mode was seen as 
part of the channel activity.  Since this mode accounted for << 50% of events 
even when it was present, it accounts for a small minority (<< 10%) of total 
events.  Moreover, its rare occurrence indicates that this Popen is clearly not 
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representative of the functional behavior of these mutations.  Rather, it appears 
to be an infrequently visited mode of the channel.  We thus report NPopen values 
ignoring this rare mode.   
The macroscopic and microscopic data display correlating shifts for the 
target mutations versus target + reporter mutations.  However, there are 
apparent quantitative differences between the following comparisons (in the 
background of a target mutation): Imax9’/Imax wild type (11–17) and NPopen9’/NPopen 
wild type (14–116, reflecting a similar shift in over the range of our measured 
NPopen values).  These differences are accounted for by our observation of a high 
Popen mode.  If channels are in this mode ~ 1% of time, then that effectively limits 
the range over which Imax can shift—adding a fixed ~ 0.01 to each NPopen value 
would limit the maximal possible Imax shift to 50 since Popen,max at EC50 is 0.5.  The 
present results for Imax shifts accord with this observation well: the drastic gating 
pathway mutations that ELFCAR identifies display a near-maximal 11–17-fold 
increase in Imax when a reporter mutation is added.  On the other hand, EC50 
increases are 4–26-fold, corresponding to  decreases of 15-680-fold which are 
quantitatively similar to the microscopic NPopen results.  Since the high Popen 
mode would account for, at most, a small minority of the total open conductance, 
it is not reflected in the EC50 shifts.  Thus, the macroscopic (Imax and EC50) data 
are in accordance with the drastic change in function obvious in microscopic data 
(Figure 3.5). 
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Figure 3.9. Agonist-induced voltage-clamp currents.  Each panel shows the inward 
macroscopic current elicited near EC50 (Table 3.1) and at a saturating concentration as 
downward deflections for one of 4 receptors: A) , B) 9’, C) D174ND180N, D) 
9’D174ND180N.  Note that Imax is similar for  and 9’, but that Imax increases 
significantly when the L9’S mutation is introduced in the background of the target 
mutation (D174ND180N).   
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Figure 3.10. For extracellular domain mutations with  > 2, the normal recovery of SuCh 
towards full agonism in the presence of an L9’S reporter mutation is blocked.  The gray 
bars represent receptors with a wild type pore domain, while the white bars represent 
receptors with a L9’S mutation.  The wild type receptor and four mutations to the right all 
show the characteristic increase in efficacy in the presence of the L9’S pore mutation, 
while the three mutations on the far left do not. 
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3.9 Additional Discussion 
As with mutant cycle analysis for short-range interactions, ELFCAR 
reveals if two probed perturbations are functionally independent ( = 1) or 
interacting (  1).  In the case of interaction (functional dependence),  > 2 or < 
0.5 are possible.  The main utility of the ELFCAR procedure is to identify 
mutations that significantly decrease the ability of an allosteric receptor to be 
activated.  For LGICs, this corresponds to significant decreases in the gating 
parameter ().  When EC50s are used as the functional assay, a result of  = 1 
indicates that the residues are non-interacting.  However, in this case, if there is 
no recovery of maximal activation, and the initial target did impact receptor 
function, then ELFCAR can be used to suggest a likely impact on binding to the 
receptor.  Further experiments, such as incorporation of a series of fluorinated 
aromatic unnatural amino acids, can then be pursued to determine the residue’s 
impact on binding for perturbations that do not functionally couple to allosteric 
activation (Figure 3.8).   
Biological variation in oocyte experiments can be significant.  Thus, in 
ELFCAR a reporter is introduced to produce an unambiguous, systematic 
increase in Imax that is significantly larger than normal oocyte-to-oocyte variation 
(see error bars in Figure 3.7).  In fact, the ~ tenfold increase in Imax upon adding 
a reporter in the presence of a strongly functionally coupled target is a definitive 
indication—from whole-cell data alone—of the significance and functional role of 
the target residue.  The functional change corresponding to the increase in Imax 
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we describe could, in theory, happen for any allosteric receptor.  However, the 
relatively similar Imax values for the wild type receptor with and without the 
reporter βL9’S mutation (Figure 3.9B and A, respectively) show that the 
significant qualitative difference in whole-cell current isn’t immediately evident for 
all receptors.  Consequently, the use of reporter mutations with larger  shifts 
than the target mutation should allow ELFCAR to be used to identify more subtle 
deleterious gating mutations, especially for LGICs with lower  values (such as 1 
<  < 20).  It is also worth noting that Imax is only one of several components of 
the whole-cell data, beyond the EC50, that can be used to assess a target’s 
functional role.  Some of these were covered in Chapter 2, such as analysis of 
whole-cell activation and deactivation kinetics where applicable.  Here I’ll briefly 
highlight that, in addition to any systematic changes in expression level (Imax), the 
Hill coefficient (nH) contains information about channel activation. 
ELFCAR is also a valuable tool for application to targets that do not yield a 
significant functional change, some of which may still play significant roles in 
allosteric function.  Specifically, because Ω is large in some cases, the EC50 shift 
caused by the target alone can be quite small; it is barely over twofold in the case 
of αY190F.  Such a small shift in EC50 can be hard to interpret.  ELFCAR thereby 
expands the utility of whole-cell recording to identify functionally significant 
residues that may not be identified based on EC50 shift alone.  ELFCAR also 
enables the identification of a broader range of residues than merely those which 
lie directly along the pathway of the gating structural transduction.  Any mutated 
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target that leads to a change in the relative stabilization of the closed and open 
states can produce a positive ELFCAR result.  ELFCAR can therefore enable the 
identification of important inter-residue functional interactions—even at a 
distance—anywhere in the receptor.   
 
3.9.1 ELFCAR Methodology 
Based on the results and analysis presented in this chapter, we developed 
a specific set of protocols in order to efficiently implement the core component of 
ELFCAR.  This use of mutant cycle analysis is summarized in Figure 3.11, which 
distills the essence of Figure 3.8.   
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Figure 3.11. (Previous page). The application of ELFCAR involves: (a) identification of a 
gain-of-function reporter mutation, (b) making the mutated allosteric receptors, (c) 
expressing them in a heterologous system or some other system for functional assay, (d) 
obtaining functional data for the allosteric receptors, and (e) analyzing this data to 
calculate .  For many allosteric receptors, once all necessary mutants are made, steps c–
e can be performed rapidly (< 1 week) and in parallel.  For each target to be evaluated, 4 
receptor sets are needed for mutant cycle analysis: wild type, target, reporter, and target + 
reporter.  But, in practice, the reporter and wild type will be the same for any given 
receptor, so each new Ω value requires 2 functional measurements: target and target + 
reporter.   
 
See our book chapter: ‘Using Mutant Cycle Analysis to Elucidate Long-
Range Functional Coupling in Allosteric Receptors’ in Methods in Molecular 
Biology Allostery: Methods and Protocols for more details and notes regarding 
applying this methodology.     
 Several other acronyms were considered before we ultimately selected 
ELFCAR; some of the other acronyms we considered are included in Appendix 
C. 
 
3.9.2 Single-Channel Data and Its Correlation to Whole-Cell Data 
 Since the single-channel recordings were performed at the midpoint of the 
macroscopic dose-response relation (EC50), analysis of closed dwell time 
histograms did not provide a way to readily distinguish non-conducting closed or 
unbound dwells from the desensitized states of the channel.  As a result, detailed 
modeling was difficult.  However, if we take the longest closed component in 
each mutant as the desensitized state, all NPopen values are shifted to larger 
values in such a way that the substantial increase in NPopen upon addition of 
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βL9’S is preserved.  On the other hand, what is readily evident from the closed 
dwell time histograms and single-channel traces is that the decrease in NPopen is 
caused largely by a shift in the closed dwell times (Figure 5).  In the 3 
extracellular domain targets for which single-channel data were obtained here, 
these long closings account for > 80% of the total closed dwell time.  Also, 
consistent with previous reports, addition of a βL9’S mutation increases open 
dwell time, generally ~ 3–5-fold for the primary component (under the present 
analysis parameters).  This primary open dwell time component constitutes at 
least 80% of the total time that the channel spends open in each case. 
For reasons discussed in the supporting information, we were unable to 
find a specific correlation between the single-channel measurement of NPopen 
and the whole-cell measurement of Imax.  However, based on a combined 
interpretation of single-channel NPopen of the receptors without the reporter 
mutation and Ω from ELFCAR, we estimate that, of the three receptor sets that 
we studied via single-channel recording, the γD174NδD180N mutation is the 
most functionally perturbing, while the γW55YδW57Y mutation is the least.  The 
single-channel traces in the left panels of Figure 3B and C demonstrate this 
qualitatively. 
Analysis of single-channel records isn’t possible for all LGICs, some of 
which have complex kinetics or single-channel conductances that are too small 
for systematic study.  Thus, ELFCAR provides some of the information previously 
accessible primarily by single-channel recording in more straightforward and 
readily implemented whole-cell dose-response measurements.  As a whole, 
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ELFCAR is most powerful as one tool in a broader toolbox of approaches to 
understanding how allosteric receptors, such as LGICs, function at the molecular 
level.  
 
3.10 Future Studies 
Several applications and expansions of ELFCAR may be of interest.  I will briefly 
outline them here. 
A) It is worth reiterating that, for some receptors, functional changes are 
difficult to assess by single-channel recording alone.  Several reasons 
exist for this, such as: low single-channel conductance, larger numbers of 
subconductances, and difficulty in achieving a sufficiently pure population 
of receptors.  The 5-HT3A, GABA(C)R, and possibly GlyR are just some of 
several allosteric receptors for which ELFCAR may prove particularly 
useful.    
B) Along these lines, it would be interesting to directly show the broad 
applicability of ELFCAR to other allosteric receptors—even beyond LGICs.  
This would likely require alternative functional assays beyond 
electrophysiology.  In the selection of other allosteric receptors to pursue, 
the implications of Figure 3.2 should be considered for both the wild type 
receptor and the reporter. 
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C) Several aspects of the binding sites of allosteric receptors could be probed 
with ELFCAR. 
a. The possibility of different functional interactions of the different 
binding sites with the channel pore could be examined.  For the 
fetal muscle-type receptor (α2βγδ) that was the focus of these 
studies, the two binding site affinities are significantly different for 
ACh.  It would be interesting to compare the functional coupling of 
various agonists to the channel pore, including agonists with more 
similar binding affinities, such as epibatidine.  These data could be 
compared to data from experiments in receptors that contain more 
nearly equivalent binding sites, such as the adult muscle-type 
nAChR (α2βεδ) or 5-HT3A.  This could produce a correlation 
between the ability of agonists to activate (gate) receptors and their 
ability to bind to the receptor. 
b. The long-range functional coupling of mutations in (or near) two 
different binding sites could be probed in receptors where one of 
the binding region mutations can act as a reporter.  The results of 
such studies could be used to address the functional coupling 
between binding sites that leads to the phenomena of cooperativity 
in some allosteric receptors. 
D) The fact that the β and δ subunit pores seem to be more strongly 
functionally coupled to the binding site than the α and γ subunit pores is of 
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interest.  A more detailed ELFCAR study of these subunit asymmetries 
could be pursued. 
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Chapter 4 
 
Activation of Wild Type and Mutant 
Muscle-Type Nicotinic Acetylcholine Receptors  
by Acetylcholine, Choline, and 
Tetramethylammonium 
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4.1 Introduction 
 In Chapter 1, I introduced an experiment that the Dougherty group did with 
unnatural amino acids to demonstrate a cation-π binding interaction to TrpB 
(α1Trp149) (Figure 4.1) of the muscle-type nicotinic acetylcholine receptor 
(nAChR)(1).  I also discussed the fact that the functional measurements in those 
experiments were EC50 values that are combined measures of binding and 
gating.  In order to unambiguously assign all rates of a kinetic scheme, even one 
as simple as Model 4.1, single-channel data are required. 
     (Model 4.1) 
A previous study showed that mutation of TrpB to phenylalanine had a 
significant impact on channel function, primarily by diminishing the ability of the 
channel to gate.  Specifically, the channel opening rate, β, was decreased nearly 
100-fold(2).  Given that TrpB is unambiguously in the aromatic binding box 
(Figure 4.1) we hypothesized that the different functional roles assigned by these 
two studies were based on the fact that mutating tryptophan to phenylalanine 
produces a substantial change of both size and electrostatics, while the 
fluorinated tryptophans used in the Dougherty group study are subtle 
perturbations in which essentially only the residues’ ability to form a cation-π 
interaction is systematically altered.   
In this chapter, I will describe attempts to find and optimize a set of 
mutants and agonists to facilitate measuring detailed kinetics, including the 
channel opening rate, β, for the muscle-type nAChR. 
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Figure 4.1.  Left:  An image of the nAChR from Torpedo, pdb file 2BG9(3). The approximate 
position of the membrane is shown as thick grey bars.  Right:  The “aromatic box” of 
AChBP, pdb file 1I9B(4).  Residues are labeled according to the “loop” convention(5).  
TrpB (green) is the key residue for many of the studies reported in this chapter and 
Chapter 5.   
 
 
4.1.1 Experimental Design 
  
 Before starting work on assembling the equipment necessary for single-
channel recording (Chapter 2), we considered several aspects of the recording 
process in order to ensure that isolation of 1 to a few ion channels in a patch of 
membrane was statistically and technically feasible for nAChRs being 
heterologously expressed in X. laevis oocytes using nonsense suppression.  
Based on whole-cell currents routinely observed for mono-fluorinated tryptophan 
introduced by nonsense suppression at TrpB of a few μA(1), heterologous 
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expression of muscle nAChR in X. laevis oocytes is a system well-suited for the 
isolation of a patch of membrane with a single ion channel, even when this 
unnatural amino acid is introduced by nonsense suppression (see Chapter 2 for 
supporting calculation). 
 A separate, but overlapping, consideration is that the number of events 
(openings and closings) that can be collected in time periods on the order of 
minutes (1 to 30 minutes) must be ~ 500 to 50,000.  Thus, a channel that 
desensitizes very quickly (< 10 ms), or which has very slow opening and closing 
rates (i.e., ~ 1 s-1)(6) may not produce enough data for statistical analysis.  
However, muscle nAChR has relatively fast rate constants and does not 
desensitize this quickly(7, 8).   
 On the other hand, some rates, such as the channel opening rate, β, for the 
muscle-type nAChR are at the upper end of resolution for most single-channel 
recording.  Several tools to control the rates in Model 4.1 include: introduction of 
mutations, varying agonists, varying voltage, and varying temperature.  Of these 
tools, mutating receptors and use of varying agonists are some of the most 
widely used, probably because they can achieve the largest effects on rates.  
Changes to voltage and temperature-dependent studies have also been used (9–
12).   
 In order to obtain seals of the resistances shown in the experiments 
discussed here (10–100 gigaΩ) and a resultant signal-to-noise ratio of > 3 (for fc 
~ 10 kHz or smaller), several aspects of the electrophysiology recording 
apparatus must be optimized.  Since the ultimate goal is to be able to measure 
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current fluctuations on the order of one trillionth of an ampere (pA), sources of 
extraneous noise must be meticulously eradicated and/or compensated. 
 In addition to the techniques for reducing the several types of noise 
discussed in Appendix B, Section 2.1 (careful electrode design, proper tip 
immersion in the bath, and appropriate low-pass filtering), physical (macroscopic) 
disruptions may impact the ability to measure small current variations.  For 
example, vibrations present in the building are damped by mounting the 
recording chamber, manipulator, dissecting scope, and light on a vibration 
isolation table with heavy table top.  Additionally, the integrity of the cell 
membrane is important and membrane disruptions introduced during the 
stripping process must be minimized.  Moreover, recording at lower 
temperatures, 18–20 °C, increases chances that the oocyte membrane will 
remain intact.  Lastly, we use potassium as the permeant ion, since it has the 
largest conductance, thereby increasing the signal-to-noise ratio.   
 With these considerations in mind, we designed and built (see Chapter 2 for 
description) an electrophysiology rig capable of detecting current fluctuations of 
~3 pA with durations of just ~ 50 µs, at bandwidths of up to 10 kHz (when fs = 50 
kHz to 100 kHz).  In order to obtain reliable event detection in this range, the 
typical precautions for creating electrodes with proper physical characteristics 
must be carefully observed(13)—in some cases they were even enhanced, as 
described in Chapter 2.   
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4.2 Results and Discussion 
All single-channel data presented in this chapter are in the cell-attached 
configuration and at positive pipette potentials.  Thus, channel openings here will 
always be shown as downward deflections. 
 
4.2.1 Early Single-Channel Studies: Acetylcholine (with Bruce Cohen; 
Some Data Were Collected on Bruce Cohen’s Single-Channel Rig) 
 
 Single-channel recording of the wild type, fetal mouse muscle nAChR 
((α1)2β1γδ) produced the following traces (Figure 4.2). 
 
Figure 4.2. Wild type mouse muscle nAChR single-channel records at macroscopic EC50 
(50 μM ACh), shown at fc = 5 kHz.  The applied pipette potential was + 60 mV.  The specific 
receptor here is (α1)2β1γδ.  Upper: 1 second trace, with scale bar.  Lower: 100 ms 
expansion of upper trace 
 
 5-F-W (F1W) was introduced in the (α1)2β1γδ receptor at αW149 (TrpB) by 
nonsense suppression.  Figure 4.3 compares wild type and (α1W149F1W)2β1γδ 
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single-channel traces.   
  
  
Figure 4.3. Single-channel recording of (α1)2β1γδ and (α1W149F1W)2β1γδ.  In each case, ACh 
is applied in the pipette at 300 µM.  Upper traces show several seconds of data of 
(α1)2β1γδ (at left) and (α1W149F1W)2β1γδ (at right), while lower traces show ~ 100 ms.  Less 
activation of the (α1W149F1W)2β1γδ is qualitatively evident.  The channel open currents were 
5–6 pA at an applied pipette potential of + 100 mV.   
 
The primary impact of the fluorination effect that we observed was a sevenfold 
decrease in apparent agonist binding rate (k1) using acetylcholine as the agonist 
(Figure 4.4).  The channel opening rate, β, was not significantly impacted by 
fluorination of TrpB (40,000 s-1 versus 45,000 s-1 for wild type at 300 µM ACh).  
However, the ability of the experiment to resolve rate constants that are fast (> 
~40,000 s-1) was in question—if fluorination was decreasing β, we might not be 
able to see this effect.  Indeed, the channel opening rate of ACh has been much 
discussed, and is usually estimated at 60,000 s-1, or even faster(14, 15).  
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Figure 4.4. Measured rate constants for the WT ((α1W149F1W)2β1γδ; filled circles) and  
(α1W149F1W)2β1γδ (filled squares).  Data for the mutant was obtained at a single 
concentration (300 µM ACh).  In each of the four graphs, rates (y-axis) are given in s
-1
 and 
concentrations (x-axis) are given in µM ACh. 
 
 
Table 4.1.  A table summarizing the rate constants from the previous figure.  By far the 
largest change is in k+, the association rate of the agonist with the receptor. 
 
4.2.2 The L9’S Mutation  
  
In the wild type receptor from the previous section ((α1)2β1γδ), a mutation 
in the channel pore at β1L9’S has been widely studied(16–19).  In the nAChR, 
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the highly conserved M2 channel pore lining helix (dark gray in Figure 4.1) is 
often numbered starting with 1’ at the cytoplasmic end.  Thus, the 9’ location is 
roughly in the middle of the membrane.  When mutations are made to more 
hydrophilic residues, such as LeuSer, the receptor becomes much more 
sensitive to agonist and the EC50 decreases.  This has proven useful in many 
experiments that probe mutations that otherwise increase EC50.  Thus, in the 
experiments in the previous section, recording on the (α1W149F1W)2β1γδ receptor 
at concentrations significantly above EC50 was not possible due to the fact that 
channel block prevented reliable current sizes and events.  For example, Figure 
4.5 is a single-channel trace of the (α1)2β1L9’Sγδ channel at its EC50 of 1.2 µM 
ACh.  This mutation—and in some cases multiple L9’ mutations, which have 
been shown to have a cumulative effect(18)—are used in several studies in this 
chapter as well as the next chapter. 
 
Figure 4.5.  Single-channel record of (α1)2β1L9’Sγδ.  Openings are shown as downward 
deflections.  This recording was at a pipette potential of +100 mV and 1.2 µM ACh, which is 
the macroscopic EC50 for this receptor. 
 
 
4.2.3 Single-Channel Recording on (α1)2β1L9’SγδL9’S at 300 μM TMA 
 Given that we could not be sure that the channel opening rate was 
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completely resolved, we sought a system with a significantly lower channel 
opening rate, preferably no larger than 5,000 s-1-10,000 s-1, so that this rate 
would be within the resolution of our single-channel rig.  One such partial agonist, 
which also displays a cation-π interaction with TrpB is tetramethylammonium 
(TMA)(20).  The kinetic parameters for activation of (α1)2β1γδ by TMA have been 
previously reported(21): β = 3023 s-1 and α > 150 s-1 ( = β/α = ~ 20).  The EC50 
is 868 μM, so Popen doesn’t saturate until several mM TMA.  Thus, the right shift 
(increase) in EC50, which the introduction of the fluorinated tryptophans we wish 
to study would cause, may make the concentrations of TMA required untenably 
large.  Thus, we chose a specific pair of pore mutations that have been 
previously characterized with TMA and the fluorinated tryptophan series: 
LeuSer at β9’ and δ9’.  Since the impact of 9’ mutations (LeuSer) is 
hypothesized to be an increase the in channel open time (i.e., a decrease in the 
channel closing rate)(16, 22), combining them should result in clusters of the 
channel being predominantly open, punctuated with brief closures.  These should 
be of an easily resolvable average duration: 1/(3023 s-1) = 330 μs).  The EC50 of 
TMA on (α1)2β1L9’SγδL9’S was reported as 48 μM(20).  Thus, we chose an 
initial concentration of TMA well above this (300 μM) for our single-channel 
experiments (Figures 4.6 and 4.7).   
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Figure 4.6.  Approximately 1 minute of single-channel activity of (α1)2β1L9’SγδL9’S with 
300 µM TMA in the pipette.   Unlike other traces in this chapter, this is shown at full 
bandwidth (cut-off frequency, fc, of 20 kHz). 
 
 
Figure 4.7.  One second of single-channel activity of (α1)2β1L9’SγδL9’S with 300 µM TMA 
in the pipette.  Shown at fc = 5 kHz. 
  
As expected for a concentration above the previously reported 
macroscopic EC50, the channel is mostly open.  Many brief channel closures (< 
100 μs), several less brief closures (~ 10 ms), and 2 long closures (> 30 ms) are 
visible.  Now, using the clean-up procedure described in Appendix B, we 
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replace sections of data that were poorly idealized with baseline, as in Figure 
4.8. 
 
Figure 4.8. A 30 ms section of (α1)2β1L9’S1γδL9’S at 300 μM TMA.  The data (black) and 
corresponding detected events (red) are shown before (upper) and after (lower) clean up.  
In both cases, channel openings are shown as downward deflections.  In the upper trace 
there is clearly a region of many misdetected brief openings.  
 
On the other hand, some segments have brief openings from the closed state.  
These appear well resolved, and are left unaltered for the analysis—as in the two 
brief openings in Figure 4.9. 
 
Figure 4.9. A 160 ms section of (α1)2β1L9’SγδL9’S at 300 μM TMA.  Channel openings are 
shown as downward deflections.  Two brief openings from the longer of the two closed 
states (right) are evident.   
 
 We then define clusters as being delimited by closed states longer than 100 
ms (i.e., 100 ms is the critical time, τcrit, for cluster duration); if the channel is 
closed for longer than this amount of time, then it is likely in a desensitized state.  
Additionally, clusters were required to exhibit at least 8 events: 4 cycles of 
181 
 
opening and closing.  This clean-up and cluster definition yielded a record of 
12,584 events when a dead time, τd, of 20 μs was imposed.  As discussed in 
Appendix B, the number of states in each class was determined by adding 
states (closed states first) until the LL reached a plateau (Table 4.1).  
# of closed states LL LL 
1 56107.22 NA 
2 75945.95 19838.73 
3 76339.57 393.62 
4 76388.21 48.64 
5 76646.14 257.93 
 
Table 4.2. Variation of LL with number of closed states.  LL increases as the number states 
(in this case, closed states) are added to a model.  The increase between 4 and 5 states is 
discussed in the text. 
 
 The large increase upon addition of a fifth state (red) is not physically 
meaningful.  This highlights an important admonition in building kinetic models 
from single-channel data—the statistical fits (maximizations of the log likelihood) 
must be viewed critically.  In the case of adding a fifth closed state above, the 
resultant rates (and histogram when fitted to the corresponding number of 
components, below (Figure 4.10)) have no basis in the observed data.  In 
particular, one component (corresponding to a rate constant of > 100,000 s-1, the 
channel opening rate), is grossly exaggerated (see histogram).  In addition to the 
use of the histogram to eliminate models such as the one with 5 closed states, I 
demonstrated that the aberrant LL value was specifically caused by the mis-
estimation of the channel opening rate.  When I fixed the channel opening rate 
constant at 22,000 s-1, the LL increased only slightly (~ twofold) when a fifth 
closed state was added.   
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Figure 4.10. Closed dwell time histograms with successively additional components from 
QuB.  5 different fits are shown.  From top (previous page) to bottom: 1, 2, 3, 4, and 5 
components.  When more than one component is shown, the dark black line is the sum of 
the components and a light gray line shows the specific contribution of each component.  
These 5 histograms correspond to the LL values given in Table 4.1. 
 
The number of open states was determined in a similar manner, but was 
more straightforward, as there was only one component in the open histogram 
(Table 4.2). 
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# of open states LL LL 
1 76388.21 NA 
2 75909.54 -478.67 
 
Table 4.3. Variation of LL with number of open states.  LL decreases upon the addition of a 
second open state.  There is clearly only one open state. 
 
 The final model should thus have 4 closed states (black) and 1 open state 
(red), as shown in Model 4.2. 
 
Figure 4.11. Model 4.2, a 5 state model of the nAChR. Each number above or below a line 
corresponds to a rate (units: s
-1
) for the corresponding forward or reverse transition.  The 
numbering of the states corresponds to the order that they were input into QuB.  One 
possible physical interpretation of this data is that the first two steps (43 and 31) are 
binding steps, 12 is the gating step, and 25 is desensitization. 
 
In order to verify the validity of this model (beyond the use of statistics and fits to 
histograms), we simulate data, with the final model above as input in QuB.  The 
result (Figure 4.12) is compared qualitatively to what actual data looked like (see 
Figure 4.9, above).  Indeed, the simulated data are quite similar to the original, 
another piece of support that this model fits the observed data.   
 
Figure 4.12. A 160 ms section of simulated data based on the final TMA model 2, above.  
Channel openings are shown as downward deflections. 
  
 The rate constant in this final model that corresponds to the channel 
opening rate (β) is from state 12 and is 22,700 s-1, nearly eightfold higher than 
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expected (3,023 s-1).  Although we have not collected data with TMA on 
(α1)2β1γδ, compared to previous studies’ findings(20), we see that the β9’, δ9’ 
mutant seems to have significantly increased the channel opening rate.  Based 
on the gating rates in the above mechanism, β = 22,700 s-1 and α = 260 s-1.  
Thus Popen = 22,700 s
-1/(22,700 s-1 + 260 s-1) = 0.989 and  = β/α = 87.   
  Comparing our Popen to the previously reported value of Popen for (α1)2β1γδ 
(0.886)(21) we find that TMA on (α1)2β1L9’SγδL9’S has a high open probability.  
Indeed, as the value of  = 87 indicates, TMA acts essentially as a full agonist on 
(α1)2β1L9’SγδL9’S.    
 Unfortunately, this value for the channel opening rate is still near the 
resolution of our single-channel rig (see Chapter 2).  Thus, we may still not be 
completely resolving this rate constant.  Consequently, we sought an agonist with 
an even lower opening rate constant.  Choline is a nAChR partial agonist with 
reported β = 50 s-1, α = 1400 s-1, and  = 0.035 (for the adult mouse muscle 
type, (α1)2βεδ(23)).   
 
4.2.4 Initial Single-Channel Recording on (α1W149F1W)2β1L9’SγδL9’S at 
2.0 mM Choline 
  
 I have obtained a single patch with data from (α1W149F1W)2β1L9’SγδL9’S  at 
2.0 mM choline and recorded at multiple pipette potentials (Figure 4.13). 
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Figure 4.13. (α1W149F1W)2β1L9’SγδL9’S single-channel activity at 2.0 mM choline.  Each trace 
is 1 second of channel events at fc = 5 kHz.  Left: Pipette potential of +50 mV.  Right: Same 
patch at a pipette potential of +70 mV 
 
Note that increasing the pipette potential (HP) from +50 mV to +70 mV creates a 
noticeable increase in the both the open channel current and the baseline (leak 
current).  From this information (as well as the current at HP = + 30 mV (results 
not shown)) we have Table 4.4. 
 
Table 4.4. The variation of open channel current amplitude with varying applied pipette 
potentials applied to (α1W149F1W)2β1L9’SγδL9’S with 2.0 mM choline 
 
 A plot of the current-voltage relationship (I-V) is shown in Figure 4.14.  This 
line has R2 = 0.971 and slope = 0.05 pA/mV = 50 pS.  This is the slope 
conductance.  The reversal potential was -22 mV, a result that warranted further 
consideration since, based on the solutions we are using (see Materials and 
Methods, Chapter 2), we expect a reversal potential of 0 mV.  Indeed, other 
single-channel experiments across positive and negative pipette potentials 
(Chapter 6) as well as whole-cell measurements of the reversal potential of 
HP (+) in mV Channel I (pA)
30 2.5
50 3.8
70 4.5
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devitellinized oocytes (Chapter 2) indicate that for the recording solutions used 
throughout my thesis, the single-channel reversal potentials for nAChRs are ~ 0 
mV.  The low reversal potential estimated for this patch was probably due to the 
fact that no rectification behavior could be estimated since recordings were only 
performed at positive pipette potentials. 
 
Figure 4.14. An I-V plot of the data in Table 4.4.  The black line (linear regression) was 
extrapolated to negative pipette potentials in order to estimate the reversal potential. 
 
4.2.5 Single-Channel Recording on (α1)2β1L9’SγδL9’S Using 5 mM 
Choline  
 
 Figure 4.15, Upper shows data from a gigaseal that lasted just over an 
hour.  In this case, 5 mM choline was applied in the pipette to α12βL9’S9’γδL9’S 
and there was significant channel activity during the entire record.  Interestingly, 
the macroscopic phenomenon of desensitization (state 5 of Model 2) seems to 
manifest itself here at the single-channel level—the number of active channels 
decreases until, at the end, only a single channel is active (though presumably 
the other channels are still in the patch, and ligand bound).  It is worth keeping in 
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mind that over the course of this file, over 180,000,000 samples were taken (the 
sampling frequency was 50 kHz).  A one second section of data at the end of the 
recording is shown (Figure 4.15, Lower). 
 
 
Figure 4.15. Single-channel recording of (α1)2β1L9’S9’γδL9’S at 5 mM choline.  Recordings 
were performed at a pipette potential of +70 mV.  Upper: > 1 hour of recording.  Lower: 1 
second of data showing that the channel is mostly open, but has some brief closures 
 
 An all points histogram can be used to evaluate the number of active 
channels in a patch as well as their relative conductances (Figure 4.16). 
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Figure 4.16. An all points histogram for a single-channel recording with multiple 
simultaneously active channels.  When the component at ~ 20 pA is included (the effective 
baseline in this case) 7 components are visible, corresponding to at least 6 different open 
channels.    
 
 This choline data appear to still have some brief closures like the ACh and 
TMA data shown above, but those closures are generally of longer durration.  
Thus, we expect the channel opening rate to be slower than the 22,000 s-1 for 
TMA.  A three-state model fit to a small portion of data with 5 mM choline 
indicates that β ~ 3,000 s-1.  However, it does not appear that 5 mM choline was 
a high enough concentration to saturate the binding equilibrium.  In this case, this 
measurement of β is actually the apparent channel opening rate, β’.  Higher 
concentrations of choline will be needed in order to accurately measure β (such 
as the concentration dependent data shown in Figure 4.4).  However, these 
higher concentrations of choline cause increasing levels of open channel block 
that will convolute analysis and themselves introduce further brief closures.     
 In summary, I have performed single-channel recording with multiple 
agonists on (α1)2β1L9’SγδL9’S and (α1W149F1W)2β1L9’SγδL9’S.  The ultimate goal 
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of this project is to develop a model for receptor activation of a wild type nAChR 
and compare this to rates that we measure for the receptor when a fluorinated 
tryptophan is substituted by nonsense suppression at TrpB.  Since accurate 
measurement of β proved difficult, we ultimately picked a different nAChR to 
characterize.  In the next chapter (5), I will present single-channel data for the 
neuronal α4β2 receptor that, in combination with whole-cell data, establish a 
cation-π interaction to TrpB of that receptor.  Those experiments are performed 
with the highly relevant agonists nicotine and a smoking cessation drug, Chantix® 
(varenicline).   
 If further experiments on the muscle-type nAChR are desired in which the 
channel opening rate (β) can be resolved, the TMA data I’ve gathered thus far on 
(α1)2β1L9’SγδL9’S suggest another system that might work.  The channel 
opening rate increased ~ eightfold relative to previously reported channel 
opening rates with TMA on (α1)2βγδ.  Thus, since choline is probably not viable 
without further receptor perturbations, the channel opening rate for TMA on 
(α1)2β1γδ could be measured.  If it is ~ 3,000 s
-1, as has been previously 
reported, then perhaps using TMA with a single 9’ mutation (either βL9’S or 
δL9’S) will produce a sufficiently low EC50, while still reducing the channel 
opening rate (relative to ACh) to a resolvable rate (< 10,000 s-1).   
 The use of the epsilon subunit (in place of gamma) in future studies offers 
two distinct advantages: (1) it produces receptors with a larger single-channel 
conductance, which increases SNR, and (2) it produces receptors with nearly 
equivalent binding sites, which should simplify the kinetic analyses.  It was 
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therefore characterized at the whole-cell and single-channel levels with ACh. 
   
4.2.6 Whole-Cell Characterization of (α1)2β1εδ  
 
 I have performed whole-cell characterizations of the mouse adult nAChR 
((α1)2β1εδ) (Figures 4.17 and 4.18). 
 
Figure 4.17. Sample opus trace on the receptor (α1)2β1εδ.  At 215 μM ACh (above the EC50 
of 70 μM; see next figure), significant whole-cell currents are observed, 60 μA in this case 
(y axis).  Also, a moderate amount of whole-cell desensitization is evident. 
 
 
Figure 4.18. Whole-cell dose response curve for (α1)2β1εδ.  The x-axis is concentration of 
agonist (ACh).  The EC50 (70 µM ACh, m2) and Hill coefficient (1.3, m3) are given in the 
inset. 
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4.2.7 Single-Channel Characterization of (α1)2β1εδ (with Bruce 
Cohen) 
 
 The mouse adult receptor ((α1)2β1εδ) was also characterized by single-
channel recording (Figure 4.19, and 4.20, Right).  Like the fetal receptor (Figure 
4.19, and 4.20, Left), it exhibited some channel block at 300 µM ACh that 
manifest as a combination of brief closures and a reduction in single-channel 
conductance. 
 
Figure 4.19.  Single-channel recording of nAChRs at 300 μM ACh.  The applied pipette 
potential was + 100 mV in each case and 8 seconds of data (2 seconds per line) are shown 
for each at fc = 2 kHz.  Left: (α1)2β1γδ.  Right: (α1)2β1εδ   
 
 
Figure 4.20. All points histograms of the data points corresponding to the single-channel 
data shown in the previous figure.  The corresponding chord conductances are 61 pS 
((α1)2β1γδ) and 65 pS ((α1)2β1εδ).  This increase in conductance for (α1)2β1εδ is less than 
expected, perhaps due to increased channel block. 
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More detailed kinetic analysis of the (α1)2β1εδ receptor was performed 
using QuB; the results are presented in Figure 4.21.  These kinetics should be 
considered in light of the fact that they were performed for data at a single 
concentration (300 µM ACh).  Ideally a minimum of 3 concentrations are used 
and fitted simultaneously (see next section).   
 
Figure 4.21. Summary comparison of rate constants, , and Popen for the ((α1)2β1γδ) (black) 
and ((α1)2β1εδ) (red) receptors.  The relationship between  and Popen for full agonists is 
highlighted by the fact that a significant reduction in  for the full agonist ACh only 
produces a small decrease in Popen.  The relationship is different for partial agonists, 
especially for  < 1.  In the case of the epsilon-containing receptor, the main difference 
that these kinetic studies revealed was an increase in the channel closing rate, α.  This 
change was also largely responsible for the decrease in .   
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4.2.8 Progress Towards a Kinetic Model for 
(1)21L9’SD174ND180N 
 
 We were interested in producing a kinetic model for 
(1)21L9’SD174ND180N for reasons covered in detail in Chapter 3.  Briefly, it 
is one of a few receptors that exhibit a significant coupling between the channel 
pore mutation (βL9’S) and the extracellular domain mutations in the 
complementary subunits (D174ND180N).  Single-channel data were recorded 
at EC50 (160 μM ACh) as well as 500 μM ACh and 2000 μM ACh (Figure 4.22). 
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Figure 4.22. 3 pairs of single-channel traces for ACh activation of 
(1)21L9’SD174ND180N at indicated concentrations.  In each pair, the upper trace is the 
actual data collected and the lower trace is simulated data based on the model.  The scale 
bar in the top trace applies to all traces.   
 
 Based on the data collected across these 3 concentrations and the 
approach to data analysis outlined in Appendix B, a kinetic model was developed 
using QuB (Model 4.3).  As suggested by Model 4.1, the models here were fixed 
so that the rate of 54 (first binding) was twice that of 41 (second binding) and 
14 (second unbinding) was twice that of 45 (first unbinding).  The extra 
closed state (3) was added to account for long closed periods that are 
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qualitatively evident in the traces in Figure 4.22 and generally characteristic of 
nAChRs.  This is the probably the desensitized state.  The result was Model 4.3: 
. 
The simulated data in Figure 4.22 were then refit to a 5 state model, producing 
the three models in Figure 4.23. 
 
 
Figure 4.23. The 3 models for re-fitting simulated data at the concentrations given in 
Figure 4.22.  Varying p values in the first two steps correspond to the different 
concentrations.   
 
The combined qualitative agreement of the traces in Figure 4.22 and the 
quantitative similarities of the rates for the models in Figure 4.23 indicate that a 
reasonably stable model for these data has been obtained.  These data are 
further in agreement with the fact that the D174ND180N mutation on its own 
drastically diminishes the channel’s ability to gate, while L9’S restores some of 
this (Chapter 3).  Based on this single-channel data and QuB modeling, I 
estimate  for (1)2L9’SD174ND180N to be ~ 10.  The channel opening rate, 
β, is ~ 3000 s-1, and this is the first receptor for which I can confidently report an 
estimate of β. 
 
197 
 
4.2.9 Agonist-Free Single-Channel Recording of (α1)2β1L9’SγδL9’S 
  
 An alternative approach to learning about the impact of mutations, including 
pore domain mutations such as L9’S and L9’A, is to study the openings of the 
channels in the absence of agonist.  The gating equilibrium constant () for these 
spontaneous openings in the wild type nAChR has been estimated at ~ 10-6(24, 
25).  However many mutations, including L9’S, significantly increase , making  it 
feasible to study spontaneous openings of mutated nAChRs.  Figure 4.24 shows 
single-channel data for (α1)2β1L9’SγδL9’S and a corresponding open dwell time 
histogram is given in Figure 4.25. 
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Figure 4.24. Single-channel records of (α1)2β1L9’SγδL9’S with no agonist applied.  A 
special pipette holder that had never been exposed to agonist was used for these 
experiments.  Upper: 10 seconds of spontaneous openings, 1 second per line.  At least a 
few overlapping channel openings are present, so we know that there are multiple 
channels in this patch. Lower: examples of the three different open durations apparent in 
the single-channel data.  Brief (~ 100 µs), intermediate (several ms), and long (> 10 ms).  
See the open dwell time histogram below. 
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Figure 4.25. Open dwell time histogram of spontaneous openings of (α1)2β1L9’SγδL9’S.  
Over 10,000 events are represented in this histogram, which was fitted to 3 components.  
High resolution, qualitative examples of these openings are shown in the previous figure. 
 
Given high whole-cell agonist-induced currents (20–50 μA), I expect multiple 
channels per patch.  Indeed, Figure 4.24 indicates that there are at least two 
channels in the patch analyzed here.  While this has essentially no impact on 
analysis of the channel’s open dwell time, multiple channels in a patch make a 
detailed analysis of the closed dwell times in terms of the kinetics of the receptor 
difficult.  One or more component may be reduced by a factor of N, where N is 
the number of channels in the patch.  Nevertheless, the following three-
component fit of the closed dwell times suggests multiple distinct components 
(Figure 4.26).   
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Figure 4.26. Closed dwell time histogram of spontaneous openings of (α1)2β1L9’SγδL9’S.  
Over 10,000 events are represented in this histogram, which was fitted to 3 components. 
 
I’ve found that spontaneous openings of (α1)2β1L9’Sεδ also show multiple 
different open dwell times (data not shown).  Further characterization of 
spontaneous openings of receptors containing one or two L9’S pore mutations 
could prove interesting in developing gating models of the nAChR. 
 
4.3 Materials and Methods 
 The materials and methods used for whole-cell and single-channel 
recording in this chapter were described in Chapter 2.  All conventional mutants 
were made by site-directed mutagenesis (Section 2.2).  As in the past, for 
incorporation of unnatural amino acids, we inject the subunit(s) to be suppressed 
in excess.  In some experiments, the α1 subunit was suppressed at TrpB 
(α1Trp149), so the injected mRNA ratios were 10:1:1:1.  This solution was mixed 
in a 1:1 ratio with F1W-tRNA and 50 nl of the resulting solution were injected per 
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oocyte.  Note that single-channel experiments at multiple concentrations on the 
(1)2L9’SD174ND180N receptor were all performed in the cell-attached 
pipette configuration.  Thus, each concentration was collected on a different 
patch.  Data analysis is described in Appendix B.  The ε subunit was provided 
by Purnima Deshpande.   
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Chapter 5 
 
 
Nicotine Binding to α4(L9’A)2(β2)3 and  
Varenicline (Chantix
®
) Binding  
to (α4L9’A) 2(β2)3 and (α4L9’A)3(β2)2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sections 5.2 through 5.4 of this chapter are reprinted from Nature, 458. Xinan Xiu, Nyssa L. 
Puskar, Jai A. P. Shanata, Henry A. Lester, and Dennis A. Dougherty.  Nicotine Binding to Brain 
Receptors Requires a Strong Cation-π Interaction, 354–357. Copyright (2009) with permission 
from Nature.  
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5.1 Introduction 
 
In Chapter 4, I used a variety of agonists and mutants in an attempt to 
learn about the rate at which ion channels open, as well as to build kinetic 
models of a mutant nicotinic acetylcholine receptor.  However, as the name 
implies, the nicotinic acetylcholine receptors (nAChRs) bind nicotine in addition to 
their endogenous agonist acetylcholine.  This binding is particularly strong in 
brain nAChRs (Figure 5.1).  The resultant activation of these receptors from 
nicotine binding triggers dopamine release that initiates and sustains nicotine 
dependence mediated by mesolimbic reward(1, 2). 
The muscle-type nAChRs were the focus of Chapters 3 and 4; previous 
studies of binding to these receptors showed a cation-π interaction between 
acetylcholine (ACh) and TrpB(3).  However, similar studies showed no similar 
binding pattern to nicotine(4).  Moreover, the binding mode of nicotine to 
neuronal nAChRs was not known, despite its key role in nicotine addiction and 
resultant therapeutic strategies for smoking cessation (see Section 5.6, below).  
This chapter explores the binding of nicotine, a highly addictive, yet widely 
available drug, and varenicline (Chantix®), a smoking cessation treatment, to the 
α4β2 neuronal nAChRs. 
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FIgure 5.1.  An artists’ rendition of the interaction of nicotine and brain receptors.  Nicotine 
from cigarette smoke gets to the brain quickly, where it has a wide range of cognitive 
effects.  Figure courtesy of Wolfe Gleitsman 
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5.2 Nicotine Binding to Brain Receptors Requires a Strong 
Cation-π Interaction  
 
Nicotine addiction begins with high-affinity binding of nicotine to 
acetylcholine (ACh) receptors in the brain.  The end result is over 4,000,000 
smoking-related deaths annually worldwide and the largest source of 
preventable mortality in developed countries.  Stress reduction, pleasure, 
improved cognition, and other CNS effects are strongly associated with 
smoking.  But, if nicotine activated ACh receptors found in muscle as 
potently as those in the brain, smoking would cause intolerable and 
perhaps fatal muscle contractions.  Despite extensive pharmacological, 
functional, and structural studies of ACh receptors, the basis for the 
differential action of nicotine on brain versus muscle ACh receptors has 
not been determined.  Here we show that at the α4β2 brain receptors 
thought to underlie nicotine addiction, the high affinity of nicotine is the 
result of a strong cation-π interaction to a specific aromatic amino acid of 
the receptor, TrpB.  In contrast, the low affinity of nicotine at the muscle-
type receptor is largely due to the fact that this key interaction is absent, 
even though the immediate binding site residues, including the key TrpB, 
are identical in the brain and muscle receptors.  At the same time a 
hydrogen bond from nicotine to the backbone carbonyl of TrpB is 
enhanced in the neuronal receptor relative to the muscle-type.  A point 
mutation near TrpB that differentiates α4β2 and muscle-type receptors 
appears to influence the shape of the binding site, allowing nicotine to 
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interact more strongly with TrpB in the neuronal receptor.  ACh receptors 
are established therapeutic targets for Alzheimer’s disease, schizophrenia, 
Parkinson’s disease, smoking cessation, pain, attention deficit-
hyperactivity disorder, epilepsy, autism, and depression(5).  Along with 
solving a chemical mystery in nicotine addiction, our results provide 
guidance for efforts to develop drugs that target specific types of nicotinic 
receptors. 
 
Nicotinic acetylcholine receptors (nAChR) comprise a family of ≥ 20 
homologous subtypes that mediate fast synaptic transmission throughout the 
central and peripheral nervous systems(6). The neuronal receptors are found in 
the central nervous system (CNS) and autonomic ganglia.  Of these, the subtype 
most strongly associated with nicotine addiction and the target of recently 
developed smoking cessation drugs is termed α4β2(7-11). The high nicotine 
affinity of α4β2 receptors, when combined with the ability of nicotine to cross the 
blood-brain barrier and its favorable pharmacokinetics, allows nicotine at the 
submicromolar concentrations in tobacco smoke to acutely activate these 
receptors, providing reward, cognitive sensitization, and perhaps other effects.  In 
addition, the high-affinity interaction allows smoked nicotine to act as an 
intracellular pharmacological chaperone of α4β2 receptors, leading to the 
upregulation of receptors thought to underlie effects of chronic exposure(10, 12).  
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In previous studies of the nAChR of the neuromuscular junction (muscle-
type), we showed that an important contributor to ACh binding is a cation-π 
interaction to a specific tryptophan (TrpB, residue 149, Figure 5.2)(13). These 
results were subsequently supported by the important series of crystal structures 
of ACh binding proteins (AChBP)(14, 15).  These structures revealed the 
‗aromatic box‘ structural motif of Figure 5.2, and the aligning residues are 
predominantly aromatic throughout the Cys-loop family of neurotransmitter-gated 
ion channels. In other Cys-loop receptors, a cation-π interaction between the 
natural agonist and one of the aromatics is always seen, although its precise 
location varies(16).  Interestingly, when nicotine activates the muscle-type 
nAChR, there is no cation-π interaction(17), consistent with its relatively low 
affinity for this receptor. This suggested that a cation-π interaction could 
discriminate between high affinity neuronal receptors and low affinity muscle-type 
receptors.  However, subtle effects must be involved, as the nAChRs of the CNS 
and neuromuscular junction are homologous throughout most regions of 
sequence and are essentially identical in the immediate vicinity of the agonist 
binding site (Figure 5.7). 
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Figure 5.2. The binding site of AChBP, thought to resemble that of nAChRs.  Shown are 
the four principal ‘loops’ that define the binding site(6).  Also highlighted are TrpB (149) 
studied here; its backbone carbonyl (green star); and the α carbon on position 153, which 
has also been mutated here.  Note that loop C contributes two aromatic residues; the other 
loops each contribute one. The image is of Protein Data Bank file 1I9B(14).   
 
 
Here we describe studies of the α4β2 neuronal receptor. We find a 
remarkable alteration of binding behavior:  both ACh and nicotine make a strong 
cation-π interaction to TrpB.  In addition, a hydrogen bond from nicotine to the 
backbone carbonyl of TrpB that is weak in the muscle-type is much stronger in 
the α4β2 receptor.  Taken together, these two noncovalent interactions fully 
rationalize the differential affinity of nicotine in the brain versus the 
neuromuscular junction.  
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A cation-π interaction between a drug and a receptor can be revealed by 
incorporation of a series of fluorinated amino acid analogues (Figure 5.3); a 
consistent trend in receptor response indicates a binding interaction.  Such an 
experiment is enabled by the nonsense suppression methodology for 
incorporation of unnatural amino acids into receptors and channels expressed in 
Xenopus oocytes.  While we have found the nonsense suppression methodology 
to be broadly applicable(18, 19), implementing the methodology for study of the 
α4β2 neuronal nAChRs proved to be especially challenging, requiring new 
strategies.  The α4β2 receptors express in Xenopus oocytes at inadequately low 
levels for nonsense suppression experiments. However, recent studies showed 
that the Leu9‘Ala (L9‘A) mutation in the M2 transmembrane helix of the α4 
subunit greatly improves expression without altering the pharmacological 
selectivity of the receptor(20). Therefore, all studies of α4β2 described here 
included this mutation. As with other mutations of L9‘, the L9′A mutation lowers 
EC50 by influencing receptor gating in ways that are fairly well understood and 
that do not distort the present analysis of the binding site (some 60 Å from the 9‘ 
position)(21, 22).  In addition, previous studies of the muscle-type receptor used 
a comparable mutation at L9‘, and control experiments established that it did not 
alter binding trends(13, 23). 
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Figure 5.3. Agonists and unnatural amino acids considered here.  a) Structures of ACh and 
nicotine.  b) Unnatural amino acids considered here.  If not otherwise indicated, an a, b, c, 
or d group is H.  Br, bromo group; CN, cyano group.  c) The backbone ester strategy for 
modulating a hydrogen bond 
 
The nAChRs are pentameric.  The muscle-type receptor has a precise 
stoichiometry of (α1)2β1γδ.  However, the α4β2 receptor can have variable 
stoichiometry.  In particular, there are two forms of α4β2, (α4)2(β2)3 and 
(α4)3(β2)2, which we will refer to as A2B3 and A3B2(12, 24, 25), respectively.  
Agonist binding sites are at the appropriate α-β interfaces. The A2B3 form has 
higher sensitivity for nicotine and may be upregulated during chronic exposure to 
nicotine; our studies have focused on it.  Controlling the ratios of mRNAs injected 
into the oocyte can reliably control subunit stoichiometry in the wild type receptor. 
213 
 
However, in a nonsense suppression experiment, the subunit that contains the 
stop codon where the unnatural amino acid has been incorporated can exhibit 
low and variable expression levels.  Therefore we sought a second, independent 
indicator of the stoichiometry of the α4β2 receptor.  We now report that the A2B3 
and A3B2 forms of the α4(L9‘A)β2 receptor show markedly different rectification 
behaviors.  As indicated by either voltage ramp or voltage jump experiments, 
A2B3 is substantially more inward rectifying than A3B2 (Figure 5.8).  Thus, in all 
our experiments with unnatural amino acids, the stoichiometries of mutant 
receptors are monitored by measuring I-V relations with voltage jumps. For each 
mutant receptor studied, we determined the fraction, (outward current at +70 
mV/inward current at –110 mV), and a value ≤ 0.1 establishes the desired A2B3 
stoichiometry (Table 5.1, Supplementary Discussion).  With these 
methodological developments in hand, incorporation of unnatural amino acids 
into the α4β2 receptor becomes feasible (Figure 5.4).  
 
 
Figure 5.4. Nonsense suppression in the α4β2 receptor.  Shown is a wild-type recovery 
experiment, in which Trp is incorporated at the TrpB position. a) Representative traces of 
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voltage-clamp currents.  Bars represent application of ACh at concentrations noted. b) Fit 
of data in a to the Hill equation.  Error bars indicate s.e.m; n = 6–8. 
As shown in Table 5.1 and Figure 5.5, a compelling ―fluorination‖ trend is 
seen for both ACh and nicotine at TrpB of the α4β2 receptor.  This is in sharp 
contrast to the results at the muscle-type receptor, in which no such trend is seen 
for nicotine activation.  Further support for an important cation-π interaction for 
both agonists is provided by the large perturbation induced by a cyano (CN) 
group—which is strongly deactivating in a cation-π interaction—compared to a 
bromo (Br) group, which is roughly isosteric to CN but much less deactivating. 
 
We have also evaluated other residues that constitute the aromatic box of 
the ACh binding site (Table 5.1).  The results for α4β2 very much parallel our 
previous findings for the muscle-type receptor (Supplementary Discussion).  This 
indicates that it is specifically the interaction with TrpB that discriminates the two 
receptor subtypes. 
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Figure 5.5. Fluorination plots.  Note that in both plots, all data sets share the point at x = 
32.6 kcal mol
-1
 (cation-π energy for Trp); y = 0 (black circle).  Moving to the left then 
corresponds to monofluoro-, difluoro-, trifluoro-, and tetrafluoro-TrpB.  Cation-π binding 
energies (x-axes) are from (13). a) Muscle-type receptor.  The designation WT indicates Gly 
at position 153. b) α4β2 receptor 
 
The EC50 values reported here represent a measure of receptor function; 
shifts in EC50 can result from changes in ligand binding and/or receptor gating 
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properties.  By ascribing the results to attenuation of a cation-π interaction, we 
are effectively concluding that it is ligand binding that is being modulated by 
fluorination, but that conclusion is not incontrovertible.  To resolve this ambiguity, 
we evaluated the gating behaviors of key receptors using single-channel 
recording.  For the wild type and the receptor with F3-Trp at TrpB, we compared 
the probabilities that the channel is open (Popen) at nicotine concentrations that 
evoke half-maximal macroscopic steady-state currents (EC50 = 0.08 μM and 1.2 
μM, respectively).  Any differences between the two Popen values must result from 
differences in gating behaviors.  As suggested by Figure 5.6 and as confirmed 
by further single-channel analysis (Figure 5.9 and Supplementary Discussion), 
the wild type and mutant receptors have Popen values that are essentially 
indistinguishable.  Thus, the shift in EC50 for F3-Trp is primarily, if not exclusively, 
a consequence of changes in binding.  We conclude that fluorination of TrpB of 
the α4β2 (A2B3) receptor primarily impacts sensitivity to nicotine by decreasing 
nicotine‘s cation-π interaction with this residue. 
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Figure 5.6. Single-channel recordings from wild type α4β2 (conventional expression) and 
the F3-Trp mutant (nonsense suppression) at site B, with nicotine applied at EC50 values 
(0.080 and 1.2 μM, respectively).  Lower traces are expansions of the regions marked by a 
bar in the upper traces.  Records were obtained in the cell-attached configuration with a 
pipette potential of +100 mV and are shown at 2 kHz bandwidth.  Channel openings are 
shown as downward deflections. 
 
These results indicate that nicotine is positioned more closely to TrpB in 
the α4β2 agonist binding site than in the muscle-type.  This suggested that 
another nicotine binding interaction could also be altered.  An important chemical 
distinction between ACh and nicotine is that only the latter can act as a hydrogen 
bond donor, through the pyrrolidine N+-H (Figure 5.3A).  Examination of the 
AChBP crystal structures (Figure 5.2)(26) suggested that the backbone carbonyl 
associated with TrpB could act as the hydrogen bond acceptor, and several 
groups have shown the importance of this interaction(26-28).  Previously, we 
probed this potential hydrogen bond in the muscle-type receptor by replacing the 
(i+1) residue with its α-hydroxy analogue (Figure 5.3C).  This converts the 
backbone amide to a backbone ester, which is well-established to be a 
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substantially poorer hydrogen bond acceptor.  In the muscle-type receptor, this 
change raised the nicotine EC50 by a modest factor of 1.6(29).  We now find that 
for precisely the same change in the α4β2 receptor, the nicotine EC50 increases 
19-fold, a relatively large effect for such a subtle mutation(30-32).  Recall that the 
backbone ester substitution does not destroy the hydrogen bond, it simply 
attenuates it.  Importantly, ACh, which cannot make a conventional hydrogen 
bond to the carbonyl, shows no shift in EC50 in response to this mutation (Table 
5.1). This establishes that the ester mutation does not globally alter the 
binding/gating characteristics of the receptor. 
 
The differential affinity of nicotine for α4β2 versus muscle-type receptors 
results from stronger interactions in the former with TrpB–both cation-π and 
hydrogen bonding.  Since the two receptors are identical with regard to the five 
residues that make up the aromatic box, a factor ‗outside the box‘ must be 
influencing its precise geometry, such that nicotine can approach TrpB more 
closely in α4β2 than in muscle-type nAChR.  Pioneering work has identified 
residues responsible for the fact that α4β2 receptors show consistently higher 
affinity than the homopentameric α7 neuronal receptors(33).  At a particular 
residue in loop B–position 153, only four residues from TrpB–mutations strongly 
influence affinity.  In high affinity α4β2 receptors this residue is a Lys, and is 
proposed to form a backbone hydrogen bond between loops B and C that helps 
shape the aromatic box (Figure 5.2).  In the lower affinity α7 neuronal receptor, 
residue 153 is a Gly, and molecular dynamics simulations of α7 suggest that a 
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Gly at 153 discourages the formation of the hydrogen bond between loops B and 
C.  Interestingly, the aligned residue in the muscle-type receptor is also a Gly, 
and a naturally occurring G153S mutation is gain-of-function and associated with 
a congenital myasthenic syndrome(34).  We now report that the muscle-type α1 
G153K mutant shows much higher affinity for nicotine, and that, when this 
mutation is present, the cation-π interaction to TrpB is strong.   The data are 
summarized in Table 5.1 and Figure 5.5.  As expected, the ACh cation-π 
interaction is maintained in the muscle-type receptor with the G153K mutation.  
These data indicate that the loop B-loop C hydrogen bond that is naturally 
present in α4β2 shapes the aromatic box such that nicotine can make a closer 
contact to TrpB, and that this structural feature is absent or weaker in the 
muscle-type receptor.  
 
Taken together, the present results indicate that the higher affinity of 
nicotine in the brain relative to the neuromuscular junction is a consequence of 
enhanced interactions with TrpB.  A cation-π interaction that is absent in the 
muscle-type receptor is quite strong in α4β2.  In addition, a hydrogen bond to a 
backbone carbonyl that is weak in the muscle-type is enhanced in α4β2.  Both 
effects are quite substantial, and in combination they are more than adequate to 
fully account for the differential sensitivity to nicotine of the two receptors.  The 
side chain of residue 153 in loop B distinguishes the two receptor types and 
apparently influences the shape and/or electronic properties of the binding site 
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aromatic box, allowing a stronger interaction between nicotine and TrpB in high 
affinity receptors.    
Methods Summary 
Whole-cell electrophysiological characterization of agonist-induced 
responses.  Rat α4β2 and mouse (α1)2β1γδ ion channels were expressed in 
Xenopus laevis oocytes.  For α4β2 receptors, subunit stoichiometry was 
controlled by varying the α4:β2 subunit ratio and verified by voltage jump 
experiments. Dose-response measurements for these channels were performed 
with a holding potential of -60 mV. 
 
Unnatural amino acid/α-hydroxy acid incorporation.  Unnatural amino acids 
and α-hydroxy acids were prepared, coupled to dCA and ligated to 74-mer 
THG73 as described previously(19).   
 
Single-channel characterization of α4β2.  Single-channel recording was 
performed in the cell-attached configuration with a pipette potential of +100 mV.  
Popen values were calculated from event-detected data using Clampfit 9.2 single-
channel search. 
 
Full methods and any associated references are available in the online version of 
the paper at www.nature.com/nature. 
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5.3 Online Methods 
 
5.3.1 Whole-Cell Electrophysiological Characterizations of the 
Agonist-Induced Responses 
Rat α4 and α2 mRNAs as well as mouse α1, β1(L9‘S), γ, and δ mRNAs 
were obtained from NotI linearizations of the expression vector pAMV, followed 
by in vitro transcription using the mMessage mMachine T7 kit (Ambion, Austin, 
TX). The mutations for each subunit were introduced according to the 
QuikChange mutagenesis protocol (Stratagene).  
To express wild type neuronal ion channels, α4L9‘A mRNA was co-
injected with β2 mRNA at various ratios (total mRNA 10–25 ng/cell). Stage V-VI 
Xenopus laevis oocytes were injected and incubated at 18 C for 24–48 h (whole-
cell recording) or 60–90 h (single-channel recording). 
Agonist-induced currents were recorded in two-electrode voltage clamp 
mode using the OpusXpress 6000A (Molecular Devices Axon Instruments) at a 
holding potential of -60 mV. Agonists were prepared in Ca2+-free ND96 solution 
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and applied for 12 s followed by a 2 min wash with Ca2+-free ND96 solution 
between each agonist application. Acetylcholine chloride and (-)-nicotine tartrate 
were purchased from Sigma/Aldrich/RBI (St. Louis, MO). Dose-response data 
were obtained for ≥ 6 concentrations of agonist and for ≥ 5 oocytes. Mutants with 
Imax of ≥ 100 nA were defined as functional. EC50 and Hill coefficient were 
calculated by fitting the dose-response relation to the Hill equation. All data are 
reported as mean ± SEM. 
Voltage jump experiments were performed in the absence of ACh and 
also at EC50 concentration of ACh. The membrane potential was held at -60 mV, 
and stepped to 10 test potentials at 20 mV increments between +70 mV and -
110 mV for 400 ms each. The voltage was then held for 600 ms at -60 mV 
holding potential between each episode. To isolate the ACh-induced currents, 
control traces ([ACh] = 0) were subtracted from the steady-state amplitudes of 
the ACh-induced currents of the test pulses. Normalized I-V curves were 
generated using current amplitudes normalized to that at -110 mV. For each 
α4L9‘Aβ2 mutant, normalized I+70 mV ± s.e.m. from ≥ 5 cells was reported.  
 
5.3.2 Unnatural Amino Acid/α-Hydroxy Acid Incorporation 
Nitroveratryloxycarbonyl (NVOC)-protected cyanomethyl ester forms of 
unnatural amino acids and α-hydroxythreonine cyanomethyl ester were 
synthesized, coupled to the dinucleotide dCA, and enzymatically ligated to 74–
mer THG73 tRNACUA(19). The unnatural-amino-acid–conjugated tRNA was 
deprotected by photolysis immediately prior to co-injection with mRNA containing 
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the UAG mutation at the site of interest. Approximately 10–25 ng mRNA and 25 
ng tRNA-amino acid or tRNA-hydroxy acid were injected into stage V–VI oocytes 
in a total volume of 70 nL. For unnatural amino acid mutagenesis experiments in 
the muscle-type receptor, the α1, β1, γ, and δ subunits were co-injected in a 
10:1:1:1 ratio.  All muscle-type receptors contained a L9‘S mutation in the β 
subunit. 
The fidelity of unnatural amino acid incorporation was confirmed at each 
site with a ‗wild type recovery‘ experiment and a ‗read-through/ reaminoacylation‘ 
test. In the ‗wild type recovery‘ experiment, UAG mutant mRNA was co-injected 
with tRNA charged with the amino acid that is present at this site in the wild type 
protein. Generation of receptors that were indistinguishable from the wild type 
protein indicated that the residue carried by the suppressor tRNA was 
successfully and exclusively integrated into the protein. In the ‗read-through/ 
reaminoacylation‘ test, the UAG mutant mRNA was introduced with (1) no tRNA, 
(2) tRNA THG73 that was not charged with any amino acid, or (3) tRNA THG73 
enzymatically ligated with dinucleotide dCA. Lack of currents in these 
experiments validated the reliability of the nonsense suppression experiments. 
 
5.3.3 Single-Channel Characterization of α4β2 
Single-channel recording was performed in the cell-attached configuration 
on devitellinized Xenopus laevis oocytes at 20 ± 2C with a pipette potential of 
+100 mV, as described previously(31, 35). Pipettes were fabricated from thick-
walled (I.D. = 0.80 mm, O.D. = 1.60 mm) KG-33 glass (Garner Glass Company, 
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Claremont, CA) and coated with sylgard (World Precision Instruments, Sarasota, 
FL); they had resistances of 10–20 MΩ. The bath solution contained 120 mM 
KCl, 5 mM HEPES, 1 mM MgCl2, and 2 mM CaCl2, pH = 7.4, so that the reversal 
potential for agonist-induced currents of devitellinized oocytes was ~ 0 mV, and 
the transmembrane potential of the patch was ~ -100 mV. The pipette solution 
contained 100 mM KCl, 10 mM HEPES, 1 mM MgCl2, 10 mM K2EGTA, pH = 7.4, 
and was supplemented with the indicated concentrations of nicotine. Data were 
collected using a GeneClamp 500B amplifier (Axon Instruments, Union City, CA) 
at full bandwidth (50 kHz; 4-pole Bessel, -3 dB) with a CV-5 100 GU headstage.  
The signal was then low-pass filtered (Avens Signal Equipment, AP220, 8-pole 
Bessel, -3 dB 20 kHz) and sampled with a Digidata 1320A and Clampex 9.2 
(Axon Instruments, Union City, CA) at 50 kHz.  Only patches that showed no 
simultaneous activations were analyzed.  For each mutant, this was ≥ 3 patches 
from oocytes from 2 different donor frogs. Data were filtered offline (Gaussian, -3 
dB, 5 kHz) and electrical interference at harmonics of 60 Hz was removed if 
necessary. Event transitions were detected with Clampfit 9.2 (single-channel 
search).  A dead time, τd, of 100 μs was applied to all events. Open and closed 
dwell time histograms were generated as described previously(36) and fitted 
using the predefined log-transformed exponential probability density function in 
Clampfit 9.2.  To delineate clusters, a critical closed duration, τcrit, was defined 
using two separate methods (Supplementary Discussion); in both cases closed 
dwell times longer than τcrit were excluded from further analysis. Sojourns to a 
subconductance state (< 85% of the full conductance level) were treated as 
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closed and accounted for < 10% of the total openings in all records.  The time-
average probability that the channel is open (Popen) was calculated as the total 
open time divided by the revised total closed time.  
 
5.4 Supplementary Information 
 
5.4.1 Supplementary Figures 
 
Figure 5.7. Sequence alignment for Loops A, B, C, and D in the vicinity of the aromatic 
binding box. The five residues of the aromatic box: TyrA, TrpB, TryC1, TyrC2, and TrpD, 
are highlighted in green. They are universally conserved in these subunits. G153 (α1) is 
the fourth residue after TrpB, highlighted in blue.  
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Figure 5.8. Rectification behaviors of A2B3 and A3B2 L9'A 42 nAChR. Upper) 
Representative voltage traces and current responses for voltage jump experiments. 
Lower) I-V curves for A2B3 (solid line) and A3B2 (dotted line). The inset shows positive 
voltages, where A2B3 and A3B2 exhibit markedly different behavior. 
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Figure 5.9. Comparison of Popen at macroscopic EC50 for wild type and F3-TrpB 42 (A2B3) 
over a range of crit values between 5 ms and 5000 ms reveals essentially equivalent gating 
behaviors. Error bars are mean ± s.e.m. and are smaller than the symbol when not shown. 
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5.4.2 Supplementary Table 
 
Table 5.1. Functional characterization of 4(L9’A)2 wild type A3B2, and A2B3 TyrA, TrpB, 
TyrC1, TyrC2, Thr (B+1), and muscle-type receptor Thr (B+1) and 1(G153K) nAChRs. All 
muscle-type receptors contain a L9’S mutation in the  subunit. EC50 values (M), Hill 
coefficients (nH) and current size at +70 mV (normalized to current size at -110 mV). ND = 
not determined. *Muscle-type Thr150 and Thr150Tah values (italicized) were previously 
reported(25). 
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5.4.3 Supplementary Discussion 
5.4.3.1 Controlling the Stoichiometry of 42 Receptors 
 As in the case of previous studies20,21, we find that the stoichiometry of 
42 receptors can be controlled by altering the ratio of the subunits of mRNA 
during injection. Our criteria for defining a pure population of A2B3 4(L9‘A)2 
receptors are whole-cell dose-response curves that fit a single component and 
very strong inward rectification such that (Imax at +70 mV)/(Imax at -110 mV) < 0.1. 
An alternative analysis which can also demonstrate a mixed population of 
receptors is the production of intermediate EC50 values when fit to a single 
component. As shown below, by a 3:1 4:2 mRNA ratio, the EC50 value has 
reached the higher EC50 value, which is the A2B3 stoichiometry. 
4:2 ratio EC50 (M ACh) 
100:1 0.023 ± 0.002 
10:1 0.023 ± 0.001 
6:1 0.15 ± 0.02 
3:1 0.44 ± 0.03 
1:1 0.40 ± 0.01 
1:10 0.43 ± 0.02 
 
Injection of an mRNA ratio 4(L9‘A):2 of 10:1 or higher produces pure 
populations of A3B2, while a ratio of 1:3 or lower guarantees a pure population of 
A2B3.  In the experiments described here, we injected a 1:3 ratio of mRNA.   
Note that the 4(L9′A) mutation lowers EC50 in a multiplicative fashion, 
depending on how many 4 subunits are present.  As such, our A3B2 receptor 
(with three L9′A mutations) actually has a lower EC50 than our A2B3 receptor 
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(with two L9′A mutations), even though the binding site from the A2B3 
stoichiometry is clearly that of the high sensitivity receptor. 
 
5.4.3.2 TyrA, TyrC1, and TyrC2 Display Similar Interactions in Muscle-Type 
and 42 
In addition to TrpB, we have performed extensive studies of other 
aromatic residues in and around the aromatic box (Table 5.1). Briefly, when 
comparing 42 to the muscle-type receptor, very similar results are seen. TyrC1 
is very sensitive to substitution, establishing a key role for this residue, likely in 
receptor gating. TyrA appears to be a hydrogen bond donor (large effects for Phe 
and MeO-Phe substitutions), and while it is generally more sensitive to 
perturbations in the neuronal receptor, the basic trends are the same. TyrC2 is 
very permissive in both the muscle-type and 42 receptors.   
 
 
5.4.3.3 Single-Channel Recording and Analysis of Select 42 Receptors 
Here we have used single-channel measurements to convincingly 
establish that the fluorination approach is changing agonist binding, not channel 
gating. Macroscopic data establish the large successive shift in function (EC50) 
upon fluorination, and single-channel data establish that gating is unperturbed, 
since the probability that the channel is open, Popen, is essentially 
indistinguishable for wild type and F3-TrpB at corresponding points on the dose-
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response relation. At saturating agonist concentrations, Popen,max approaches 
/(+1) for the 4-state model given below. Our analysis starts by comparing the 
Popen values at the macroscopic EC50. The Popen values that we report are directly 
related to the gating equilibrium constant, , by ½ * /(+1).   
 
Definition of clusters and calculation of Popen 
Because (a) single-channel channel measurements of Popen are seldom 
reported for 42 receptors, and (b) we find that Popen depends strongly on the 
value chosen as the critical closed duration, crit, we report Popen values for the 
range 5 ms ≤  crit ≤ 5000 ms using two different methods to identify crit (below 
and Figure 5.4, above). The first is the commonly used method: the longest one 
or more components of the closed dwell time histogram are considered as 
sojourns in the desensitized state for all of the channels in the patch(37). The 
value for crit was defined based on the closed dwell time histograms fitted with 
multiple components, as previously described(38). These components are similar 
for wild type and F3-TrpB, resulting in similar crit values: crit1 of 1470 vs 1530 ms 
and crit2 of 42 vs 52 ms, respectively. The similarity of the closed dwell time 
histograms for these receptors (and the resultant crit values) can be taken as 
evidence that fluorination does not significantly impact desensitization. Moreover, 
whole-cell data show that the wild type and the F3-TrpB receptors exhibit similar 
extent and kinetics of macroscopic desensitization (data not shown). When either 
of the crit values calculated from the closed dwell time histogram is applied, Popen 
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is essentially indistinguishable for wild type and F3-TrpB. The Popen values for wild 
type and F3-TrpB at crit1 and crit2 are given here ± s.e.m. 
 
Receptor Popen (crit1) Popen (crit2) 
Wild type 0.07 ± 0.02 0.88 ± 0.06 
F3-TrpB 0.06 ± 0.03 0.82 ± 0.05 
 
Because our recordings are at an intermediate concentration (EC50), some 
closed dwells may reflect agonist dissociation, others may reflect channel closure 
followed by re-opening without agonist dissociation, while still others may reflect 
sojourns in desensitized states of varying duration. As a result, a definition of crit 
can be distorted by the relatively low number of long non-conducting sojourns. 
Thus, we also compared calculated Popen values for a wide range of possible crit 
values (3 orders of magnitude), including those calculated from the closed dwell 
time histogram. Figure 5.9 shows that, regardless of how we define crit (5 ms ≤  
crit ≤ 5000 ms), no systematic difference in Popen is observed between wild type 
and F3-TrpB with nicotine as agonist—their gating behaviors are essentially 
indistinguishable. Thus, the value chosen for crit does not affect our conclusion 
that the gating behavior, as measured by Popen, is not significantly impacted upon 
fluorination in the F3-TrpB mutant. 
 
A small shift in the channel open duration does not account for the EC50 shift of 
F3-TrpB 
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Fits to open dwell time histograms reveal that the main component of the 
channel open duration, which accounted for > 90% of the conductance in both 
wild type and F3-TrpB receptors, is shifted 2.4-fold, from 23 ms (wild type) to 
9.6 ms (F3-TrpB). Because the closed dwell time histograms, fitted with multiple 
components, displayed similar contributions from the major components for wild 
type and F3-TrpB, interpreting the 2.4-fold shift in open duration in terms of the 
channel closing rate, , would imply a modest 2.4-fold shift in  in the F3-TrpB 
receptor. We consider these results in terms of a standard, linear 4-state model 
with two sequential agonist binding steps followed by a gating step: 
 
for which, 
 
where KD is the equilibrium agonist dissociation constant (k-1/k1) and  is the 
gating equilibrium constant (/). We see that a 2.4-fold change in  accounts for 
at most a 1.5-fold shift in EC50. Thus, both comparison of Popen as well as 
consideration of kinetics, to the extent possible for data at EC50, indicate that the 
overwhelming majority of the 15-fold increase in nicotine‘s EC50 in the F3-TrpB 
receptor versus wild type is caused by changes to binding rather than the 
subsequent conformational changes that open the channel. Taken together, 
macroscopic and single-channel experiments show that fluorination modulates 
nicotine binding in a way that is systematically correlated to the energy of a 
cation- interaction. 
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5.5 Additional Figures: Single-Channel Nicotine Data and Dwell 
Time Histograms 
 
 
Figure 5.10. This figure shows longer traces of the single-channel data that was shown in 
Figure 5.6, above.  As in that figure, nicotine was applied at macroscopic EC50 and channel 
openings are shown as downward deflections. 
 
 
 
Figure 5.11. Pooled open dwell time histogram for multiple patches of single-channel 
events of wild type A2B3 with nicotine applied at its EC50.  A 2 component fit is shown as 
an overlaying black line.  The components (% in parenthesis) are: 23 ms (66%) and 1.7 ms 
(34%). 
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Figure 5.12. Pooled open dwell time histogram for multiple patches of single-channel 
events of F3-TrpB in A2B3 with nicotine applied at its EC50.  A 2 component fit is shown as 
an overlaying black line.  The components (% in parenthesis) are: 9.6 ms (55%) and 0.87 
ms (45%). 
 
 
 
Figure 5.13.  Pooled closed dwell time histogram for multiple patches of single-channel 
events of wild type A2B3 with nicotine applied at its EC50.  A 4 component fit is shown as 
an overlaying black line.  The components (% in parenthesis) are: 2800 ms (15%), 480 ms 
(33%), 12 ms (25%), and 0.31 ms (27%).   
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Figure 5.14. Pooled closed dwell time histogram for multiple patches of single-channel 
events of F3-TrpB in A2B3 with nicotine applied at its EC50.  A 4 component fit is shown as 
an overlaying black line.  The components (% in parenthesis) are: 4000 ms (22%), 610 ms 
(28%), 17 ms (15%), and 0.32 ms (35%).   
 
 
5.6 Introduction to Varenicline Binding to Nicotinic Acetylcholine 
Receptors 
 
Having shown that nicotine binds to neuronal nAChRs via a cation-π 
interaction to TrpB, a natural next question is how this information is relevant to 
the treatment of nicotine addiction.  Cytisine (Figure 5.15) is a small molecule 
that has been used to help people quit smoking in Eastern Europe for several 
decades(39).  Cytisine is a partial agonist of neuronal nAChRs(40), though it has 
markedly different efficacy at the A3B2 and A2B3 stoichiometries.  Cytisine‘s 
structure displays some key features of the nicotinic pharmacophore(41), 
including a hydrogen bond acceptor and a positive charge.  These features are 
also present in ACh and nicotine (Figure 5.15).  
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Figure 5.15. 4 agonists of the neuronal nAChRs.  Upper) The molecules are drawn with 
hydrogen bond acceptors in red and cationic nitrogens in teal.  Lower) The corresponding 
electrostatic potential surface for each molecule.  In these plots, ‘warmer colors’ (red and 
orange) represent regions of higher electron density, as measured by interaction with a 
probe positive charge (sodium ion).  ‘Colder colors’ (teal, blue) represent relatively 
positively charged regions.   
 
However, at best, cytisine increases smoking cessation < twofold above 
placebo(2).  One path to the design of small molecule therapeutic strategies that 
aid smoking cessation began with cytisine.  Using cytisine as a lead compound 
and making direct modifications to it produced α4β2 antagonists (Figure 5.16).  
A revised strategy was to develop a partial agonist of α4β2 that also had a very 
high affinity for the receptor. 
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Figure 5.16. This figure shows the structures of several molecules that have played key 
roles in the history of strategies for smoking cessation as well as ongoing efforts to 
improve these strategies.  Varenicline (Chantix®) is the focus of the remaining studies in 
this chapter.  Figure is from(2). 
 
In May of 2006 varenicline (Chantix®) was approved as an aid to smoking 
cessation treatments.  It is believed that varenicline achieves its therapeutic 
effect by binding the α4β2 receptor, where it acts as a partial agonist (Figure 
5.17, Left).  With high binding affinity, varenicline appears to act as a competitive 
antagonist of nicotine when they are simultaneously present (Figure 5.17, 
Right), though the detailed mechanism of action is not known(2). 
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Figure 5. 17. Left) The current responses of α4β2 receptors to various doses of varenicline 
and a high dose of nicotine.   In these experiments in HEK cells, varenicline’s efficacy 
relative to nicotine was ~ 45%.  Right) When varenicline is added to α4β2 receptors 
activated by nicotine, the nicotine response is decreased in a dose-dependent way.  
Figures are from(42). 
 
Varenicline more than doubles the chance of smoking cessation, from 
18% with placebo to 44%; the odds of long-term abstinence (through 1 year) are 
more than threefold higher than placebo with varenicline(2).  While clearly a 
major benefit in fighting smoking addiction, these numbers also highlight how 
addictive nicotine is.  Even with varenicline, most people still can‘t quit smoking.  
These numbers also indicate the need for continued improvement in smoking 
cessation treatments.  Varenicilne was designed specifically to have high 
potency at α4β2, but not α3β4 human nAChRs(2, 42).  However, it is becoming 
increasingly clear that other receptors also can be activated by many nAChR 
agonists.  This can lead to unwanted side effects.  Additional concerns have 
been raised specifically about varenicline producing adverse mental health 
consequences, including suicidal ideation and suicide(43, 44). 
 In order to design a drug that is more effective and has better specificity, 
the detailed mechanism of action must be known.  We therefore sought to 
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determine how varenicline binds to the A2B3 and A3B2 α4β2 nAChRs.  Whole-
cell experiments performed by Ximena Da Silva, Nyssa Puskar, and Angela Blum 
indicate that varenicline binds to these neuronal receptors in a similar way as 
nicotine.  Specifically, a systematic increase in EC50 was seen upon successive 
fluorination at TrpB.  We then used single-channel recording with varenicline to 
determine if the gating properties of the receptor change upon fluorination of 
TrpB. 
 
5.7 Results 
 
Single-channel recording was performed in the cell-attached configuration 
on the wild type A2B3 and A3B2 receptors as well as A2B3 and A3B2 receptors 
with F3W introduced at TrpB by nonsense suppression.  In each case, data 
reported here are for varenicline applied at 10 times the EC50. 
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Figure 5.18. Single-channel records of wild type A2B3 (conventional expression; Left) and 
F3-Trp introduced at TrpB (nonsense suppression; Right).  All recordings are in the cell-
attached configuration with a pipette potential of +60 mV.  Data are filtered at 2 kHz for 
display and openings are shown as downwards deflections.  Varenicline concentrations 
(in the pipette) are: wild type (28.5 nM) and F3-TrpB (270 nM).  The single-channel 
conductances were 43 pS and 42 pS, respectively.  Each set of traces represents 10 
seconds (upper), 1 second (middle), and 50 ms (lower).  The lower traces are expansions 
of the regions in the middle traces designated with bar over the trace. 
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Figure 5.19. Single-channel records of wild type A3B2 (conventional expression; Left) and 
F3-Trp introduced at TrpB (nonsense suppression; Right).  All recordings are in the cell-
attached configuration with a pipette potential of +60 mV.  Data are filtered at 2 kHz for 
display and openings are shown as downwards deflections.  Varenicline concentrations 
(in the pipette) are: wild type (9 nM) and F3 F3-TrpB (120 nM).  The single-channel 
conductances were slightly variable: wild type A3B2 (50–55 pS), and ~ 40 pS for F3-TrpB.  
Each set of traces represents 10 seconds (upper), 1 second (middle), and 50 ms (lower).  
The lower traces are expansions of the regions in the middle traces designated with bar 
over the trace. 
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Figure 5.20. (Above and previous page) 4 closed dwell time histograms each representing 
data from 1 patch for each of the 4 receptors studied in these single-channel experiments.  
In each case, varenicline is applied at 10 times the respective macroscopic EC50 values at 
the concentrations stated above.  In each case, the histogram is fitted to 4 components.  
These histograms were used to  determine  the values of τcrit. 
 
 
 
Figure 5.21. Calculated Popen values when 2 different values of τcrit are used.  Under both 
analyses, for both A2B3 and A3B2, the difference in Popen between wild type and F3W at 
TrpB is minimal (see discussion).  
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Figure 5.22. Pooled closed dwell time histograms of multiple patches, each at 10 times the 
respective macroscopic EC50 values for wild type A2B3 (28.5 nM varenicline) and A2B3 
with F3W at TrpB (270 nM varenicline).  There is a greater contribution from the long dwell 
time components in the F3-TrpB (lower) histogram than the wild type (upper) distribution 
(see discussion). 
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Figure 5.23. Pooled open dwell time histograms of multiple patches each at 10 times the 
respective macroscopic EC50 values for wild type A2B3 (28.5 nM varenicline) and A2B3 
with F3W at TrpB (270 nM varenicline).   Overlaying the histogram are shown 2-component 
fits (red) and 3-component fits (blue).  For the 2 component fit, the components (% in 
parenthesis) are (upper histogram, wild type): 53 ms (50%) and 3.8 ms (50%); (lower 
histogram, F3-TrpB): 19 ms (53%) and 1.2 ms (47%).  It is not clear what states the two or 
three open dwell times in the above histogram represent.  However, openings of 
monoliganded receptors could account for at least one additional component (see 
discussion).  
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5.8 Discussion and Future Studies 
 
5.8.1 Popen and Dwell Times 
The quantitative analysis of Popen under different analysis scenarios shows 
that Popen is similar for wild type and F3-TrpB A2B3 and A3B2 (Figure 5.21).  This 
is true whether τcrit1 or τcrit2 are used.  These different values of τcrit impact 
which of the long components of the closed dwell time histogram are excluded 
from the calculation of Popen.  Either way, the conclusion is the same—Popen, 
which depends only on the gating equilibrium constant, —is not significantly 
altered by incorporation of F3W at TrpB at either stoichiometry.  Specifically, as 
with nicotine, successive fluorination of TrpB causes a systematic decrease in 
varenicline‘s potency (increase in EC50).  EC50 depends on just two properties: 
binding and gating.  Thus, since this single-channel data indicate that this 
decrease in potency is not caused by any significant change in the channel‘s 
gating properties, based on this combination of single-channel and whole-cell 
data, we conclude that varenicline makes a cation-π interaction to TrpB.  
A more detailed analysis of the dwell time histograms is instructive.  Here I 
will consider the A2B3 data in detail.  Open dwell times give information about 
the channel closing rate, α.  As with the nicotine A2B3 data, the open dwell time 
histograms and resulting fitted distributions are quite similar for the wild type and 
F3W-TrpB.  Specifically, consider the open dwell time distributions when fitted to 
two components (blue lines in Figure 5.23).  Both components of the wild type 
distribution are shifted to ~ threefold longer times than in F3-TrpB.  Specifically, 
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the longest component shifts 2.7-fold from 53 ms in wild type to 19 ms, and the 
shorter component shifts 3.3-fold from 3.8 ms in wild type to 1.6 ms.  Since both 
components contribute roughly equally (50% versus 53% and 50% versus 47%; 
see Figure 5.23), we can quantitatively relate these shifts to potency.  Based on 
the quantitative relationship between EC50 and  given in Section 5.4.3, the 
decrease in open dwell time for the F3-TrpB receptor can account for, at most, a 
1.7-fold increase in EC50.  This is a small amount of the actual 9.5-fold EC50 shift 
(2.85 nM to 27 nM).   
A similar quantitative analysis of the A2B3 closed dwell time histograms to 
determine kinetic parameters would require recording with varenicline across 
multiple concentrations.  However, qualitatively and based on fairly similar τcrit 
values, the closed dwell time histograms do not appear to indicate a significant 
systematic shift in the duration of any of the closed dwell time components.  On 
the other hand, there is an increase in the relative contribution of the two longer 
closed components in Figure 5.22 from wild type to F3-TrpB.  The difference in 
these relative contributions to the long closed components is also apparent 
qualitatively in some single-channel traces—the raw Popen values in some wild 
type and F3-TrpB varenicline patches appear different.  Although these impact 
the apparent Popen, these longest closed dwells (usually 1–10 seconds) almost 
certainly reflect a desensitized state for these recordings, since they are 
performed at 10 times EC50.  Additionally, the rate of entry into the desensitized 
state for F3-TrpB may be faster than for wild type, producing briefer clusters.  
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These changes to desensitization should not impact EC50, so they do not factor 
into the quantitative analysis except for the purposes of defining τcrit. 
5.8.2 Recording and Analysis at Low Agonist Concentrations 
In general, it is important when working with potent agonists such as 
varenicline (and epibatidine) to take into account the experimental concentrations 
used.  For experiments at nM or lower concentrations, the forward rate for 
agonist association (k+) can impact data analysis.  For example, in single-
channel recording, assuming a k+ value of 10
8 M-1 s-1, an experiment at 100 nM 
will produce closed dwells of ~ 100 ms that correspond to this binding rate.  For 
whole-cell experiments, time resolution isn‘t quite as high.  Nevertheless, a drug 
application of 0.1 nM could require ~ 100 seconds to reach the maximal 
response based on the forward binding rate alone.  It is therefore particularly 
important to inspect opus traces at concentrations < ~ 10 nM to ensure that they 
reach a stable, maximal current value during the drug application. 
 
5.8.3 Nicotine, Varenicline, and Partial Agonism 
Varenicline is a partial agonist, and the single-channel conductance does 
not appear significantly lower for it than for nicotine.  Therefore, τcrit1, which 
produces Popen values of ~ 0.2–0.4 is probably a more realistic value.  In fact, 
these values produce agreement with other data.  For example, compare Popen 
values in this range to the relative activation achieved by saturating doses of 
varenicline and nicotine in Figure 5.17(2). 
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 In further single-channel work characterizing these agonists, it would be 
interesting to elucidate the mechanism of partial agonism for nicotine and 
varenicline.  This could be pursued in the context of recent models of nAChR 
partial agonism(45, 46).  Consistent with some of these models, I observe brief 
closures in α4β2 single-channel data with both nicotine and varenicline.  Since 
these occur even at low concentrations—nM in these experiments—they are 
probably not due to open channel block.  A more likely explanation is that they 
correspond to the channel re-opening and therefore reflect the channel opening 
rate, β.  Since these are brief closures, β is large.  From the closed dwell time 
histograms above (Figures 5.13, 5.14, and 5.22) there is one component that is 
<< 1ms.   
 
5.8.4 Other Further Studies 
I regularly observe multiple components in open dwell time histograms for 
nAChRs, including muscle-type and neuronal receptors.  This is even true for 
spontaneous openings (of α1β1L9‘SgγδL9‘S; see Chapter 4).  When agonist is 
present, for nAChRs with two binding sites different open dwell times could 
correspond to receptors that have agonist bound at just one of the binding sites.  
These are termed monoliganded openings.  Another possibility is that the two 
different monoliganded openings of receptors with two nonequivalent binding 
sites have different durations and/or conductances.  The binding sites of the 
muscle-type fetal nAChR ((α1)2β1γδ) do not have equivalent KDs(47-49).  If 
monoliganded openings of different binding sites account for some of the 
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different components of the open dwell time histograms, I would predict that the 
more similar binding site affinities of the ((α1)2β1εδ) receptor (adult nAChR) 
would produce open dwell time distributions that were more similar than those of 
the fetal type.  
 For both nicotine and varenicline, the agonist potencies are markedly 
different between the A2B3 and A3B2 stoichiometries.  Determining the cause of 
this difference would be of interest.  These further studies would be most 
interesting on wild type receptors without the L9‘A mutation, which significantly 
impacts agonist potency.  However, without the L9‘A mutation α4β2 receptors, 
especially the A2B3 stoichiometry, express at relatively low levels.  The next 
chapter develops and implements methods for single-channel characterization of 
the wild type α4β2 receptor.   
 
 
5.9 Materials and Methods for Varenicline Experiments 
 
5.9.1 Whole-Cell Electrophysiological Characterizations of the 
Agonist-Induced Responses 
Same as the description of α4L9‘Aβ2 in the nicotine studies, above. 
 
5.9.2 Unnatural Amino Acid Incorporation 
Same as the description of α4L9‘Aβ2 in the nicotine studies, above. 
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5.9.3 Single-Channel Characterization of α4β2 
Recording solutions, electrodes, and experimental setup was the same as 
in the nicotine studies, above.  Various concentrations of varenicline were used, 
including 10 and 100 times the macroscopic EC50 value.  In a few experiments, 
lower concentrations (0.1 times EC50) were used.  The data that produced all 
dwell time histograms in the results section are for 10 times the respectively 
macroscopic EC50 values. 
Because defining the closed dwell times accurately was essential for the 
Popen analysis, we sought a strategy that minimized the number of both 
misdetected channel openings and brief openings that did not reach full 
conductance.  These openings must otherwise be manually rejected.  Data were 
filtered offline (Gaussian, -3 dB, 2–5 kHz) and electrical interference at 
harmonics of 60 Hz or other frequencies was removed if necessary.  Event 
transitions were detected with Clampfit 9.2 (single-channel search).  Analyses 
were performed at various dead times, τd, between 40 and 200 μs.  Dead times 
were applied either to all events or to events from the baseline only.   
Open and closed dwell time histograms were generated as described 
previously(36) and fitted using the predefined log-transformed exponential 
probability density function in Clampfit 9.2.  To delineate clusters, two critical 
closed durations based on the long components of the closed dwell time 
histograms were defined.  These values (τcrit1 and τcrit2) were determined, as 
described in the supplementary discussion (Section 5.4.3), above.  Closed dwell 
times longer than the respective τcrit values were excluded from further analysis.  
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Sojourns to a subconductance state (< 70% of the full conductance level) were 
treated as closed and accounted for < 10% of the total openings in all records 
when τd of 200 μs was applied from the baseline.  The time-average probability 
that the channel is open (Popen) was calculated as the total open time divided by 
the revised total closed time. Only sections of data files that showed no 
simultaneous activations were analyzed.  For each mutant, this was ≥ 3 patches 
obtained from oocytes from ≥ 2 different donor frogs.   
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Chapter 6 
 
 
Single-Channel Recording Distinguishes 
the High and Low Affinity Stoichiometries 
of the α4β2 Neuronal Nicotinic Receptor 
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6.1 Introduction 
The 42 nicotinic acetylcholine receptor (nAChR) is a pentameric 
neurotransmitter-gated ion channel that mediates fast synaptic transmission in 
the brain. The α4 and β2 subunits can be arranged in at least 2 different 
stoichiometries(1, 2): (4)2(2)3 and (4)3(2)2, abbreviated A2B3 and A3B2, 
respectively(3).  Receptors containing 4 and 2 subunits account for 90% of the 
high affinity nicotine binding sites in the brain(4).  In addition to being targets for 
smoking cessation drugs(5, 6), nAChRs are therapeutic targets for pain, 
Alzheimer’s disease, Parkinson’s disease, epilepsy, autism, attention deficit–
hyperactivity disorder, depression, and schizophrenia(7, 8). 
In order to optimize therapeutic treatments of these diseases and 
disorders, it is essential to specifically target the appropriate receptor 
subtypes(9).  We therefore sought to identify a unique phenotype that 
discriminates the two 42 stoichiometries.  Here we report that the 42 A2B3 
and A3B2 rectification behaviors are significantly different at the single-channel 
level.  Based on these differences, we develop and present the first method for 
identifying essentially pure populations of functional A2B3 receptors. 
 
 
6.2 Results 
In this study we expressed rat A2B3 and A3B2 receptors in Xenopus 
laevis oocytes by biasing the ratios of injected 4:2 mRNA.  An mRNA ratio of 
1:1 produced pure A2B3 with an EC50 of 0.6 M acetylcholine (ACh), while 30:1 
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produced essentially pure A3B2 with an EC50 of ~ 100 M ACh (see discussion).  
These EC50 values are similar to previously published values(10, 11).  4:2 
mRNA ratios of 1:2 produced significantly smaller whole-cell currents (< 50 nA in 
response to 500 M ACh at 96 h post-injection versus ~ 1 A for 1:1), and 4:2 
ratios of 1:5 and 1:8 gave no response to 500 M ACh after 36 h. 
Our strategy for uncovering a distinct phenotype for the two α4β2 
stoichiometries was inspired by recent whole-cell studies of the receptor that 
contained a mutation in the channel pore termed 4L9’A(3, 12).  This mutant 
receptor showed a significant difference between the whole-cell rectification 
behaviors of the A2B3 and A3B2 stoichiometries.  A2B3 was significantly more 
inwardly rectifying than A3B2, a difference that allowed for sufficiently pure 
populations to be identified using voltage jump and voltage ramp experiments.  
Here, we report that whole-cell data for the wild type α4β2 receptor showed 
similar rectification behavior for the two stoichiometries, with both displaying 
nearly complete inward rectification (Figure 6.1).  
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Figure 6.1. Current voltage relationship for wild type α4β2.  Blue: 1 μM ACh on A2B3 (1:1).  
Red: 20 μM ACh on A3B2 (30:1).  Both showed significant activation of inward currents at -
110 mV (> 1 μA), but very little current in the outward direction at up to +70 mV.  Each data 
point is the average of 2 oocyte’s responses.  Cells with lower activation (~ 300 nA) may 
display slightly more outward current, but these values were difficult to measure reliably. 
 
Surprisingly, then, single-channel recording of a patch with an A2B3 channel 
recorded at multiple pipette potentials revealed that these channels have non-
trivial outward conductances (Figure 6.2).  The 30:1 stoichiometry displayed a 
qualitatively similar single-channel IV relationship.  These data cannot be readily 
correlated to the whole-cell data of Figure 6.1.  We therefore characterized 
rectification behavior, as well as NPopen (the probability that exactly one channel 
in the patch is open), single-channel conductance(s), and channel open dwell 
time (o).  Our goal was to determine if single-channel recording could be used to 
distinguish the high (A2B3) and low (A3B2) affinity receptors.    
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Figure 6.2. The current voltage (IV) relationship for A2B3 (1:1).  The slope conductance is 
26 pS over the entire voltage range.  The slope conductance at negative membrane 
voltages is 36 pS.  Current values near the reversal potential (~ 0 mV) were difficult to 
measure, especially in the outward direction (rare events). 
 
Because previous experiments have been performed with nicotine(3, 13), 
preliminary studies began using 50 μM nicotine (Figures 6.3, 6.4, and 6.5). 
 
Figure 6.3. 1.0-second single-channel recording of 10:1 α4β2 channels with 50 μM nicotine 
(predominantly A3B2; see text for discussion).  Recordings are in the cell-attached 
configuration with a pipette potential of +100 mV; fc = 5 kHz.  The openings were raggedy 
and difficult to quantitatively analyze. 
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Figure 6.4. Dwell time histograms for single-channel data corresponding to the nicotine 
data shown in Figure 6.3, above.  Left) Open dwell time histogram with the distribution 
fitted to one component (blue) and two components (red).  Very few openings longer than 
1 ms were observed.  Right) Closed dwell time distribution fitted to three components 
(blue) 
  
 
 
 
Figure 6.5. Single-channel recording of A2B3 channels with 50 μM nicotine.  Recordings 
are in the cell-attached configuration with a pipette potential of +100 mV; fc = 5 kHz.  Left) 
100 second trace.  Right) 50 ms trace highlighting two channel openings.  These openings 
were of low conductance and very brief duration, making quantitative analysis difficult. 
 
  
 
As these nicotine single-channel events show, the openings were brief and low 
conductance.  Based on the analysis that we proposed, the fact that nicotine’s 
outward openings would likely be either less frequent, shorter, or both, meant 
that it was not a viable agonist.  ACh, though, produced more events, including 
some outward events of measurable duration for both stoichiometries (Figure 
6.6). 
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Figure 6.6. ACh-induced single-channel currents of the α4β2 receptor in the cell-attached 
configuration.  Each respective upper trace is at a pipette potential of +100 mV (inward 
currents are shown as downward deflections), while the lower traces are at pipette 
potentials of -100 mV (outward currents are shown as upward deflections).  Traces are 
filtered at 2 kHz for display.  Left) the A2B3 stoichiometry (1:1) at 500 μM ACh.  Right) 
A3B2 at 10 µM ACh 
 
We find a significant difference between the single-channel rectification of the 
two stoichiometries.   A2B3 receptors pass essentially no outward current, with 
NPopen < 0.0001 at a pipette potential (PP) of -100 mV (Figure 6.6, Table 6.1).  
We now define a pure population of A2B3 receptors as having an NPopen ratio 
(NPopen at +100 mV)/(NPopen  at -100 mV) of < 0.03.  On the other hand, A3B2 
receptors show small but significant outward currents at negative PP and display 
an NPopen ratio of ~ 0.1 (Figure 6.6, Table 6.1).  While the channel rectification 
measured by NPopen ratio is different for the two stoichiometries, this difference is 
not evident from the single-channel I-V relations (Figure 6.2; see Discussion).    
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PP (mV) NPopen, 1:1 NPopen, 30:1 
100 0.0057 0.0057 
-100 0.00006 0.00059 
ratio 0.01 0.10 
 
Table 6.1. NPopen values for A2B3 and A3B2.  These numbers are based on ~ 500 inward 
events and 30 outward events at each stoichiometry.  Each number represents data from 1 
cell-attached patch at the concentrations used in Figure 6.6.   
 
 
Figure 6.7. High resolution traces of the data in Figure 6.6.  Here, the data are filtered at 5 
kHz to allow brief events to be visualized.  As in Figure 6.6, each respective upper trace is 
at a pipette potential of +100 mV (inward currents are shown as downward deflections), 
while the lower traces are at pipette potentials of -100 mV (outward currents are shown as 
upward deflections).  Left) the A2B3 stoichiometry (1:1) at 500 μM ACh.  Right) A3B2 at 10 
µM ACh 
 
As can be seen qualitatively in Figure 6.7, and quantitatively in Figure 
6.8, τopen contains two components at positive pipette potentials for both 
stoichiometries.  While the longer of these two components is essentially 
unchanged in the two stoichiometries (2.1 ms versus 1.7 ms), the shorter 
duration component shifts from 0.12 ms to 0.22 ms, a 1.8-fold increase from 
A2B3 to A3B2.  Moreover, we find that the single component that describes the 
open dwell time distributions of both stoichiometries at negative pipette potentials 
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is of similar duration to the short duration component of the inward currents and 
also increases from A2B3 to A3B2.  In this case 2.7-fold from 0.09 ms to 0.24 ms 
(Figure 6.9 and Table 6.2).   
 
 
Figure 6.8. Open dwell time histograms for inward currents of α4β2 receptors.  Each 
histogram is fitted to two components (blue).  Upper) A2B3.  Lower) A3B2.  As is 
summarized in Table 6.2, the longer dwell time component is ~ 2 ms for both 
stoichiometries, while there is a twofold shift in the duration of the shorter component.  
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Figure 6.9. Open dwell time histograms for outward currents of α4β2 receptors.  Each 
histogram is fitted to one component (blue).  Upper) A2B3.  Lower) A3B2.  As is 
summarized in Table 6.2, the there is an approximate 2.7-fold shift in open dwell times 
from 0.09 ms (A2B3) to 0.24 ms (A3B2).  
 
 
 
 
 
 
268 
 
PP (mV) g (pS) # events openms (%) openms (%)
1:1, 100 40 +/- 8 558 0.12 (57) 2.1 (43) 
1:1 , -100 19 +/- 4 30 0.09 (100) NA 
30:1, 100 48 +/- 5 486 0.22 (63) 1.7 (37) 
30:1, -100 28 +/- 6 31 0.24 (100) NA 
 
Table 6.2. (Previous page).  Single-channel conductances and τopen for A2B3 and A3B2.   
Shown are values recorded at +100 mV and -100 mV pipette potentials.  The τopen values 
are from the fitted components of the open dwell time histograms in Figures 6.8 and 6.9.   
 
Finally, we analyze the conductances (g) of A2B3 and A3B2 and find no 
significant difference in average conductance at positive pipette potentials (Table 
6.2).  A2B3 channels appear to have a lower conductance at negative pipette 
potentials (Table 6.2); however, these openings of A2B3 receptors are 
sufficiently rare and brief that rigorous characterization of their conductance 
proved difficult.  In order to verify the open dwell times of outward currents for 
both stoichiometries, we performed a systematic analysis of τopen over a range of 
applied dead times (τd).  We find that over the range 0.06 ms–0.24 ms, τopen 
decreases with increasing τd.  For both stoichiometries, the decrease seems to 
level off at the lowest values of τd.  Quantitatively, when fit with an exponential 
function and extrapolated to a τd of 0, the values of τopen are very similar to the 
values in Table 6.2.  For A2B3 the values are 0.08 ms (τd analysis) versus 0.09 
ms (histogram).  For A2B3 the values are 0.24 ms (τd analysis) versus 0.24 ms 
(histogram). 
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Figure 6.10. Graphs of τopen versus τd for A2B3 (upper) and A3B2 (lower).  In both cases, 
dead times were applied in 20 μs increments between 0.06 ms and 0.26 ms.  The sampling 
rate was 50 kHz.  Extrapolation to τd = 0 produces τopen values of 0.08 ms and 0.24 ms for 
A2B3 and A3B2 receptors, respectively.  These values are in strong agreement with the 
values in Table 6.2 and open dwell time graphs in Figure 6.9.  
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Our quantitative analysis of single-channel events at +100 mV and -100 
mV pipette potentials is qualitatively supported by voltage ramp experiments 
(Figure 6.11). 
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Figure 6.11. (Previous page).  Voltage ramp experiments support quantitative analysis.  In 
each case, single-channel recording was performed in the cell-attached configuration and 
ACh was applied at 10 μM.  Pipette potentials (voltage on y-axis) Upper) The voltage ramp 
protocol used.  The red line shows the applied pipette potential, which started at +60 mV, 
then was stepped to -100 mV and ramped over 3 seconds (A2B3) or 4 seconds (A3B2) to 
+100 mV.  The pipette potential was then ramped symmetrically back to -100 mV and 
stepped to + 60 mV.  Middle) A2B3 channels show inward current (downward deflections), 
but essentially no outward current (upward deflections).  Lower) A3B2 channels show 
inward current (downward deflections), but also outward current (upward deflections).   
 
6.3 Discussion and Future Studies 
Previous studies of the α4β2 receptor have reported multiple open dwell 
times and conductances(1, 10, 11, 14-17).  However, these properties have not 
been investigated in controlled stoichiometry.  We sought to use single-channel 
methods to distinguish between the wild type high (A2B3) and low (A3B2) affinity 
α4β2 receptors.  Consistent with previous reports, we find significant inward 
rectification of the α4β2 receptor(11, 16, 18, 19).  We further find that both A2B3 
and A3B2 exhibit this rectification at the whole-cell (Figure 6.1) and single-
channel (Figure 6.6) levels.   
 
6.3.1 Open Dwell Times  
  This difference in single-channel rectification is attributable to a nearly 
tenfold shift in the NPopen ratio (Table 6.1).  This quantitative difference is 
supported qualitatively by Figure 6.11.  Another characteristic difference of the 
two stoichiometries is their open dwell time distributions.  When inward open 
dwell times are fitted to two components, both A2B3 and A3B2 have a short 
duration component that accounts for ~ 60% of openings and longer duration 
components that account for ~ 40% of openings (Table 6.2).  However, the 
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duration of the short openings is shifted from 0.12 ms (A2B3) to 0.22 ms (A3B2).  
This ~ twofold difference is paralleled by an even larger, ~ threefold difference in 
the open duration of the outward currents of the A2B3 and A3B2 receptors: 0.09 
ms to 0.24 ms.  Interestingly, in the outward direction, the long openings are 
completely absent at both stoichiometries—there is only one component in each 
open dwell time histogram (Figure 6.9).  The disappearance of this component 
may reflect part of the underlying mechanism of rectification of these receptors: 
two types of openings in the inward direction, but only one type of opening in the 
outward direction.  Although the outward openings reported here are brief and 
rare, our measurement of τopen is further supported by the analysis shown in 
Figure 6.10. 
In experiments on the A3B2 receptor at 100–200 μM ACh (EC50 and 
above) single-channel currents displayed very raggedy openings that could not 
be analyzed quantitatively for conductance, NPopen ratio, or τopen.  Thus, our 
single-channel recordings on A3B2 are at lower ACh concentrations.  On the 
other hand, the A2B3 showed activations that could be quantitatively analyzed 
over a wider concentration range.  The A2B3 data in Figure 6.7 was recorded at 
500 μM ACh, well above the macroscopic EC50.  At this concentration, binding 
should be saturated and all openings should be visible.  In particular, outward 
openings, which aren’t diminished by channel block.  These high concentration 
data on A2B3 convincingly establish the relatively stronger inward rectification 
versus A3B2.  Our NPopen measurements at high ACh concentration (data not 
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shown) agree with recent results indicating that the low affinity A3B2 
stoichiometry has a higher Popen than the A2B3 stoichiometry(20).      
 
6.3.2 Single-Channel Conductance, NPopen, and Rectification 
Previous studies considered the single-channel conductances of human 
42 A2B3 and A3B2 receptors and reached different conclusions concerning 
their relative assignment(1, 10).  While experimental conditions differed for the 
two studies, it remains possible that the difficulty in assigning the A2B3 and A3B2 
conductances is a result of their being multiple conductances in both populations.  
We find that with rat A2B3 and A3B2 receptors, the more significant difference is 
in single-channel rectification, with A2B3 receptors exhibiting essentially 
complete inward rectification. 
 One of the quantitative descriptions of channel behavior that we present 
here is NPopen, a parameter that combines the intrinsic probability of the channel 
being open (Popen) with the number of receptors in each patch (N).  A potential 
complication in any experiment that compares NPopen values is the possibility of 
multiple channels in the patch.  While a lower limit for N can be determined 
based on the maximal number of simultaneous, overlapping openings in a given 
record, the exact number of channels cannot be determined.  This is especially 
true for low values of NPopen.   
In order to make comparisons that avoid a potential impact of varying N, 
we compare parameters unaffected by it: the ratio of NPopen’s at two different 
voltages for the same patch, single-channel conductance, and τopen.  Our results 
274 
 
indicate that the primary mechanism by which the difference in rectification of the 
A2B3 and A3B2 stoichiometries is achieved is via changes in the single-channel 
NPopen ratio.  This provides a clear-cut criterion for the identification of pure 
populations of the high affinity A2B3 receptor in single-channel experiments.  The 
~ twofold shift in the short duration inward openings and the ~ threefold shift in 
the duration of the outward openings provide a further quantitative basis for a 
difference between the two stoichiometries that is not impacted by N. 
The previously identified mechanism for strong inward rectification of both 
stoichiometries of the 42 receptor is block by intracellular polyamines, 
especially spermine(16, 19).  Thus, we speculate that a specific interaction 
between intracellular residues of the 2 subunit is responsible for the more 
favorable interactions that make A2B3 more strongly inward rectifying than A3B2.  
Adenosine triphosphate (ATP) chelates spermine.  In preliminary experiments, 
we’ve found that injection of oocytes with 50 nl of 100 mM ATP (final 
concentration in oocyte ~ 5 mM ATP) 1 hour prior to opus recording significantly 
decreased oocyte health and increased oocyte leak.  This made determination of 
rectification difficult.  In order to pursue the possibility that ATP can modulate 
rectification at the single-channel and whole-cell level, I recommend longer 
recovery times of 2–6 hours post ATP injection. 
A recent study(18) has addressed rectification of nAChRs by expressing 
muscle-type nAChR in oocytes.  They related the excitation-contraction coupling 
of motor control to inward rectification and Ca2+ permeability, and modulated 
these properties with mutations in the nAChR channel pore.  The L9’A mutation 
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that we have used in the past to differentiate the high and low affinity α4β2 
receptors in whole-cell recording is also a pore mutation of the nAChR.  Many 
further studies of the relationship between rectification, pore mutations, and 
spermine would be of interest.   
 
 
6.3.3 Control of α4β2 Expression Levels and Stoichiometry 
The α4L9’A mutation had previously been used to increase expression 
levels to enable studies of the α4β2 receptor with unnatural amino acids(3).  In 
an effort to increase expression and sustain pure populations of A2B3, I injected 
oocytes with a 1:1 mRNA ratio and incubated them post injection in 5 μM nicotine 
for up to a few days.  Subsequent rinsing of the oocytes in incubation media for 5 
hours produced a whole-cell response to nicotine that was < 50 nA, versus > 500 
nA response to ACh.  Consistent with previous findings about nicotine 
sequestration in oocytes, experiments with multiple rinses and a total of 27 hours 
in incubation media after nicotine exposure did not fully restore responses to 
nicotine or ACh(21).  The method developed below was sufficient to control 
stoichiometry.  
In order to get sufficient expression of the wild type α4β2 receptor (Figure 
6.12), I used post-injection incubation times of up to several days (see Materials 
and Methods).   
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Figure 6.12. Whole-cell voltage-clamp recordings performed on the OpusXpress 6000A.  
Left: A2B3 at 1 and 100 µM ACh.  Right A3B2 at 100 and 1000 µM ACh.  As the scale bars 
indicate, the expression of A3B2 is significantly higher than A2B3.   
 
Even after 204 hours α4β2 receptors expressed at a 1:1 ratio produced a 
pure population of the high affinity, A2B3 with EC50 of ~ 0.6 µM ACh (Figure 
6.13).  Once incubated for several days, expression levels were high enough (2–
5 µA) that single-channel experiments could be performed with a reasonable 
chance of getting patches with channel activity.  I did not find a significant 
difference in expression between cells injected with 3 μg or 30 μg total mRNA.  
For expression of A3B2 receptors, fairly high expression was seen (2.5–
50 µA) after 96 hours (Figure 6.14).  Over the course of the long incubations that 
facilitated recording of A2B3, injection of a 30:1 mRNA ratio resulted in some 
contamination of a high affinity component.  The EC50 of this component was 
consistent with it arising from A2B3 receptors.  This slow increase in percent 
A2B3 may be due to an insufficient amount of α4 mRNA being present in the 
oocyte after several days.  Nevertheless, taken together, these long incubations 
of α4β2 receptors indicate that at least some of the wild type neuronal receptors 
can be expressed in oocytes for several days without changes to pharmacology.   
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Figure 6.13. ACh dose-response curves for whole-cell experiments with oocytes injected 
with a 1:1 ratio of α4:β2 mRNA.  These produce a pure population of the high affinity 
(A2B3) receptor, even after a long incubation (204 hours, in this case).  m2 is the EC50 and 
m3 is the Hill coefficient. 
 
 
Figure 6.14. ACh dose-response curves for whole-cell experiments with oocytes injected 
with a 30:1 ratio of α4:β2 mRNA.  Left) After 96 hours of incubation, the A3B2 population is 
> 90% pure.  Right) After 205 hours of incubation, 10–20% of a second, higher affinity 
component is evident.  This additional component reduced the EC50 (m2) and Hill 
coefficient (m3) relative to the 96 hour incubation.  Note that, at an equivalent incubation 
time (204 hours), the α4β2 population of oocytes injected with a 1:1 ratio appears to be 
pure A2B3 (previous figure). 
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A question arises for single-channel experiments performed with nicotine 
in the pipette: could the nicotine from the pipette leak into the bath and impact 
recordings and stoichiometry(21, 22)?  The following calculation suggests that 
this should not present a major issue in our experimental setup.  The calculated 
volume of the solution in the pipettes that I use for cell-attached single-channel 
recording is: ~ 20 mm * 0.4 mm2 *  = ~ 10 L.  A direct measurement of the 
volume of a few filled pipettes gave a range of 5–7 μl.  The resultant calculation 
of the concentration of nicotine in the recording chamber is based on a chamber 
volume of 200–300 μl, which is the solution level during recording (see chapter 
2). The volume of solution that leaks out of the pipette is not macroscopically 
significant, even over a long recording (1 hour).  Assuming that 5% of a 10 μl 
solution of 50 μM nicotine leaks during a recording, the eventual concentration of 
nicotine in the recording chamber would be 0.13 μM.  This is a fairly low 
concentration.  As long as adequate rinses are done between each recording, 
concentrations of nicotine in the μM concentration range in the pipette (nM in the 
bath solution) are unlikely to impact recordings and stoichiometry over the course 
of the average lifetime of an oocyte for single-channel recording (a few hours).  
 
 
6.4 Materials and Methods 
6.4.1 Receptor Expression 
Neuronal rat nicotinic acetylcholine receptor (nAChR) and  subunits 
were expressed in pAMV vectors.  Not1 linearized circular bacterial plasmid 
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DNAs were used as templates for in vitro transcription using T7 mMessage 
mMachine enzyme kits (Ambion) to make mRNA.  mRNA concentrations were 
determined using a NanoDrop-1000 spectrophotometer (Thermo Scientific, Inc., 
Wilmington, DE). 
Injection ratios of the and mRNA ranged from 30:1 to 1:8 by mass at 
a total concentration of 0.06–0.6 g/l.  Stage V-VI Xenopus laevis oocytes 
(Nasco, Fort Atkinson, WI) were injected with 50 nl of the mRNA mixture (3–30 
ng). To overcome low expression, oocytes were incubated for 2 to 9 days post-
injection, especially for studies of the A2B3 receptor.  Oocytes were incubated in 
media containing 2% equine serum at 172˚C. 
 
6.4.2 Whole-Cell Recording 
The OpusXpress 6000A (Axon Instruments, Union City, CA) was used in 
the two-electrode voltage clamp mode for whole-cell dose-response 
measurements.  Oocytes were superfused with Ca2+-free ND96 (contents, in mM: 
96 NaCl, 2 KCl, 1 MgCl2, 5 HEPES) at flow rates of 4 ml min
-1 during 15 s drug 
application and 3 ml min-1 during 115 s wash periods.  Dose-response data were 
obtained for  5 oocytes at  12 ACh concentrations each and fitted to the Hill 
equation to determine EC50 values.  Before single-channel recording, expression 
levels were verified with 500 M ACh, typically ~ 1 A for 1:1 and ~ 10 A for 
30:1. 
Whole-cell voltage jumps were performed in the absence of ACh and at 1 
μM ACh (1:1) and 20 μM ACh (30:1).  As previously described, membrane 
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potentials were held at -60 mV, then stepped to 10 test potentials at 20 mV 
increments between +70 mV and -110 mV for 400 ms at each potential(3).  
Voltage was held at -60 mV for 600 ms between each episode. To isolate the 
ACh-induced currents, currents from the control traces ([ACh] = 0) were 
subtracted from the steady-state amplitudes of the ACh-induced currents of the 
test pulses.  Normalized I-V curves were generated by normalizing all current 
amplitudes to responses at -110 mV.  
 
6.4.3 Single-Channel Recording 
Single-channel recording was performed in the cell-attached configuration 
on devitellinized oocytes at 20 ± 3C with an applied pipette potential of 
+100 mV, as described previously(23, 24).  Pipettes fabricated from thick-walled 
(I.D. = 0.80 mm, O.D. = 1.60 mm) KG-33 glass (Garner Glass Company, 
Claremont, CA) and coated with Sylgard (World Precision Instruments, Sarasota, 
FL) typically had resistances of 8–20 M.  The bath solution contained, in mM, 
120 KCl, 5 HEPES, 1 MgCl2, 2 CaCl2, pH = 7.4, so that the transmembrane 
potential of the patch was ~ -100 mV and the reversal potential for agonist-
induced currents of devittelinized oocytes was ~ 0 mV.  The pipette solution 
contained, in mM, 100 KCl, 10 HEPES, 1 MgCl2, 10 K2EGTA, pH = 7.4, and was 
supplemented with the indicated concentrations of ACh from a 1.00 M stock 
solution.   
Data were collected using a GeneClamp 500B amplifier (Axon 
Instruments, Union City, CA) with a CV-5 GU headstage at full bandwidth (4-pole 
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Bessel, -3 dB, 50 kHz).  The signal was then low-pass filtered (8-pole Bessel, -3 
dB, 20 kHz) and sampled with a Digidata 1320A and Clampex 9.2 (Axon 
Instruments, Union City, CA) at 50 kHz.  The voltage ramp protocol was 
described in Figure 6.11.  Data were filtered offline (Gaussian, -3 dB, 5 kHz) and 
electrical interference at harmonics of 60 Hz was removed, if necessary.  After 
manual baseline adjustment, event transitions were detected with Clampfit 9.2 
(single-channel search).  A dead time, τd, of 60 s was applied to all events, 
except for the τd analysis, when values between 60 s and 240 s were applied.  
The time-average probability that exactly one channel in the patch is open 
(NPopen) was calculated as the total open time divided by the total closed time.  
Open dwell time histograms were generated from the Clampfit results files and 
fitted using Clampfit’s predefined log-transformed exponential probability density 
function(25).  The number of components used in the fit was determined by using 
compare models with a confidence level of 0.95. 
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Appendix A 
Derivation of an Equation for EC50 
Although an expression (Equation A.1) for EC50 of a receptor in terms of 
the binding equilibrium constant (KD) and the gating equilibrium constant () has 
been given(1), we were unable to find a published derivation of this equation.  
This appendix provides a derivation of Equation A.1. 
  
EC50 =KD *
1+ 2+ Q
Q +1
           Equation A.1 
 
This specific equation is based on the following, 4-state model for activation of 
an allosteric receptor (R) that requires the separate, sequential binding of two 
molecules of agonist, A, before the inactive, closed receptor (Rc) becomes the 
active receptor (Ro). 
        Model A.1 
where, 
  
KD =
k-1
k1
 and, 
  
Q =
b
a
 
Through other modeling studies (personal communications from Kristin 
Gleitsman and Shawna Frazier) we know that similar models have a relationship 
between EC50, KD, and  that is at least qualitatively similar to that given in 
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Equation A.1.  Additionally, plots with unequal binding affinities (different KDs for 
the first and second binding steps) produce similar relationships. 
 We begin by writing the expression for the proportion of activated 
receptors—the open receptors divided by the total number of receptors: 
][][][][
][
22
2
occc
o
RARAARR
RA

           Expression A.1 
 
We know that, at EC50, half of all receptors that can be activated are activated.  
Therefore, at EC50, the probability that the channel is open, Popen, reaches half of 
its maximal value.  Thus, since: 
  
Popen,max =
Q
Q +1
, we can write 
  
Popen,EC 50 =
Q
2(Q +1)
. 
This expression for Popen,EC50 represents the scenario that occurs when the 
applied drug concentration, [A], is the EC50  (Concept A.1) 
 
 The next step is to transform Expression A.1 to be in terms of KD and , 
as in Equation A.1.  We start by writing the expressions for these values—the 
equilibrium dissociation constant (KD) and equilibrium gating constant ()—
based on the definition of equilibrium constants.  In this case, because there are 
two receptor binding sites, we effectively write an expression for a value that is 
twice the first equilibrium constant and half the second equilibrium constant.   
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From the first binding equilibrium: 
]][[
]][[2 2
AAR
AR
K
c
c
D  . 
alternatively, 
][2
][
][
A
ARK
R
c
Dc          Equation A.2 
 
From the second binding equilibrium: 
][2
]][[
2
c
c
D
RA
ARA
K     
alternatively, 
D
c
c
K
ARA
RA
2
]][[
][ 2   .        Equation A.3  
 
And finally from the gating equilibrium: 
][
][
2
2
c
o
RA
RA
        
alternatively, ][][ 22
co RARA   .           Equation A.4 
   
To eliminate all of the terms, I chose to write the numerator of Expression A.1, 
as well as each of the 4 terms of the denominator, solely in terms of [A], [ARc] 
(which will drop out of the equation entirely), KD, and .  Equations A.2 and A.3 
meet this criterion, but Equation A.4 doesn’t; substituting Equation A.3 into A.4, 
gives: 
D
c
o
K
ARA
RA
2
]][[
][ 2

  .           Equation A.5 
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Substitution of Equations A.2, A.3, and A.5 into Expression A.1 yields the 
following expression: 
D
c
D
c
c
c
D
D
c
K
ARA
K
ARA
AR
A
ARK
K
ARA
2
]][[
2
]][[
][
][2
][
2
]][[



  . 
Simplifying gives, 
  
Q[A]
KD
KD
[A]
+ 2+
[A]
KD
+
Q[A]
KD
 . 
 
The expression for the proportion of activated receptors is now in the terms of the 
desired parameters.  So now we invoke Concept A.1 and rearrange for EC50.  
Before doing that, we may find it convenient to take the inverse, yielding 
Expression A.2:   
  
KD
[A]
+ 2+
[A]
KD
+
Q[A]
KD
Q[A]
KD
 .            Expression A.2 
 
Since we took an inverse, when we apply concept 1, we’ll use the inverse: 
  
Q
2(Q +1)
æ 
è 
ç 
ö 
ø 
÷ 
-1
=
2(Q +1)
Q
    .          Equation A.6 
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Moving KD in the denominator of the denominator of Expression A.2 to the 
numerator and distribution gives: 
  
KD
2
[A]
+ 2KD + [A]+ Q[A]
Q[A]
  . 
 
Which produces the following expression for the inverse of the proportion of 
activated receptors: 
  
KD
2
Q[A]2
+
2KD
Q[A]
+
1
Q
+1  . 
 
Next we invoke the inverse of Concept A.1 (by applying the result of Equation 
A.6).  At [A] = EC50, we have: 
  
KD
2
QEC50
2
+
2KD
QEC50
+
1
Q
+1=
2(Q +1)
Q
  . 
 
Rearranging gives: 
  
KD
2
QEC50
2
+
2KD
QEC50
=
Q +1
Q
  . 
 
Which simplifies to: 
  
KD
2
EC50
2
+
2KD
EC50
= Q +1  . 
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Now let’s add 1 to both sides and factor: 
  
KD
2
EC50
2
+
2KD
EC50
+1= Q + 2  . 
which can also be written as: 
  
KD
EC50
+1
æ 
è 
ç 
ö 
ø 
÷ 
2
= Q + 2  . 
 
Finally, we can rearrange for EC50 in terms of KD and : 
  
EC50 =
KD
Q + 2 -1
  .             Equation A.7 
 
Rationalize the denominator to yield: 
  
EC50 =
KD
Q + 2 -1
x
Q + 2 +1
Q + 2 +1
=KD
Q + 2 +1
Q + 2-1
  . 
 
Rearranging and simplifying yields Equation A.1: 
  
EC50 =KD *
1+ Q + 2
Q +1
  .             Equation A.1 
 
I prefer leaving this expression in the form of Equation A.7, which is simpler and 
clearly shows the relationship between the three parameters, especially since  
only occurs once in it.  Equation A.7 readily captures the following important 
qualitative characteristics of the relationship between EC50, KD, and :  
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(1) As the strength of the binding interaction increases—KD decreases—
the receptor can be activated with less drug, so EC50 goes down.  EC50 
and KD are directly proportional. 
(2) As the channel becomes easier to gate— increases—the receptor 
can be activated with less drug, so EC50 goes down.  EC50 and KD are 
inversely proportional.   
(3) Since the exponent on KD is 1, while the exponent on  is ½, changes 
to binding will have a more significant impact on EC50 than changes in 
gating.  
(4) At small values of  (< 2) the relationship between EC50 and  will 
have an asymptote because the “+ 2” component of the sqrt( + 2) in 
the denominator will dominate the expression.  This is a crucial feature 
that leads to Figure 3.2 and the behavior that facilitates ELFCAR (see 
Chapter 3). 
Reference 
1. Kalbaugh, T. L., VanDongen, H. M., and VanDongen, A. M. (2004) Ligand-
binding residues integrate affinity and efficacy in the NMDA receptor, Mol 
Pharmacol 66, 209-219. 
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Appendix B 
Single-Channel Data Analysis:  
Theory and Practice 
 
B.1 Theoretical Considerations in Single-Channel Recording 
 The aim of a single-channel recording experiment may be to determine an 
average open time (τopen) and/or closed time (τclosed), the probability that a 
channel is open (Popen), or to determine a set of several rate constants.  Such 
rate constants can provide a detailed description of the transition probabilities 
between several kinetically distinct states.  The nAChRs often have two main 
conductance levels termed classes.  In this case the classes are conducting and 
non-conducting.  Single-channel recording provides a direct observation of the 
agonist-induced interconversion between the conducting and non-conducting 
classes.  However, in each class, there may be any number of states.  States are 
thermodynamically and/or conformationally distinct physical manifestations of the 
channel which are not directly observable by measurement of current.  
Considering a 3-state kinetic model with one bound, closed state, Figure B.1 
characterizes the relationship between states and classes.  The time spent 
continuously in a given class is known as a dwell (or sojourn), thus green lines 
represent closed dwells and red lines represent open dwells.  In this case there 
are two closed states that have the same observable property (0 conductance) 
but are physically different (one has ligand bound (blue) the other is unbound 
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(yellow)).  This type of process is known as an aggregated Markov process and 
the following discussion will outline the process for determining transition rates 
(kinetics) between states of aggregated Markov processes. 
 
Figure B.1. Activity of a single ion channel.  The observable class is open (red) or closed 
(green).  The time spent in the open dwells is τopen, while time spent in closed dwells is 
τclosed.  Single-channel recording can also be used to determine the transitions of a 
channel between various kinetic states (see text). 
 
B.1.1 Homogeneous and Aggregated Markov Processes 
 In order to generate a set of rate constants, a model that relates the 
various states, which are hypothesized to be kinetically distinct, is proposed.  In 
addition to bound versus unbound states, common examples of physically 
distinct states of the nAChR that are thought to correspond to kinetically distinct 
states include desensitized states, as well as open states in which only 0 or 1 of 
the 2 binding sites are occupied.  These types of open states are termed 
unliganded and monoliganded, respectively.  Desensitized states are ligand 
bound states that are non-conducting and don’t arise from a gating transition(1). 
 The transitions of LGICs between open and closed in the presence of 
agonist are stochastic.  Thus, the class that a channel is in at any given time is 
Unbound, 
closed
Bound, closed
Bound, open
Closed
Open
{Class
State
closed dwells 
within burst
burst burstinterburst  dwell
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independent of all classes that the channel was in previously.  Moreover, the 
class of the channel after a time interval, t, depends only on the present class.  
For most single-channel data, the transition probabilities do not vary over time—
they are stationary, homogeneous Markov processes.  Thus, the interconversion 
of states of the receptor is characterized by being memoryless (Markov 
processes) and time independent (homogenous).  If a record contains only one 
open channel at a time and much of the record is open, then the assumption of 
stationarity can be tested by comparing rate estimates from early bursts to rate 
estimates separately generated for later bursts.  In single-channel experiments 
performed at high agonist concentrations (>> EC50), the nAChR will usually be 
predominantly in the desensitized state.  Typically, these states manifest as long 
non-conducting (closed) dwells and should be removed for Popen analysis and 
should be incorporated as additional non-conducting states in kinetic analysis. 
 
B.1.2 Event Detection (Idealization)  
 In order to determine τopen, τclosed, and Popen, and perform detailed kinetic 
analysis, single-channel data must first be converted to a form that can be readily 
analyzed.  In the case of detailed kinetic analysis, a variety of statistical 
calculations (particularly matrix algebra and log likelihood (LL) determination) are 
required.  Since the gating of nAChRs, once agonist is bound, is proposed to 
take place nearly instantaneously(2, 3), the first step is to convert the data to a 
series of binary events—either open or closed.  Once a section of data has been 
baseline corrected and cleaned-up as described below, the final step is to 
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translate it into a set of binary dwell times (assuming that no subconductances(4) 
are observed).  This process, known as event detection (or idealization), 
prepares data for determination of dwell time and/or modeling by assigning each 
data point to one of the classes.  Each such section of data analyzed may 
represent one or more bursts, or clusters at higher agonist concentrations.   
One method for event detection involves assigning each data point to a 
class simply based on which class’ current amplitude that data point’s current 
value is closest to.  This half-amplitude threshold detection method can be 
applied rapidly, particularly to filtered data (Figure B.2).  Note that a high level of 
filtering will cause loss of information of brief events.  The other event detection 
method that is used is segmental k-means (SKM) (Figure B.2).  SKM is a 
statistical method, which uses a user-defined model to determine the most likely 
sequence of states present in the data.  In each iteration of SKM, the model 
parameters are re-estimated and the most likely sequence of states re-
determined.  This process is iterated until the likelihood is maximized. 
 Once data are in the idealized form, we can ascertain information beyond 
measures of the single-channel current amplitude(s) of events in a patch.  With 
hundreds or thousands (and sometimes tens-of-thousands) of events, detailed 
kinetic information about the states of the ion channel and interconversion 
between them can be obtained.  We now have idealized single-channel data 
from which we can plot a histogram of either the time that the channel spends 
open or closed.  Section B.3 of this appendix details how to produce these 
histograms in Clampfit 9.2.   
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Half-Amplitude Idealization (fc = 20 kHz) 
 
 
Half-Amplitude Idealization (fc = 10 kHz) 
 
 
 SKM Idealization (fc = 20 kHz) 
 
Figure B.2. Comparison of data and the event detected form of data (red lines).  The 3 
traces are each of the same 1.00 s section of data.  Inward currents are displayed as 
downward deflections (cell-attached patch with 2 mM choline on α1Wα49F1-Wβ1L9’SγδL9’S).  
These figures illustrate the relationship between idealized results and the data from which 
they are generated.  In each case, the baseline was defined as the purple line.  Upper) half-
amplitude idealization of data that has been filtered at a cut-off frequency, fc, of 20 kHz.  
Middle) half-amplitude idealization of data with fc = 10 kHz.  Lower) SKM idealization of 
data with fc = 20 kHz.  For half-amplitude idealization, the appropriate level of filtering is 
particularly important as can be seen from the many misestimations, mainly of brief 
openings from a closed state, at fc = 20 kHz.   
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B.1.3 Probability Distribution Functions and Transition Rate Matrices 
 If detailed kinetic models for an ion channel are desired, the next step is to 
determine the components of the Q matrix(5), whose entries are the transition 
rates between different kinetic states.  We start by fitting the dwell time 
histograms with probability density functions (pdfs), whose lifetimes in a given 
class equal a multiexponential with a number of components equal to the number 
of (unobservable) states in that class.  The pdf for channel open (or closed) 
lifetime is an exponential distribution, and the mean of any pdf is given by: 
∫   ( )  
 
  
. 
This mean is the inverse of the sum of all transition rates leading out of the class, 
and can therefore be used to find the lifetime of the channel for any given state.  
Consequently, we can learn about the kinetics of a state provided that a 
probability density is present in the corresponding dwell time histogram.  Thus, if 
there are multiple states in a class, the pdf for that class is a mixture of 
exponential densities for which:  
 ( )       
          
              
    . 
and the probability of a given dwell time (t) in class a is given by: 
  ( )      
    ∑(    )
   
 
Here, πa is a row vector representing the equilibrium probabilities for the process 
to enter the states, and 1 denotes a column vector of ones of appropriate length.  
The joint probability distribution of the dwell time series a1, a2, …, aL is often 
simplified as: 
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where, 
     (  )   
            . 
Thus, for the case of X(t), a stationary Markov process in continuous time, 
the (finite) number of states, designated 1, 2, …, N, and the interstate transitions 
are given by the Q matrix, whose off-diagonal elements (qij) are the transition 
rates between states i and j.  In more familiar terms: 
          [
    (                   |                 )
 
]. 
Considering, then, a 3-state model in which there is one conducting state (open, 
RO) and two nonconducting states (desensitized, RD) and (closed, RC), we have: 
.         (Model B.1) 
For Model B.1, the corresponding transition rate matrix is: 
[
          
        
      
] . 
Here β’ is the apparent channel opening rate and α is the channel closing rate.  
The rate at which the channel enters RD is k+D, while k-D is the rate that the 
channel re-enters the open state from RD.  In each case, the rates are related to 
dwell time histograms.  For example, consider a channel that can be in only one 
of two states: RC or RO.  In this case, every time the channel opens, it leaves the 
closed, non-conducting state.  This represents the length of a dwell in the closed 
dwell time histogram.  Thus, the channel opening rate, β, for this channel is the 
inverse of the average closed dwell times.  The channel closing rate, α, for this 
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channel is the inverse of the average open dwell times.  In Model B.1, β’ is used 
to represent the fact that this rate may be concentration dependent.  If that is the 
case, then it is the higher concentration values, where β’ has an asymptote when 
plotted versus concentration, that represent the actual channel opening rate, β.   
For more complex models with more states, the precise correlation 
between closed and open dwells and rate constants often becomes more 
complicated.  For example, the transition rate matrix for a 5-state model (Model 
B.2) can be written.  Model B.2 allows openings from the monoliganded or 
doubly liganded closed states.  Note that there are still only 2 classes: conducting 
and non-conducting. 
 
    (Model B.2) 
In this model, the opening rate constants are represented by subscripts indicating 
the number of ligands, for example, β1 is the monliganded channel opening rate.  
The resultant Q matrix is: 
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. 
 
 In order to determine what each transition probability (rate) is, we employ 
maximum likelihood estimation.  In this technique, the goal is to determine the 
most likely value for the unknown parameter(s), , given the observation of the 
data, x.  The likelihood function is: 
 ()   (         |). 
Most frequently, the logarithm is taken, and so the log-likelihood (LL) is the 
relevant function.  In order to determine the values of the transition rates 
(unknown parameters) that best fit the observed data, the partial derivative of the 
LL is computed with respect to each parameter of interest.  Thus, having 
characterized the likelihood surface, a search of that surface for the global 
maximum in all parameters is undertaken, giving the maximum likelihood 
estimation (MLE). 
 This procedure can be thought of as the inverse procedure of linear 
regression.  Instead of using the data to generate a model, we are setting the 
model and determining the extent to which the data support that model—the LL.  
For the exact same set of data, the LLs for different models can be compared—
higher LLs indicate a higher chance of generating the data actually found in the 
experiment from the postulated model.  Of course, arbitrarily adding states to the 
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model will increase the global maximum on the likelihood surface, since the 
number of free parameters has been increased.  Thus, if the number of states in 
a class cannot be determined with some confidence from that class’ dwell time 
histogram, LLs are compared as states are added, until a plateau in LL is found 
(for example, see Table 4.1)(6, 7).  For large data sets (> ~ 10,000 events, and 
LL/event ~ 5 or more), a criterion of LL > 10 is often imposed. 
  
B.1.4 Faster is Better—An Analytical Derivative of the Likelihood 
Function 
 In a key finding, Qin et al.(7) derived an analytical derivative of the 
likelihood function, thereby greatly decreasing the computational time necessary 
to maximize the likelihood function.  This reduced computational time was also 
valuable since it facilitates increased comparison of the LL of various models, as 
well as increased fine tuning of dead time (τd).  Moreover, their technique allows 
for rate constant constraints to be used, and for global fitting across multiple sets 
of experimental conditions (concentration, voltage, temperature, etc.)(8, 9).     
 
B.1.5 Likelihood Surfaces 
 The more well-defined the likelihood surface and clearer the global 
maxima, the more likely the calculation will converge to the correct value.  We 
will now consider several factors that affect the quality of likelihood surfaces.  
Each derives from experimental parameters, and so can be controlled by 
appropriate forethought in experimental planning. 
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Figure B.3 shows two dimensions (of several) for 3 likelihood surfaces(7).  
These represent variations in the ratio of the rate constant to the sampling rate at 
which the data were collected.  Higher sampling rates (fs), which correspond to 
lower kt, give a better-defined likelihood surface, which increases chances of a 
successful convergence and generally reduces computational time. 
 
Figure B.3. The impact of sampling rate on the likelihood surface.  Higher sampling rate 
(lower k∆t) sharpens the likelihood surface significantly over this fourfold range.     
  
Figures B.4A and B demonstrate the impact of significant amounts of 
noise (standard deviations, , of 0.5, 1, and 2 times the current measured)(7).  
Not surprisingly, the likelihood surface for  = 2 times the channel current (i.e., 
the signal-to-noise ratio (SNR) = 0.5) is almost entirely flat—this calculation 
would not converge since the noise is larger than the signal.   
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Figure B.4. Impact of signal-to-noise ratio (SNR) on the likelihood surface.  Note that at 
these levels of SNR, if fast rate constants are being considered (> 1000 s
-1
), then the data 
must be analyzed directly, without filtering.  In the rig used for collection of most data for 
this thesis, typical RMS noise was 0.3–0.5 pA.  Since most signals were 2–6  pA, this gave 
SNR of ~5–10 and thereby allowed for significantly faster rates to be considered, even with 
filtering.  Interestingly, it was determined that the likelihood surface at the maximum can 
be made equivalent by collection of extra data.  In this case, 60 times as much data is 
required for  = 2.0 versus  = 0.5(7).    
 
 It is also worth noting that, while adding more parameters increases the 
global maximum, it also flattens the maximum of the likelihood surface; thus if 
there are more parameters than actual states, the model will often not converge. 
This optimization method (with analytical derivative calculation of the likelihood 
slopes and missed event correction) was then incorporated into kinetic modeling 
software (along with standard MLE and SKM event detection) called QuB(7, 10-
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12).  Our methods for application of this software are similar to those published, 
and are outlined in the Preparing for Data Analysis section below.   
     
B.2 Experimental Considerations in Single-Channel Recording 
B.2.1 Signal Conditioning 
 In its most basic form, single-channel data recording just involves 
measurements of current over time.  In order to obtain the best possible temporal 
resolution, a high sampling rate (fs)—the number of data points taken per second 
(Hz)—is desirable.  Specifically, according to the Shannon-Nyquist sampling 
theorem, the signal must be sampled at at least twice the rate of the fastest 
component of interest in the signal, otherwise distortion may occur (Figure B.5).   
 
Figure B.5. Sampling rates slower than 2 times the fastest component do not accurately 
represent the signal.  Usually > 2.5x the fastest rate is a safe cut off.  More data (higher fs) 
can be collected if the quantity is reasonable given available disk storage.  This figure is 
from Chapter 3, Figure 2 of(13). 
 
 In the particular case of wild type muscle nAChR, the fastest rate constant 
(channel opening) is near the detection limit, so often it is desirable to use as 
high of a sampling rate as possible.  Taking data at a high rate (i.e., > ~ 50,000 
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samples per second), though, results in significant noise.  Even if the seal 
resistance is high, noise arising in the patch (shot noise, dielectric noise), the 
electrode (RC-noise, dielectric noise of electrode glass, flicker noise), and the 
pipette holder (dielectric noise, flicker noise) impact the baseline recording and 
greatly reduce the SNR.  In order to eliminate these components, while 
preserving the integrity of the original signal, the data is low-pass filtered—the 
amplitude of signals with frequencies above a set cut-off frequency (fc) are 
attenuated (Figure B.6).  
 
Figure B.6. The attenuation of a filtered signal is proportional to its frequency.  This figure 
is from The Axon Guide, 2
nd
 Edition. 
 
Thus, low-pass filtering is the process by which the amplitude of events of 
duration less than 1/(fc) are reduced proportional to the extent to which the event 
has duration shorter than fc.  High frequency events (e.g., fast, brief events) are 
eliminated while low frequency events are passed essentially unchanged (Figure 
B.7).  This task of filtering can be accomplished electronically (through the use of 
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networks of capacitors and resistors) or by a mathematical algorithm that 
accomplishes an analogous transformation. The important consequence is that 
increasing filtering of the signal increases the SNR, but does so at the expense 
of losing information about fast events (Figure B.7). 
 
Figure B.7. An illustration of the impact of filtering.  The same signal is filtered at 4 
different cut-off frequencies (fc): 500 Hz, 300 Hz, 100 Hz, and 50 Hz.  In this case, the open 
channel is displayed as an upward deflection and the dotted lines in each of the four 
traces represent the half-amplitude cut off.  The long opening doesn’t appear to have any 
brief closings when filtered at 50 Hz, yet it has several when only filtered at 500 Hz.  The 
data will yield different dwell times and different rate constants depending on how it is 
filtered.  This figure is from Chapter 3, Figure 5 of (13). 
 
 Another consideration is the type of filter used.  For single-channel 
analysis of the nAChR, in which moderate-to-high time resolution (> 1000 Hz) is 
desired, consensus has developed around using Bessel filters. Bessel filters, 
unlike Butterworth and Tschebycheff filters, introduce far less ringing (< 1% 
overshoot of initial signal amplitude; Figure B.8). For an 8-pole Bessel filter, the 
filter rise time (tr), which is the time that it takes for the filter to go from 10% to 
90% of the response, is given by: 
   
      
  
  . 
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Figure B.8. Comparison of Bessel, Butterworth, and Tschebycheff filters.  Only the Bessel 
filter does not introduce significant overshoot.  This figure is from Chapter 3, Figure 3 of 
(13). 
 
This gives a measure of the time resolution of events that can be achieved when 
using a given level of low-pass filtering, because the amplitude of events shorter 
than tr will be significantly diminished.  For example, at fc = 5,000 Hz, tr = 
0.3321/(5,000 s-1) = 66.5 µs.  Thus, events shorter than 66.5 µs will experience a 
significant reduction of amplitude when low-pass filtered with fc = 5,000 Hz, and 
therefore be distorted or less likely to be detected during data analysis. 
The second limitation on resolution is imposed by noise, which may reach 
the detection threshold (in the case of half-amplitude) or simply be 
miscategorized as being an event (in the case of SKM idealization).  It has been 
found that the three most significant factors that enable attainment of very low 
noise, stable recordings (provided that the patch clamp amplifier noise has been 
minimized) are: the ratio of outer to inner diameter (OD:ID) of electrode glass, 
very small electrode pore diameter, and minimization of the depth of immersion 
of electrode in the bath(14).  We consistently use thick walled glass in order to 
have a fairly large OD:ID.  Moreover, the last of these (depth of electrode in 
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recording bath) can be controlled, since positioning of the electrode is done 
under a dissecting microscope.  Unfortunately, the size of the electrode pore 
cannot be made too small as this will make the probability of finding one or more 
channels in a patch too low.   
One of the most frequently observed types of noise is 60 Hz noise, which 
can arise from a number of everyday electrical components, including lights.  In 
order to eliminate this noise, data may be notch filtered or have electrical 
interference removed subsequent to acquisition.  Alternatively, a device is used 
that monitors the noise at this frequency and generates an equal but opposite 
signal, which is subsequently added to the original signal resulting in destructive 
interference of the noise.  This device is called a HumBug (see Chapter 2), and it 
works fairly well, but can introduce noise of its own. 
 
B.2.2 Preparing for Data Analysis of Single-Channel Records—
Baseline Correction and Data Clean-Up 
 The data produced from a single-channel recording may be of several 
types.  I’ll highlight three types.  (1) Often a record, even with a gigaseal, will 
show no channel activity.  (2) In other cases, current variations may be seen that 
are not of the correct conductance or which exhibit dependence on some other 
property (such as mechanosensitive channels or voltage-gated channels) 
(Figure B.9).  In any region of data for which such channel activity is present, the 
data are usually discarded—frequently this involves discarding the whole record.  
(3) On the other hand, for the nAChR, if clear current transitions are visible 
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(binary, assuming that there are only 2 classes), then these current variations 
can be correlated to channel events—actual openings and closings (Figure 
B.10).    
 
 
Figure B.9. Left) 1.00 seconds of messy data.   There are no clear conductance levels, 
rather the current fluctuations likely correspond to an endogenous channel 
(mechanosensitive or voltage-gated) or low seal resistance.  Right) The corresponding all 
points histogram for the data at left.  There are clearly not two classes.   
 
 
Figure B.10. Left) single-channel data for a cell-attached configuration of an nAChR 
((α1W149F1W)2β1L9’SγδL9’S) with 2.0 mM Ch in the pipette.  Openings are shown as 
downward deflections and qualitatively exhibit two different levels (classes).  Right: a ll 
points histogram corresponding to the 2 seconds of data shown at left.  There are clearly 
two distinct components in the histogram—0 pA for the closed state and ~4.6 pA for the 
open state.  Since this recording was at a pipette potential of +70 mV, the single-channel 
conductance is ~ 66 pS. 
 
The first step in preparing a single-channel recording for data analysis is 
to correct for any gross irregularities in the record.  These may result from 
sudden changes in the seal resistance, or gradual deterioration of the seal, which 
can cause a sloping baseline.  A sloping baseline may be corrected by manual 
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re-estimation (by eye).  If a record has been chosen that exhibits any background 
channels (mechanosensitive, voltage-gated, etc.), then those regions must be 
completely excluded.  Lastly, channel events that are decidedly abnormal—i.e. 
events that do not reach full amplitude or that do not reach full amplitude within ~ 
100 μs—are excluded. 
 In the data clean-up procedure (Figure B.11)(15), the goal is to ensure 
that each current fluctuation that deviates from baseline actually corresponds to 
current flowing through the ion channel(s) of interest in the patch.  Although 
Figure B.11 clearly shows that type (a) events are qualitatively different than the 
main channel events in this record, a more quantitative approach may be in 
order.  In this case, data clean-up may amount to going through some sections of 
the data point-by-point in order to make quantitative determinations about event 
amplitude and duration before a decision about inclusion is made.  We take the 
additional precaution, where possible, of analyzing the excluded data, especially 
of type (a), in order to ensure that the current deflections are below the time 
resolution of the experiment, do not reach full amplitude, or are a different type of 
current peak.  Often, we include type (a) data in the final analysis, where they 
produce an additional component of the open dwell time histogram.  Type (b) 
events: the case that a channel of significantly different amplitude (single-channel 
conductance) is seen, it is removed.  Type (c) events: these types of current 
readings may also occur when a channel is near or under the electrode rim.  For 
a variety of reasons—mechanical instability, physical disruption by particles in 
the bath media, disruption of membrane integrity, etc., the seal resistance may 
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be quickly altered.  The case of cleanup for events of type (a) can be more 
difficult, as these events sometimes reach half-amplitude or more.  These types 
of events have been attributed to ‘kinetic heterogeneity’ of the receptor(15).   
 
Figure B.11. Single-channel data clean-up procedure.  Channel openings are shown as 
downward deflections.  Left) The original data that was collected.  Right) Final cleaned-up 
data that is actually analyzed; see text for description.  Figure and description are 
from(15), with differences in procedure noted in text. 
 
Once the data have been cleaned up as described, a histogram of all of 
the data points (current values—all points histogram, as in Figure B.10) can tell 
us about the number of channels in the patch (at least a lower estimate, as some 
channels may be desensitized).  This histogram can also give an estimate of the 
percentage of time that the channels are open, and the percentage of time that 
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multiple channels are open at overlapping times.  Additionally, if only one 
channel is active, the current amplitude can be calculated as the difference 
between peak of the open distribution and the peak of the closed (or baseline) 
condition.  Even a short recording may give unambiguous data.  Note that 
oftentimes the open state exhibits more current noise than the closed state.  An 
example of this is the larger width of the component at 4.6 pA in the all points 
histogram in Figure B.10, Right than the width of the closed component at 0 pA.  
For ion channels in general, this is at least partially due to so-called ‘transport’ or 
‘shot’ noise, which arises from the statistical nature of ions being translocated 
over a potential barrier.  In the case of the nAChR in particular, a larger variation 
in amplitude of the open state is sometimes attributed to thermal fluctuations of 
channel structure, which cause concomitant fluctuations in channel conductance 
(termed ‘channel breathing’)(16).  At high concentrations, it may be caused by 
agonist associating with the channel pore, which is termed ‘open channel block’. 
 
B.3 A Brief Guide to Single-Channel Data Analysis in Clampfit 
9.2 
The procedures for pre-processing data in Clampfit 9.2 (version 9.2.0.11), 
performing a single-channel search (event detection), and producing and fitting 
all points, open, and closed dwell time histograms are briefly outlined here.  For 
applications and examples, see the relevant analyses in each chapter.   For more 
detailed examples of data analysis, see my lab notes (Word files with associated 
Excel summary files (Popen and τcrit, and physical data sheets).   
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1. Open the file to be analyzed (as an ‘Analysis’ window in Clampfit): 
‘File/Open Data…’.  
a. If needed, select sections with channel activity (clusters and/or 
bursts depending on the analysis) and save as a new file 
(‘File/Save As…’).  When saving a new file, be sure to specify 
under ‘Current Options’ the data range to be used.  The 
parameters can be changed by clicking the ‘Options’ button.  It is 
usually easiest to select ‘Duration of window’ and set the window 
to the desired data before saving the data segment.  I also check 
‘Start first data point at time 0’ and note the actual time range in 
the file name. 
b. If selection of a data subset is performed at this stage, this process 
is merely ‘by eye’ selection and could alter resultant calculated 
values of desensitization (clusters) and agonist binding (bursts).  
However, most of the following analysis is intended for data which 
is ~ 500–10,000 events (i.e., ~ 100 ms to 100 s of nAChR activity), 
so some sectioning of data is often recommended.  I don’t 
recommend trying to work with data sets of > 10,000 events in 
Clampfit 9.2, which may crash or freeze during event detection. 
2. Pre-process the data. 
a. Filter the data with ‘Analyze/Filter...’. 
i. The level of filtering will depend on the initial bandwidth in 
which the data were recorded and the anticipated fastest 
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rate constants of interest, as well as the seal 
resistance/RMS noise of the particular section of data to be 
analyzed.  Generally: 
ii. Select ‘Lowpass’ at the top of the box. 
iii. In the lowpass section, under ‘Type’, select Gaussian filter.   
iv. Set the ‘-3 dB cutoff (Hz)’.  For first filtering of data, usually 
use between 2,000 and 10,000 Hz. 
v. At the bottom of the box, under ‘Trace Selection’, select the 
‘Region to filter’.  Almost always, this is the ‘Full trace’. 
vi.  Click OK.  The filtering may take a while; for large (> ~ 10 
MB) files and for files of up to several minutes of data (with a 
sampling frequency, fs, of 50 kHz), filtering may take a few 
minutes. 
vii. ‘File/Save As…’ a new file.  (Since filtering can’t be undone 
in Clampfit). 
b. ‘Analyze/Adjust/Baseline…’. 
i. This process is only needed if there is significant variation or 
slope in the baseline (non-conducting class).  Baseline 
adjustment is especially important if there are sudden shifts 
in the baseline, which can make subsequent analysis 
difficult. 
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ii. For baseline drift in a file, use ‘Subtract slope of:’ and 
specify region.  This is very rare in single-channel recording, 
but the same correction can be applied for whole-cell data. 
iii. For sudden baseline shifts, use the ‘Adjust manually’ 
option. 
1. Left-click on the line to create new (yellow) square 
handles and position them with the left mouse button 
(right-click to delete).  The pink line in-between the 
yellow squares specifies where the new baseline will 
be. 
NOTE that steps a and b can be done in either order.  If extreme low-pass 
filtering is being used, it might be best to set the baseline first (but not if it is too 
difficult to determine the baseline from the original signal).  Also, for early 
analysis and/or analysis that may be performed at multiple different levels of low-
pass filtering, I recommend adjusting the baseline first.  Similarly, this may be 
preferable for analysis that will be performed at multiple different dead times (τd).   
3. Determining current levels and single-channel conductance.  
a. Create all points amplitude histogram:  
i. Choose ‘Analyze/Histogram…’. 
ii. Under Distribution, select ‘Conventional’. 
iii. Under Bins, enter the desired width.  For conventional 
histograms, the unit is pA.  Usually 0.1 or 0.2 pA is a good 
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bin width, but considering using larger values for smaller 
data sets (< ~ 100,000 data points). 
iv. In the Data box, select the desired ‘Region to process:’ 
(usually Full trace) and in the Data Range box, check Full. 
v. Select OK and the histogram will appear in a new ‘Graph’ 
window.  For large data sets (> 50,000,000 data points), this 
could take a minute or two. 
vi. If there is only ever one channel open, and the baseline is 
good, then this resulting ‘all points histogram’ should have 
two clearly defined components, one corresponding to 
closed, the other to the open channel current.  
vii. Fit the all points histogram using: ‘Analyze/Fit…’.  I usually 
fit with the Predefined Function: ‘Gaussian’ and set the 
‘Number of terms(n)’ to 2.  In the Data/Options tab, make 
sure that ‘Compare Models’ is not checked.  In the ‘Seed 
Values’ tab, check the values to see if they make sense 
based on the histogram and your guess about the open 
channel current from the data.  If not, change them. 
viii. If Popen/NPopen is << 0.05, then it can be difficult to get 
Clampfit to fit the smaller area component.  If you’re having 
lots of trouble fitting this histogram even after altering some 
of the ‘Seed Values’, consider fixing some of these values.  
If that doesn’t work, consider just zooming in on the y axis 
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and determining the peak of the component by eye.  This will 
produce a reliable estimate if there are lots of data points 
(e.g., for a long record with low NPopen). 
NOTE: Clampfit fits what it can ‘see’ on the screen. 
b. Determine the conductance (technically chord conductance, g).  
i. Take the fitted (or by eye) open channel current value and 
apply Ohm’s law (V = I*R) to calculate the single-channel 
conductance.  For example, if the observed open channel 
current is 4.1 pA and the applied pipette potential was 60 
mV, then the patch potential was ~ 60 mV (see Chapter 2 for 
supporting data).  In this case, the single-channel 
conductance is: 
      
 
 
 
      
       
      . 
1. If there are multiple conductances/subconductances, 
their values can be calculated in the above way as 
well, as long as they are present in the all points 
histogram.  If not, then use the open dwell time 
current values for these below to calculate the 
corresponding subconductance values. 
c. Format the title and axes as desired in the ‘Graph Window 
Properties’ box, by double-clicking on the graph.  This applies for 
all histograms, including the open and closed dwell time 
histograms, below. 
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i. In the ‘General’ tab, set the graph name. 
ii. For direct comparisons of a series of mutants or agonists, it 
is desirable to use the same axes/scales.  This applies to the 
open and closed dwell time histograms, below, too.  These 
can be set in the ‘X Axis’ and ‘Y Axis’ tabs. 
iii. In the ‘Plots’ tab, increase the line thickness of the plots and 
fitted data to 3 or 4.   
iv. In the ‘Color/Fonts’ tab, use large fonts (> 18 point for 
axes/labels, > 26 point for title) if exporting for display in 
PowerPoint so that they can be read.   
 
Note that the following section on event detection can often require multiple 
iterations at different parameters, such as levels of filtering of the original data file 
(varying fc), the level set for the open current, varying dead time (changing the 
‘ignore short level changes’ duration), etc.  These iterations should be 
performed for a single file for each mutant/agonist/concentration to be analyzed 
until satisfactory results are obtained, then applied to other files at the same 
conditions.  The results will be satisfactory and worth pursuing once they are 
stable to small variations in analysis parameters, produce a number of events 
that is statistically meaningful and not too large for efficient analysis, and 
generally allow for efficient use of the time of the person doing the analysis.  
Putting in extra time at this stage can save a lot of time in analysis in later steps. 
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It is worth considering comparing a given event detection of a file to event 
detection (both half-amplitude and SKM) performed in QuB from time to time.  
Both the level of misdetections and resulting fitted open and closed dwell time 
histograms should be compared.  In some cases, I found that analysis to be 
faster in QuB.  The downsides are that in QuB it is not as easy to have direct 
control of the data, such as for pooled histograms, user determination of τcrit, and 
presentation of data.  In general it is more automated.  I won’t provide a complete 
guide on analysis in QuB here, but sections B.1 and B.2 of this appendix (above) 
contain significant information on the theory behind the analysis used, including 
in QuB.  Section B.2.2 contains a description of preparing data for analysis in 
QuB.  In Chapter 4 I show some results of applied analysis using QuB.  Other 
analyses can be found in my lab notes.  They are often titled ‘Word Reports’ from 
QuB.  More information (and free download of all software) are available at: 
http://www.qub.buffalo.edu/wiki/index.php/Main_Page.  A detailed description of 
the features and use is available in the online QuB manual at: 
http://www.qub.buffalo.edu/wiki/index.php/Outline.  There is a printed copy of an 
old version of the QuB manual in lab. 
4. Use half-amplitude criterion for event detection.   
a. ‘Event Detection/Single-channel Search…’. 
b. Set the values.  In ‘Levels’, level 0 (pA) should be the baseline 
value.  For good or adjusted baselines, this should be close to 0.0 
pA.  One additional level (level 1) is automatically added.  Set this 
value to the open channel current.  Ideally these values come from 
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the all points histogram produced above in step 3.  The green line 
on the y-axis will adjust accordingly when these values are 
adjusted.  If an all points histogram has not been produced, zoom 
into a few open dwells and physically place the green line in the 
middle of the noise for the closed and open states.  For analysis of 
multiple conductances, click ‘Make’ to add additional levels and set 
their current values as above. 
c. Decide if you want to have a dynamic analysis. 
i. Check ‘Update levels automatically’ if the baseline is not 
stable.  If the open current is stable, select ‘Update 
baseline, keep deltas’, otherwise, select ‘Update all levels 
independently’ if the open current and baseline vary over 
time.   
ii. Note that if there is a variation in the open channel current or 
duration, it probably indicates either kinetic heterogeneity of 
the receptors or some other change.  This must be 
considered separately later as part of the analysis by viewing 
the stationarity of both the open/closed dwell times and the 
open/closed dwell currents.  However, an automatic, 
dynamic analysis can provide a useful tool for a first rapid 
analysis of a file, especially when combined with the ‘Accept 
Entire Category’ feature (see below).   
d. Set the dead time (τd).  All events shorter than τd are ignored.   
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i. Initial τd selection will depend on a number of factors, 
including level of filtering (see above). 
ii. In Clampfit, dead time is set in the ‘Ignore short level 
changes’ box.  You can set a duration and decide to apply 
this dead time to all levels, or some subset.  Typically 
starting parameters are τd = 100 μs; with a range of 40 μs– 
300 μs being common. 
e. Set the ‘Search Region’.  This is usually the ‘Full trace’, especially 
for sectioned data. 
f. Start the single-channel search by clicking ‘OK’.  The event viewer 
is displayed automatically, along with the first event.   
g. You can now manually accept (a), reject (r), suppressed (s), or 
accept and tag (t) each event.  Keyboard shortcuts are in 
parenthesis.  If you change your mind on a given event, its 
selection can be undone (u).  If a specific criterion for accepting 
events, such as 80% of the conductance, is being applied, this can 
be done by accepting the event and using the event monitor 
(‘Event Detection/Event Monitor…’) to compare each event’s 
duration and amplitude with the average of all previously accepted 
events for the file. 
h. For a rapid, first pass analysis, you can use: ‘Event 
Detection/Accept Entire Category’.  Do this for each level.  Once 
selected for the final level, Clampfit will automatically detect and 
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accept events based on the values set in the initial single-channel 
search.  A quick comparison of the number and types of mis-
estimations can be a good gauge of what parameters in the single-
channel search should be changed and in what direction. 
i. Once the search is completed, all of the corresponding data will be 
in the Results sheet.  I recommend going to: ‘Event 
Detection/Event Statistics…’ and copying the data corresponding 
to each level to the clipboard, then pasting in lab notes.  This gives 
a quick overview of the number of events detected and their 
average amplitude and dwell time. 
j. The data at this stage will have blue lines (for closed dwells) and 
red lines (for open dwells).  I often print a copy of these data 
(‘File/Print…’), then quit the event detection and print a copy of the 
pure data to pdfs.  In each case, the exact parameters of what is 
printed are controlled under ‘File/Page Setup…’.   Under ‘Printed 
Windows’, the ‘Number per page’ is the number of lines of data.  I 
usually do 4–10 per page.  The ‘Width’ is the number of data 
points.  The ‘X units’ unit is ms.  Under items to print, I uncheck 
everything except ‘Scale bars’. 
5. Plot logarithmic histograms of open and closed dwell times 
a. Go to the Results window.  It is a good idea to save a copy of this 
now with a new file name. 
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b. Click on the ‘Dwell Time’ column and go to ‘Analyze/Extract Data 
Subset…’.  Usually I want open and closed dwells separately with 
no other specifications.  To do this, click: ‘Condition 1’ and under 
the ‘Column’ drop down menu, select ‘C: Level’, then under 
Inclusive range, select ‘From 1 To 1’ for open dwells.  On the right, 
select a Destination sheet and click ‘Apply’.  Then, do the same for 
closed dwells by selecting ‘From 0 To 0’ and selecting a separate 
destination sheet. 
c. To produce the histogram, go to ‘Analyze/Histogram…’. 
d. Under Distribution, select ‘Logarithmic’. 
e. Under Bins, enter the desired width.  For dwell time histograms, 
the unit is bins/decade.  Usually 6–8 is a good bin width, but 
consider using larger values for larger data sets (several thousand 
events). 
f. In the Data box, select the desired ‘Row Range’ (usually Full 
Column) and in the Data Range box, check Full. 
g. Select OK and the histogram will appear in a new ‘Graph’ window.   
6. Format and fit the dwell time histograms.  The process is the same for 
open and closed dwell time histograms. 
a. Format the histogram by taking the square root of the y axis and 
rescaling. 
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b. Scale the x-axis to contain all of the dwell times that you wish to 
include in your fit.  Generally don’t include dwell times below your 
dead time. 
c. Set to ‘Analyze/Fit…’.  I usually fit the dwell time histograms with 
the Predefined Function: ‘Exponential, log probability’.  Set the 
number of components (parameters) under ‘Number of terms (n)’.  
If you don’t know how many components there are, then you can 
go to the ‘Data/Options’ tab and select ‘Compare Models’, then 
set the ‘Confidence Level’ (usually 0.95). 
d. Now click ‘OK’ and a line will be fit to the histogram.   
e. As with the all points histogram, parameters in the ‘Data/Options’ 
tab and ‘Seed Values’ tab can be altered to optimize the fit.  I 
recommend that after each fit performed, you go to 
‘Analyze/Fitting Results…’ and copy the results to the clipboard 
and paste into lab notes.   
 
Many other types of analyses are possible in Clampfit; see the Help menu for 
further guidance.  Another useful resource is the Axon CNS Guide: 
mdc.custhelp.com/euf/assets/images/Axon_Guide.pdf. 
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Appendix C 
 
Other Possible Names for ELFCAR 
 
CRARDMCA 
Coupling of Residues in an Allosteric Receptor Determined by Mutant Cycle 
Analysis 
 
CRAPMCA 
Coupling of Residues in an Allosteric Protein Determined by Mutant Cycle 
Analysis 
 
CONARAR 
Coupling Of Non-Adjacent Residues in Allosteric Receptors 
 
FCARDMCA 
Functional Coupling in Allosteric Receptors Determined by Mutant Cycle Analysis 
 
SIDRFC 
Screen for the Identification of Distant Residues that are Functionally Coupled 
 
SLIAR 
Screen for the identification of Long-range Interactions in Allosteric Receptors 
 
SLIMCA 
Screen for Long-range Interactions by Mutant Cycle Analysis 
 
SLIMCAAR 
Screen for Long-range Interactions by Mutant Cycle Analysis in an Allosteric 
Receptor 
 
SDCDRAR 
Screen for Determination of Coupling of Distant Residues in an Allosteric 
Receptor by Mutant Cycle Analysis 
 
LIARMCA 
Long-range Interactions in an Allosteric Receptor determined by Mutant Cycle 
Analysis 
 
LARDMCA 
Long-range interactions in an Allosteric Receptor Determined by Mutant Cycle 
Analysis 
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LARDRMS 
Long-range interactions in an Allosteric Receptor Determined by Reporter 
Mutation Screen 
 
 
Miscellaneous targeted choices: 
DRACULA 
Distant Residues of Allosteric receptors CoUpling identified by mutant cycLe 
Analysis 
 
SICNARALR 
Screen for the Identification of Coupled, Non-Adjacent Residues of an ALosteric 
Receptor 
 
CALTECHNAR 
mutant Cycle Analysis of Long-range Transmission of Events of a CHemical 
Nature in Allosteric Receptors 
 
SOCAL 
Screen Of Coupled residues in an ALosteric receptor 
 
DRCARFARM 
Determination of Remote Coupling of residues in an Allosteric Receptor 
FAcilitated by Reporter Mutation 
 
 
The following are a bit longer and less elegant: 
RMIFLCAR 
Reporter Mutation for the Identification of Functional Long-range Coupling in an 
Allosteric Receptor 
 
RMSFCNARAR 
Reporter Mutations as a Screen for Functionally Coupled, Non-Adjacent 
Residues in Allosteric Receptors 
 
MCASLCAR 
Mutant Cycle Analysis Screen for determination of Long-range Coupling in an 
Allosteric Receptor 
 
MCASCDRAR 
Mutant Cycle Analysis Screen for the determination of Coupling of Distant 
Residues in an Allosteric Receptor 
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MCADCRAR 
Mutant Cycle Analysis for the determination of Coupling of Residues in an 
Allosteric Receptor  
 
MCATILFCAR 
Mutant Cycle Analyis for The Identification of Long-rage Functional Coupling in 
an Allosteric Receptor. 
 
MCALCAR 
Mutant Cycle Analysis of Long-range Coupling in an Allosteric Receptor 
 
MCARLIRAR 
Mutant Cycle Analysis Reveals Long-range Interactions of Residues in an 
Allosteric Receptor 
 
MCAIDCR 
Mutant Cycle Analysis for the Identification of Distant Coupled Residues 
